data_2lo3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lo3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 16.7 mm100 . . . . . 0 C--O 1.245 0.855 0 N-CA-C 111.346 0.128 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 12.2 m-85 -134.95 150.2 50.34 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 123.705 0.628 . . . . 0.0 110.039 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -151.54 147.68 27.1 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.01 140.12 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.376 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HB2' HD13 ' A' ' 27' ' ' LEU . 43.4 t -68.2 124.95 24.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -30.83 14.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.7 m -94.8 -30.52 14.18 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.917 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.44 3.13 81.82 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.496 0.559 . . . . 0.0 114.496 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 11.8 mptt -93.58 141.45 23.87 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 122.205 -0.585 . . . . 0.0 110.934 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.82 117.1 4.97 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.816 2.344 . . . . 0.0 110.96 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.418 HD13 ' HB2' ' A' ' 20' ' ' CYS . 17.3 mt -105.59 125.77 51.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.215 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.08 152.76 23.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.484 ' O ' HG22 ' A' ' 32' ' ' ILE . 5.5 mp -56.56 -24.31 46.21 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -75.82 -28.18 58.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.782 -0.574 . . . . 0.0 110.678 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.6 -2.95 19.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 29' ' ' LEU . 7.1 tp -59.12 -42.22 85.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-O 120.423 0.154 . . . . 0.0 110.908 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.82 -51.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.22 -36.34 71.82 Favored 'General case' 0 C--O 1.26 1.608 0 CA-C-O 120.944 0.402 . . . . 0.0 111.1 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -64.17 -51.62 62.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.795 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 tt -58.58 -38.07 77.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.698 0.285 . . . . 0.0 110.339 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -68.64 -39.01 80.91 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -101.39 -6.54 23.91 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.059 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.417 -2.082 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.659 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 . . . . . 0 N--CA 1.439 -1.007 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 48.7 m-85 -111.77 121.39 44.96 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -129.9 150.78 51.04 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -86.78 132.4 32.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.471 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.08 139.48 58.72 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.726 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -53.16 -49.5 66.5 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.16 0.984 . . . . 0.0 112.057 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -88.1 -51.78 5.6 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.439 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 m -79.28 -18.24 53.09 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.471 -172.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.08 66.43 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-O 121.347 0.415 . . . . 0.0 112.445 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -96.76 141.36 22.97 Favored Pre-proline 0 N--CA 1.429 -1.52 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.56 119.28 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.185 2.59 . . . . 0.0 110.39 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 3.1 mm? -115.76 130.66 56.93 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.939 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.18 133.8 34.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -48.98 -30.69 6.32 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -67.96 -22.0 65.05 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 122.158 -0.339 . . . . 0.0 111.578 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.35 -0.8 10.88 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.262 0.554 . . . . 0.0 111.017 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.425 HD11 ' HG ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -66.87 -33.27 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.057 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 46.4 t -63.06 -58.14 8.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.757 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -63.26 -32.84 74.36 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.284 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 39.3 t60 -56.26 -55.06 37.99 Favored 'General case' 0 C--O 1.199 -1.557 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.425 ' HG ' HD11 ' A' ' 32' ' ' ILE . 91.8 mt -56.89 -37.12 70.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.633 0.254 . . . . 0.0 111.247 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 55.1 mt-10 -69.99 -32.56 70.82 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -117.6 5.26 12.38 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.565 -0.709 . . . . 0.0 111.478 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.573 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.969 -176.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -115.34 138.09 51.34 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.049 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -115.81 132.65 56.58 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.14 120.62 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.886 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.38 118.98 10.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -51.67 -50.02 61.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.413 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 5.4 ptpp? -74.0 -33.08 63.68 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.205 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.3 m -89.12 -29.67 19.2 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.848 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.08 28.28 71.86 Favored Glycine 0 N--CA 1.463 0.494 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.18 129.18 24.42 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.844 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -85.01 115.17 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.577 2.185 . . . . 0.0 111.047 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -121.73 153.87 37.66 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.066 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.94 37.15 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.11 -15.68 35.84 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -72.73 -23.6 60.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.093 0.473 . . . . 0.0 111.196 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.06 6.88 9.75 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.565 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.428 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -52.7 -47.4 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 122.728 0.411 . . . . 0.0 111.682 -176.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 12.6 p -67.15 -38.69 81.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.306 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.92 -52.48 65.22 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.586 0.708 . . . . 0.0 110.308 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.517 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 25.8 t60 -61.03 -46.71 89.64 Favored 'General case' 0 C--O 1.201 -1.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.022 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tt -57.78 -39.47 77.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 24.7 mm-40 -76.82 -27.83 55.32 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.64 5.02 12.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.276 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.517 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.225 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -133.75 145.9 50.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.207 1.003 . . . . 0.0 109.931 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -141.95 137.06 30.99 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.74 123.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.268 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 t -61.21 140.37 57.94 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.61 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.86 -49.63 76.71 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.718 0.636 . . . . 0.0 110.541 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -78.82 -31.99 46.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.8 m -104.58 -36.62 7.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -171.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.57 -8.18 80.21 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.105 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -73.94 133.29 79.09 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 117.208 0.504 . . . . 0.0 111.654 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.23 113.97 3.01 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.932 1.755 . . . . 0.0 110.071 171.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 154.12 30.9 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -74.87 146.01 42.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 123.402 0.439 . . . . 0.0 109.863 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.403 ' O ' HG21 ' A' ' 32' ' ' ILE . 4.3 mm? -65.04 -10.71 32.07 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.407 0.622 . . . . 0.0 111.842 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.24 -14.65 59.72 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.558 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.29 7.12 9.06 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.961 -0.462 . . . . 0.0 111.608 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.403 HG21 ' O ' ' A' ' 29' ' ' LEU . 8.0 tp -57.47 -48.56 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.96 -44.19 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.215 0.461 . . . . 0.0 111.186 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.38 -55.91 28.78 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.997 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 32.2 t60 -59.38 -50.22 74.79 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.829 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.22 -29.69 69.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.6 0.238 . . . . 0.0 111.49 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.39 -25.51 22.65 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.18 -10.65 21.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 O-C-N 121.822 -0.549 . . . . 0.0 111.459 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.316 0.3 OUTLIER . . . . . 0 N--CA 1.418 -2.028 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -169.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 . . . . . 0 N--CA 1.431 -1.388 0 CA-C-O 120.924 0.393 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -108.43 115.35 29.94 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.659 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -107.89 130.85 54.98 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.455 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 26.8 m -79.8 123.07 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.51 173.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.1 t -58.57 133.74 56.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.499 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -49.49 -56.55 9.42 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.932 1.395 . . . . 0.0 111.887 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.08 -38.21 18.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 119.189 -1.004 . . . . 0.0 113.508 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.03 -27.92 43.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.34 25.99 74.84 Favored Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.378 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 30.8 mmtm -103.29 128.31 27.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 123.474 0.709 . . . . 0.0 110.436 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -82.24 114.9 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.124 1.882 . . . . 0.0 110.906 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 157.35 36.77 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 140.81 45.26 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.495 ' O ' HG21 ' A' ' 32' ' ' ILE . 90.1 mt -56.36 -24.2 42.58 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -75.41 -10.13 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.94 -0.475 . . . . 0.0 112.101 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.3 5.97 12.67 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 120.878 0.371 . . . . 0.0 111.055 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.495 HG21 ' O ' ' A' ' 29' ' ' LEU . 10.9 tt -67.83 -44.35 85.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.29 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.97 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.1 -51.89 66.08 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.048 0.452 . . . . 0.0 110.096 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -59.12 -56.21 25.13 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.927 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 39' ' ' HIS . 28.0 tp -63.69 -21.66 66.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.973 0.416 . . . . 0.0 111.815 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.38 -34.01 20.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.568 175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -104.2 -7.49 20.07 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 121.301 -0.874 . . . . 0.0 111.827 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.411 ' CE1' HD12 ' A' ' 36' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.449 ' H ' ' CD ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.412 -2.374 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -126.89 145.79 50.54 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.445 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -133.67 136.55 44.82 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 34.4 m -80.65 130.28 36.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.316 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 t -69.56 135.47 50.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.798 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.51 -45.17 85.27 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.622 0.576 . . . . 0.0 112.401 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.12 -47.23 16.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.846 0.355 . . . . 0.0 111.671 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.9 m -80.37 -36.75 33.57 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.99 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 5.24 90.11 Favored Glycine 0 N--CA 1.46 0.261 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.468 -176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -101.24 130.79 24.15 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 51.7 Cg_endo -71.65 123.08 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.525 2.817 . . . . 0.0 112.698 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.95 149.39 30.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 150.93 33.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.6 mt -58.5 -28.76 65.7 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m -81.08 -7.21 59.51 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 121.676 0.75 . . . . 0.0 110.354 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.45 7.17 22.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.476 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.0 tp -52.77 -50.5 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.64 -47.5 76.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.062 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.76 -48.07 78.67 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.799 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.562 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 49.8 t60 -62.1 -55.94 23.89 Favored 'General case' 0 C--O 1.198 -1.648 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.086 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.8 pp -60.73 -27.8 68.2 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.841 -0.743 . . . . 0.0 112.863 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.06 -42.65 59.89 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.997 0.427 . . . . 0.0 111.057 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -98.66 -6.02 30.54 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.189 0.519 . . . . 0.0 111.115 -169.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.413 -2.304 0 C-N-CA 118.546 -1.262 . . . . 0.0 113.095 -172.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.028 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.43 143.27 47.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -150.32 129.58 12.83 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 27.3 m -73.94 142.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.821 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.2 t -67.92 137.34 55.14 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.379 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -57.46 -38.82 75.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.324 1.015 . . . . 0.0 111.382 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -104.5 -37.6 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.5 m -80.11 -22.52 42.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 119.764 -0.775 . . . . 0.0 112.326 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.18 -27.85 3.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.737 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -63.46 138.83 97.47 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 69.1 Cg_endo -78.33 128.45 8.89 Favored 'Trans proline' 0 C--O 1.249 1.04 0 C-N-CA 122.926 2.418 . . . . 0.0 111.63 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.98 164.06 26.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.271 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.25 147.04 26.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 16' ' ' GLN . 4.5 mm? -63.37 -18.45 63.69 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.006 0.431 . . . . 0.0 112.126 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.85 -1.85 44.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.32 6.65 5.32 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.423 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 16.6 tt -67.93 -36.74 76.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.24 -54.03 40.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.217 0 CA-C-O 120.739 0.304 . . . . 0.0 110.211 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.99 -49.51 71.28 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.078 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.22 -50.15 75.13 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.362 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.5 pp -66.43 -24.26 66.42 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.253 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -84.77 -26.25 27.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.915 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -91.6 -22.45 20.3 Favored 'General case' 0 CA--C 1.471 -2.067 0 C-N-CA 122.75 0.42 . . . . 0.0 110.394 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER . . . . . 0 N--CA 1.396 -3.142 0 C-N-CA 118.322 -1.351 . . . . 0.0 112.842 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.656 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -136.13 136.48 40.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.075 -171.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -131.85 147.42 52.48 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 20.3 m -92.07 145.0 8.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.66 142.4 29.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -61.46 -65.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.14 0.427 . . . . 0.0 112.108 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HB3' ' HZ1' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -67.23 -37.75 84.08 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.8 m -86.5 -21.99 26.67 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.349 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.99 61.37 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 121.068 0.26 . . . . 0.0 112.591 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 32.1 mmtp -87.22 123.24 70.3 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-O 119.335 -0.364 . . . . 0.0 110.91 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -86.35 114.49 1.27 Allowed 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 121.827 1.685 . . . . 0.0 108.988 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -133.14 164.02 27.97 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -58.44 140.85 53.15 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.864 0.727 . . . . 0.0 111.224 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.4 pp -61.47 -14.62 30.26 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -85.59 -31.51 22.59 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.422 0.629 . . . . 0.0 109.863 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -14.29 50.95 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 29' ' ' LEU . 10.2 tp -62.14 -28.71 45.0 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.794 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.57 -53.51 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.352 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.31 -41.71 93.76 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.972 0.415 . . . . 0.0 110.161 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.27 -57.31 13.36 Favored 'General case' 0 C--O 1.205 -1.24 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -62.89 -29.1 70.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.087 0.47 . . . . 0.0 109.997 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.68 -36.49 65.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.549 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -111.25 4.83 19.47 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 121.462 -0.774 . . . . 0.0 110.546 -170.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.419 -2.015 0 C-N-CA 118.322 -1.351 . . . . 0.0 109.702 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.402 -2.827 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -136.03 146.52 47.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.359 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 45.6 ptt85 -145.58 159.35 43.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 33.7 m -79.35 145.51 9.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 120.134 -0.627 . . . . 0.0 112.049 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 t -83.38 144.55 29.57 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.48 176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.84 -64.23 0.89 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.59 1.156 . . . . 0.0 112.0 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -71.51 -51.92 21.09 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.8 m -75.7 -30.23 59.26 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.03 11.32 74.48 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -99.67 129.48 28.74 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 37.9 Cg_endo -68.02 115.74 3.96 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.859 2.373 . . . . 0.0 112.521 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 18' ' ' ARG . 2.6 pt? -111.37 154.99 23.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.45 148.94 33.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.16 -19.48 63.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 110.179 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -82.75 -2.12 53.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.95 6.5 10.86 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.058 0.543 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.01 -42.28 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.33 -61.0 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.077 0 O-C-N 123.238 0.337 . . . . 0.0 111.159 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.16 -47.68 84.9 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 123.325 0.65 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 44.2 t60 -59.06 -53.49 57.77 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.858 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.49 -28.7 68.77 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.082 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -77.2 -28.33 53.87 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 122.229 -0.294 . . . . 0.0 111.534 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -100.86 -30.66 11.55 Favored 'General case' 0 CA--C 1.49 -1.359 0 O-C-N 121.497 -0.752 . . . . 0.0 111.165 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.524 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.34 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.39 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -165.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.468 ' H ' HD21 ' A' ' 29' ' ' LEU . 25.7 mm-40 . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.84 115.35 30.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -101.25 124.87 47.63 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.343 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.83 129.57 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -64.87 131.56 47.05 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.861 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -57.39 -37.21 72.32 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.148 0.979 . . . . 0.0 111.686 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.09 -47.69 10.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.33 0.586 . . . . 0.0 111.809 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.0 m -90.41 -21.15 22.08 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.07 33.9 87.23 Favored Glycine 0 N--CA 1.476 1.356 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -118.45 121.03 31.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -82.75 135.92 8.08 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 123.049 2.5 . . . . 0.0 113.697 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -146.79 169.28 19.42 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.752 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 137.07 43.27 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.86 0.362 . . . . 0.0 110.366 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.468 HD21 ' H ' ' A' ' 16' ' ' GLN . 1.2 pt? -59.07 -14.63 10.42 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.922 0.889 . . . . 0.0 113.027 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -82.35 -9.19 59.56 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.105 0.479 . . . . 0.0 110.816 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 6.45 5.24 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.097 0.475 . . . . 0.0 110.704 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.427 ' O ' HD12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -63.5 -35.63 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 -174.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.92 -46.96 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.313 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.95 -48.03 82.96 Favored 'General case' 0 C--O 1.273 2.329 0 CA-C-O 121.461 0.648 . . . . 0.0 110.061 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.562 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 28.6 t60 -54.97 -56.76 16.11 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.911 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.45 -35.48 72.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.831 0.348 . . . . 0.0 110.655 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -66.45 -37.97 86.33 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.162 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -117.41 4.73 12.5 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 118.72 -1.192 . . . . 0.0 113.202 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.303 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -169.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.455 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 121.85 0.833 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -139.89 137.22 34.68 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.844 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -128.92 144.71 51.26 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.1 m -85.91 136.92 21.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.136 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -67.98 120.41 14.19 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -54.37 -45.08 72.71 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 123.843 0.715 . . . . 0.0 111.027 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -69.18 -38.58 78.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.157 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 60.8 m -98.62 -22.91 15.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.2 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.12 25.3 69.18 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -103.45 111.61 65.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.641 -173.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.87 121.35 7.27 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.79 1.66 . . . . 0.0 110.278 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 pp -126.06 148.69 49.28 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.987 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.23 149.96 49.73 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.59 0.556 . . . . 0.0 109.736 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' A' ' 16' ' ' GLN . 1.9 pt? -52.62 -32.68 42.94 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.803 0.689 . . . . 0.0 111.682 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -77.4 -21.48 53.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.915 0.486 . . . . 0.0 111.118 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 3.22 40.59 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -50.5 78.3 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.48 -41.04 90.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.8 -56.25 24.61 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.304 0.573 . . . . 0.0 109.512 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -60.66 -48.26 82.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.43 -27.12 68.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.883 0.373 . . . . 0.0 110.546 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.95 -34.37 22.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.234 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -103.15 4.65 37.17 Favored 'General case' 0 CA--C 1.478 -1.822 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.477 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.409 -2.48 0 C-N-CA 118.013 -1.475 . . . . 0.0 109.605 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 14.2 mm100 . . . . . 0 N--CA 1.425 -1.722 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -108.86 129.69 55.41 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.392 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -122.5 128.1 50.39 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.7 m -74.6 131.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.108 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.4 t -65.63 117.73 8.51 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.44 -19.75 62.32 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -52.3 4.97 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.736 0.303 . . . . 0.0 110.478 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.7 m -87.38 -16.65 34.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.24 38.97 95.74 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -117.26 129.08 25.58 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.31 114.94 3.62 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.705 2.27 . . . . 0.0 111.632 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -109.72 124.81 51.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 123.302 0.641 . . . . 0.0 110.61 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -72.33 146.85 46.84 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 16' ' ' GLN . 6.6 mp -50.28 -18.79 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -174.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -89.6 -37.22 14.82 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.988 1.267 . . . . 0.0 110.33 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.3 -12.57 43.16 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.75 -38.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.03 -48.19 89.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.074 0.234 . . . . 0.0 110.943 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.26 -56.78 16.8 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 31.5 t60 -54.83 -56.16 22.47 Favored 'General case' 0 C--O 1.204 -1.335 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.47 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.68 -28.02 69.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.081 0.467 . . . . 0.0 110.519 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -77.72 -36.96 50.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.5 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -108.44 0.13 20.87 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.497 -1.281 . . . . 0.0 111.454 -172.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.463 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.426 -1.664 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.164 -173.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.419 -1.981 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -131.41 154.54 48.54 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.183 -1.372 . . . . 0.0 108.604 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -145.71 137.75 25.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -86.31 154.75 3.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.61 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.96 142.08 29.06 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.705 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.08 -46.88 72.95 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.188 0.305 . . . . 0.0 110.635 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.508 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 68.9 mttm -73.76 -52.13 14.19 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 16.5 m -86.29 -25.32 25.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -172.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.81 -33.19 3.32 Favored Glycine 0 N--CA 1.469 0.847 0 O-C-N 121.86 -0.525 . . . . 0.0 113.314 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -52.34 135.88 41.42 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 123.93 0.892 . . . . 0.0 113.024 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.81 123.49 8.52 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.568 2.178 . . . . 0.0 110.143 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 mt -104.01 156.45 17.85 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.44 139.69 58.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -44.53 -54.33 6.14 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 124.078 0.951 . . . . 0.0 113.439 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -90.77 6.12 45.49 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.36 0.6 . . . . 0.0 111.929 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.46 -2.74 57.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.53 0.681 . . . . 0.0 109.757 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -33.57 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.6 -61.01 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 122.873 0.469 . . . . 0.0 110.36 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.155 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.505 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 47.6 t60 -57.89 -52.88 63.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.752 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.25 -35.17 74.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.17 -34.5 77.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -113.0 -1.95 14.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.391 -0.924 . . . . 0.0 113.023 -172.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.508 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 120.57 0.224 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.91 131.74 51.05 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.061 0.851 . . . . 0.0 109.849 -174.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -115.99 131.12 57.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.98 134.78 29.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.676 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.407 ' HB2' HD11 ' A' ' 27' ' ' LEU . 43.1 t -67.95 126.05 28.25 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.38 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.1 mp0 -59.03 -29.47 67.31 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.677 0.791 . . . . 0.0 110.762 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -87.92 -52.54 5.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.151 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.0 m -93.46 -14.51 26.62 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.66 99.8 Favored Glycine 0 N--CA 1.463 0.456 0 CA-C-O 121.432 0.462 . . . . 0.0 112.433 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -125.45 140.33 36.06 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.02 115.03 4.15 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.667 2.245 . . . . 0.0 112.128 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 20' ' ' CYS . 16.2 mt -99.81 120.7 40.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.05 150.45 45.55 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.438 ' O ' HG21 ' A' ' 32' ' ' ILE . 93.4 mt -56.43 -27.17 55.84 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.768 0.794 . . . . 0.0 110.874 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -71.43 -27.14 63.08 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.609 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.64 5.96 15.55 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.4 tp -60.58 -42.4 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.89 -47.0 71.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.82 -51.58 68.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.035 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.44 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 32.1 t60 -62.94 -54.05 44.6 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.028 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -62.36 -26.83 68.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.311 0.96 . . . . 0.0 112.764 -176.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -79.41 -36.37 39.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.072 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.5 -1.24 21.56 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.348 -169.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.416 -2.15 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.195 -176.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.408 ' H ' HD22 ' A' ' 29' ' ' LEU . 12.6 mm100 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -120.36 138.08 53.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -124.99 135.39 52.75 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -98.98 142.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.147 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -86.88 133.74 33.59 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -50.61 72.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -66.17 -47.87 72.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.008 0.432 . . . . 0.0 111.846 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 m -79.51 -32.91 42.44 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.676 -175.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 21.36 76.33 Favored Glycine 0 N--CA 1.461 0.345 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -95.79 123.24 56.47 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -83.81 121.56 2.89 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.467 2.111 . . . . 0.0 110.986 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.53 164.55 14.42 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.364 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 150.6 37.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.408 HD22 ' H ' ' A' ' 16' ' ' GLN . 1.7 pt? -55.89 -25.61 43.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.071 0.548 . . . . 0.0 111.869 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -86.09 -33.65 20.87 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.837 0.855 . . . . 0.0 111.517 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.57 6.19 42.22 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.158 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 tp -55.1 -43.44 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.444 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.83 -39.13 84.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.26 -51.99 60.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 37.1 t60 -57.83 -53.17 61.21 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.419 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.41 -31.76 71.69 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.891 0.377 . . . . 0.0 110.812 -174.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -72.98 -41.09 64.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -110.18 5.46 21.92 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.151 -170.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.483 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.427 -1.586 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.367 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 120.918 0.39 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 61.3 m-85 -120.66 148.26 44.16 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.999 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -147.12 138.48 24.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.06 131.61 34.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.867 0.841 . . . . 0.0 111.225 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -76.8 138.37 39.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.137 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.6 -49.65 74.29 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 124.271 1.028 . . . . 0.0 111.231 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.527 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 62.5 mttp -78.34 -11.28 59.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.6 m -128.07 -34.35 2.12 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.849 -1.14 . . . . 0.0 113.86 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.98 89.19 Favored Glycine 0 C--O 1.226 -0.358 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.27 124.85 82.33 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 123.962 0.905 . . . . 0.0 109.523 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.32 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.923 1.749 . . . . 0.0 109.111 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -109.96 157.55 19.16 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.026 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.58 142.28 29.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 124.1 0.875 . . . . 0.0 109.408 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 32' ' ' ILE . 82.3 mt -56.28 -34.07 66.09 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 m -77.74 6.18 7.95 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.835 0.826 . . . . 0.0 111.206 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.45 6.79 4.14 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.72 -0.613 . . . . 0.0 110.795 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 11.3 tt -62.07 -43.37 97.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -174.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.27 -41.39 92.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.106 0.479 . . . . 0.0 110.278 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.88 -56.72 18.62 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.835 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -58.07 -52.78 64.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.599 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -63.18 -21.67 66.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.608 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.48 -34.42 21.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.168 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -109.06 4.11 22.75 Favored 'General case' 0 CA--C 1.476 -1.885 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.246 -171.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.527 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.411 -2.412 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.639 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 N--CA 1.43 -1.435 0 CA-C-O 121.114 0.483 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.94 156.75 22.46 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.1 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -141.71 129.12 21.24 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.939 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.0 m -73.87 143.91 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.5 t -79.14 143.06 35.83 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.246 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -45.16 -55.57 5.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.755 1.622 . . . . 0.0 111.821 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.47 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -100.94 -34.63 9.7 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.459 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.8 m -82.52 -20.14 37.28 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.131 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.42 -36.12 1.56 Allowed Glycine 0 N--CA 1.473 1.108 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.579 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -51.89 139.53 31.96 Favored Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 124.581 1.152 . . . . 0.0 112.462 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.3 125.9 4.69 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.941 2.428 . . . . 0.0 112.531 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.53 150.86 27.53 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.234 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.95 45.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 32' ' ' ILE . 2.0 pt? -54.69 -30.11 54.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -82.26 -25.53 34.0 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.778 -0.576 . . . . 0.0 110.832 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.84 -9.71 39.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 29' ' ' LEU . 7.4 tp -61.82 -34.68 63.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.93 -52.41 59.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.45 -48.79 80.3 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -57.37 -52.79 63.93 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -25.86 68.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -72.71 -43.48 62.94 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.683 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -110.42 4.94 21.05 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.264 -0.898 . . . . 0.0 112.705 -170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.42 -1.972 0 C-N-CA 119.27 -0.972 . . . . 0.0 112.462 -176.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.415 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 15.9 mm100 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 121.051 0.453 . . . . 0.0 111.41 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -122.2 151.96 40.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 111.103 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.434 ' O ' HD21 ' A' ' 27' ' ' LEU . 16.2 ptt180 -135.53 154.32 51.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -92.35 136.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.737 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.2 t -66.19 132.61 48.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.623 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -51.03 -43.52 60.89 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.037 1.335 . . . . 0.0 110.631 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -82.55 -52.11 7.15 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.018 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.93 -22.23 18.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.58 8.62 86.12 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.037 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -87.06 128.3 56.23 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.88 114.93 4.16 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 122.356 2.037 . . . . 0.0 111.581 176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.434 HD21 ' O ' ' A' ' 18' ' ' ARG . 2.0 pt? -113.15 148.82 34.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.58 147.88 50.14 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 16' ' ' GLN . 85.6 mt -54.81 -32.95 60.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.069 0.461 . . . . 0.0 111.942 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -86.58 -12.04 49.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.562 0.745 . . . . 0.0 112.185 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.92 6.43 48.91 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 122.185 -0.322 . . . . 0.0 111.6 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.9 tp -51.92 -43.79 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.203 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.04 -47.86 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 123.084 0.24 . . . . 0.0 111.465 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.58 -54.71 35.67 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.148 0.579 . . . . 0.0 111.104 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -62.5 -45.84 91.18 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.628 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.31 -30.26 70.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -76.27 -27.04 56.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -94.68 -23.69 17.48 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.265 0.1 OUTLIER . . . . . 0 N--CA 1.393 -3.316 0 C-N-CA 117.633 -1.627 . . . . 0.0 110.473 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 11.8 mm100 . . . . . 0 N--CA 1.424 -1.731 0 CA-C-O 120.956 0.408 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.62 122.96 42.72 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -122.42 145.22 48.48 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.0 m -86.86 139.54 17.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.214 0.53 . . . . 0.0 110.484 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.1 t -80.66 145.26 31.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.39 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -47.17 -67.25 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 126.712 2.005 . . . . 0.0 112.998 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -90.39 -11.22 41.17 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.1 m -101.74 -32.06 10.48 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.976 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.76 73.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.73 -176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -87.55 133.91 37.12 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.34 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.31 138.3 15.74 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.982 1.788 . . . . 0.0 110.389 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.37 155.15 45.12 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -81.13 144.31 31.77 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -57.32 -24.91 58.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -69.23 -25.15 64.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 121.708 0.765 . . . . 0.0 110.503 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.46 7.05 37.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.75 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 tp -51.47 -46.28 35.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.84 -40.79 88.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.52 -54.27 34.9 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -57.23 -52.24 66.13 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.674 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.35 -32.53 70.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.149 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 -22.71 27.94 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -110.41 3.03 19.34 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.046 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.303 0.4 OUTLIER . . . . . 0 N--CA 1.411 -2.424 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.814 -175.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.434 ' H ' HD22 ' A' ' 29' ' ' LEU . 13.7 mm100 . . . . . 0 N--CA 1.427 -1.592 0 CA-C-O 120.995 0.426 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -117.52 121.26 40.52 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.154 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.532 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 17.1 ttp85 -116.17 134.31 55.07 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.72 137.07 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.179 0.514 . . . . 0.0 111.785 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.36 143.46 48.59 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.692 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.42 -42.92 87.03 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.137 0.575 . . . . 0.0 110.474 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -74.11 -52.86 11.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -86.75 -23.37 25.5 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 37.56 94.09 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -122.48 125.54 26.45 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.39 118.71 5.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.936 2.424 . . . . 0.0 111.113 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 18' ' ' ARG . 4.3 pp -113.48 152.34 30.28 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.593 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.32 131.97 46.79 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.434 HD22 ' H ' ' A' ' 16' ' ' GLN . 1.5 pt? -51.18 -29.6 14.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -73.62 -30.22 62.84 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.985 0.514 . . . . 0.0 111.141 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.9 6.54 48.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -172.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.38 -44.64 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.97 -46.32 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.653 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -63.33 -48.95 75.89 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.499 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 15.6 t60 -58.94 -58.31 9.19 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.999 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.95 -22.43 66.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.017 0.437 . . . . 0.0 111.467 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.62 -51.7 12.25 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.422 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -109.3 5.38 23.58 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 117.831 -1.547 . . . . 0.0 113.375 -170.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.499 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.313 0.5 OUTLIER . . . . . 0 C--O 1.245 0.843 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 . . . . . 0 C--O 1.238 0.455 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.24 89.58 1.31 Allowed 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 121.473 1.448 . . . . 0.0 111.61 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -87.16 -42.57 12.9 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.971 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.89 -0.19 9.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.735 0.778 . . . . 0.0 108.982 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.3 127.02 32.27 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.649 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.6 tp -117.54 119.89 36.42 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.115 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mm -85.78 100.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.56 130.98 44.73 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.157 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.15 128.53 93.89 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.08 122.74 7.84 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 120.581 0.854 . . . . 0.0 112.256 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.8 tp -105.07 89.92 3.29 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -104.8 51.63 0.76 Allowed 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 122.344 1.069 . . . . 0.0 109.005 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -121.33 98.94 46.24 Favored Pre-proline 0 CA--C 1.47 -2.134 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.26 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -63.86 127.23 19.04 Favored 'Trans proline' 0 N--CA 1.428 -2.372 0 N-CA-C 107.218 -1.878 . . . . 0.0 107.218 166.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.6 mt -97.54 130.13 46.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 16.7 mm100 -87.31 158.63 19.01 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 123.296 0.372 . . . . 0.0 111.346 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 12.2 m-85 -134.95 150.2 50.34 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 123.705 0.628 . . . . 0.0 110.039 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -151.54 147.68 27.1 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.01 140.12 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.376 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HB2' HD13 ' A' ' 27' ' ' LEU . 43.4 t -68.2 124.95 24.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -30.83 14.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.7 m -94.8 -30.52 14.18 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.917 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.44 3.13 81.82 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.496 0.559 . . . . 0.0 114.496 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 11.8 mptt -93.58 141.45 23.87 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 122.205 -0.585 . . . . 0.0 110.934 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.82 117.1 4.97 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.816 2.344 . . . . 0.0 110.96 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.418 HD13 ' HB2' ' A' ' 20' ' ' CYS . 17.3 mt -105.59 125.77 51.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.215 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.08 152.76 23.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.484 ' O ' HG22 ' A' ' 32' ' ' ILE . 5.5 mp -56.56 -24.31 46.21 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -75.82 -28.18 58.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.782 -0.574 . . . . 0.0 110.678 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.6 -2.95 19.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 29' ' ' LEU . 7.1 tp -59.12 -42.22 85.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-O 120.423 0.154 . . . . 0.0 110.908 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.82 -51.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.22 -36.34 71.82 Favored 'General case' 0 C--O 1.26 1.608 0 CA-C-O 120.944 0.402 . . . . 0.0 111.1 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -64.17 -51.62 62.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.795 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 tt -58.58 -38.07 77.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.698 0.285 . . . . 0.0 110.339 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -68.64 -39.01 80.91 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -101.39 -6.54 23.91 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.059 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.67 154.17 39.8 Favored 'General case' 0 N--CA 1.417 -2.082 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.659 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.1 m -106.82 143.86 34.29 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.57 113.57 17.82 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.36 18.4 12.05 Favored Glycine 0 C--N 1.301 -1.377 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.76 115.39 11.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.29 -2.011 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 . . . . . 0 C--O 1.205 -1.239 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.27 -10.06 15.01 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.253 1.969 . . . . 0.0 111.289 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -95.94 6.75 48.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.01 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.45 114.09 7.17 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -54.76 121.72 9.16 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.42 127.94 34.81 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.0 tt -138.12 131.08 40.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.719 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.74 113.41 16.79 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.17 152.6 42.74 Favored Pre-proline 0 C--N 1.296 -1.744 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.794 -174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.21 124.42 16.22 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.526 2.817 . . . . 0.0 113.104 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.13 162.37 30.05 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.5 -11.95 50.27 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.039 0.447 . . . . 0.0 111.093 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -85.61 130.39 51.29 Favored Pre-proline 0 CA--C 1.479 -1.763 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.66 175.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -87.3 127.72 2.5 Favored 'Trans proline' 0 N--CA 1.408 -3.52 0 C-N-CA 121.369 1.38 . . . . 0.0 108.739 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.48 104.28 13.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 122.354 1.073 . . . . 0.0 110.106 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -100.66 164.77 11.72 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.021 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 48.7 m-85 -111.77 121.39 44.96 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -129.9 150.78 51.04 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -86.78 132.4 32.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.471 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.08 139.48 58.72 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.726 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -53.16 -49.5 66.5 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.16 0.984 . . . . 0.0 112.057 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -88.1 -51.78 5.6 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.439 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 m -79.28 -18.24 53.09 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.471 -172.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.08 66.43 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-O 121.347 0.415 . . . . 0.0 112.445 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -96.76 141.36 22.97 Favored Pre-proline 0 N--CA 1.429 -1.52 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.56 119.28 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.185 2.59 . . . . 0.0 110.39 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 3.1 mm? -115.76 130.66 56.93 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.939 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.18 133.8 34.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -48.98 -30.69 6.32 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -67.96 -22.0 65.05 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 122.158 -0.339 . . . . 0.0 111.578 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.35 -0.8 10.88 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.262 0.554 . . . . 0.0 111.017 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.425 HD11 ' HG ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -66.87 -33.27 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.057 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 46.4 t -63.06 -58.14 8.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.757 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -63.26 -32.84 74.36 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.284 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 39.3 t60 -56.26 -55.06 37.99 Favored 'General case' 0 C--O 1.199 -1.557 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.425 ' HG ' HD11 ' A' ' 32' ' ' ILE . 91.8 mt -56.89 -37.12 70.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.633 0.254 . . . . 0.0 111.247 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 55.1 mt-10 -69.99 -32.56 70.82 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -117.6 5.26 12.38 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.565 -0.709 . . . . 0.0 111.478 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -77.69 163.23 26.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.969 -176.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 5.0 p -93.39 116.71 29.26 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.706 0.765 . . . . 0.0 112.43 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.23 142.05 39.74 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.15 3.74 65.17 Favored Glycine 0 C--N 1.302 -1.307 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.96 110.86 1.12 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.185 0.594 . . . . 0.0 110.501 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.414 -2.256 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.2 t30 . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.8 131.75 17.54 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 121.861 1.707 . . . . 0.0 112.151 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -84.33 -45.07 13.17 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.88 -164.38 1.04 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -76.92 138.66 39.85 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.979 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.66 114.58 10.95 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 tt -134.53 136.92 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.408 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.94 120.18 33.0 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.82 119.3 68.97 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.12 145.43 96.43 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.449 2.099 . . . . 0.0 110.553 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.73 90.41 5.81 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.641 0.734 . . . . 0.0 109.136 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -103.15 125.48 49.87 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.417 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -70.66 119.75 74.72 Favored Pre-proline 0 CA--C 1.471 -2.09 0 O-C-N 123.718 0.636 . . . . 0.0 112.061 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -65.68 126.83 16.74 Favored 'Trans proline' 0 N--CA 1.426 -2.466 0 C-N-CA 121.77 1.647 . . . . 0.0 108.794 170.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mm -95.43 126.13 47.99 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -88.62 148.68 23.94 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.338 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -115.34 138.09 51.34 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.049 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -115.81 132.65 56.58 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.14 120.62 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.886 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.38 118.98 10.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -51.67 -50.02 61.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.413 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 5.4 ptpp? -74.0 -33.08 63.68 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.205 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.3 m -89.12 -29.67 19.2 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.848 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.08 28.28 71.86 Favored Glycine 0 N--CA 1.463 0.494 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.18 129.18 24.42 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.844 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -85.01 115.17 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.577 2.185 . . . . 0.0 111.047 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -121.73 153.87 37.66 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.066 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.94 37.15 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.11 -15.68 35.84 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -72.73 -23.6 60.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.093 0.473 . . . . 0.0 111.196 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.06 6.88 9.75 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.565 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.428 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -52.7 -47.4 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 122.728 0.411 . . . . 0.0 111.682 -176.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 12.6 p -67.15 -38.69 81.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.306 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.92 -52.48 65.22 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.586 0.708 . . . . 0.0 110.308 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.517 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 25.8 t60 -61.03 -46.71 89.64 Favored 'General case' 0 C--O 1.201 -1.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.022 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tt -57.78 -39.47 77.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 24.7 mm-40 -76.82 -27.83 55.32 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.64 5.02 12.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.276 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.517 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -72.86 163.1 28.65 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.2 t -88.76 126.98 35.58 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.385 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.11 151.47 22.2 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.54 20.58 21.85 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.815 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.53 111.46 19.1 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.408 0.623 . . . . 0.0 110.291 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--N 1.3 -1.577 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.9 170.42 16.73 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.463 2.109 . . . . 0.0 112.746 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -103.7 -66.82 0.92 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.56 -48.67 0.05 OUTLIER 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -78.81 158.3 28.21 Favored 'General case' 0 C--O 1.259 1.587 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 168.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.91 148.29 38.35 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.0 mm -82.67 102.69 8.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.249 0.547 . . . . 0.0 109.681 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -98.29 111.97 24.13 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.128 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -113.76 130.59 23.65 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.51 124.56 16.58 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.826 2.351 . . . . 0.0 113.497 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 pp -103.97 147.24 27.59 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.073 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 66.62 -61.63 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.45 1.5 . . . . 0.0 111.436 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -92.09 122.16 65.49 Favored Pre-proline 0 CA--C 1.475 -1.937 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -88.01 126.58 2.07 Favored 'Trans proline' 0 N--CA 1.401 -3.945 0 CA-C-O 121.952 0.73 . . . . 0.0 111.07 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.3 mm -94.38 100.1 10.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -83.61 110.18 18.04 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 113.023 -1.899 . . . . 0.0 112.142 -169.392 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -133.75 145.9 50.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.207 1.003 . . . . 0.0 109.931 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -141.95 137.06 30.99 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.74 123.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.268 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 t -61.21 140.37 57.94 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.61 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.86 -49.63 76.71 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.718 0.636 . . . . 0.0 110.541 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -78.82 -31.99 46.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.582 ' HB3' ' OXT' ' A' ' 44' ' ' SER . 35.8 m -104.58 -36.62 7.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -171.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.57 -8.18 80.21 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.105 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.553 ' HG3' ' OXT' ' A' ' 44' ' ' SER . 30.9 mtmm -73.94 133.29 79.09 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 117.208 0.504 . . . . 0.0 111.654 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.23 113.97 3.01 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.932 1.755 . . . . 0.0 110.071 171.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 154.12 30.9 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -74.87 146.01 42.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 123.402 0.439 . . . . 0.0 109.863 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.403 ' O ' HG21 ' A' ' 32' ' ' ILE . 4.3 mm? -65.04 -10.71 32.07 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.407 0.622 . . . . 0.0 111.842 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.24 -14.65 59.72 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.558 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.29 7.12 9.06 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.961 -0.462 . . . . 0.0 111.608 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.403 HG21 ' O ' ' A' ' 29' ' ' LEU . 8.0 tp -57.47 -48.56 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.96 -44.19 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.215 0.461 . . . . 0.0 111.186 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.38 -55.91 28.78 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.997 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 32.2 t60 -59.38 -50.22 74.79 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.829 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.22 -29.69 69.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.6 0.238 . . . . 0.0 111.49 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.39 -25.51 22.65 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.18 -10.65 21.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 O-C-N 121.822 -0.549 . . . . 0.0 111.459 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.316 0.3 OUTLIER -64.37 120.95 13.2 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -169.713 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.9 t -105.94 142.21 36.03 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.396 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.05 144.07 57.51 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.04 -33.16 6.03 Favored Glycine 0 C--N 1.297 -1.626 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.96 101.79 13.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.582 ' OXT' ' HB3' ' A' ' 23' ' ' CYS . 16.8 t . . . . . 0 N--CA 1.422 -1.864 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.445 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 50.2 t30 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 1' ' ' ASN . 53.2 Cg_endo -92.83 48.92 0.42 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 121.664 1.576 . . . . 0.0 112.237 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 74.74 -60.12 0.53 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.236 1.414 . . . . 0.0 111.886 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.61 -70.98 0.28 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.09 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -99.04 158.65 15.52 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.426 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.88 121.36 19.87 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 tt -83.55 131.66 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 169.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.99 114.67 24.83 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.25 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.13 122.72 79.23 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.164 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.49 164.61 22.89 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.244 2.629 . . . . 0.0 113.955 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.5 tp -70.73 150.1 46.26 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.741 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.54 96.49 2.43 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.418 0.627 . . . . 0.0 110.204 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -113.57 124.73 30.7 Favored Pre-proline 0 C--N 1.277 -2.581 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.921 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -88.64 126.98 1.89 Allowed 'Trans proline' 0 N--CA 1.402 -3.867 0 C-N-CA 120.892 1.061 . . . . 0.0 110.22 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.5 mt -107.47 126.68 63.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -91.34 155.75 18.28 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.493 0.495 . . . . 0.0 110.73 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -108.43 115.35 29.94 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.659 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -107.89 130.85 54.98 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.455 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 26.8 m -79.8 123.07 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.51 173.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.1 t -58.57 133.74 56.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.499 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -49.49 -56.55 9.42 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.932 1.395 . . . . 0.0 111.887 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.08 -38.21 18.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 119.189 -1.004 . . . . 0.0 113.508 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.03 -27.92 43.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.34 25.99 74.84 Favored Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.378 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 30.8 mmtm -103.29 128.31 27.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 123.474 0.709 . . . . 0.0 110.436 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -82.24 114.9 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.124 1.882 . . . . 0.0 110.906 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 157.35 36.77 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 140.81 45.26 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.495 ' O ' HG21 ' A' ' 32' ' ' ILE . 90.1 mt -56.36 -24.2 42.58 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -75.41 -10.13 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.94 -0.475 . . . . 0.0 112.101 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.3 5.97 12.67 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 120.878 0.371 . . . . 0.0 111.055 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.495 HG21 ' O ' ' A' ' 29' ' ' LEU . 10.9 tt -67.83 -44.35 85.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.29 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.97 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.1 -51.89 66.08 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.048 0.452 . . . . 0.0 110.096 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -59.12 -56.21 25.13 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.927 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 39' ' ' HIS . 28.0 tp -63.69 -21.66 66.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.973 0.416 . . . . 0.0 111.815 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.38 -34.01 20.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.568 175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -104.2 -7.49 20.07 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 121.301 -0.874 . . . . 0.0 111.827 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.411 ' CE1' HD12 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -62.53 133.43 54.94 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.9 t -81.91 111.18 17.87 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.666 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.15 131.75 47.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.04 -30.96 7.59 Favored Glycine 0 C--N 1.298 -1.557 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.48 98.94 11.21 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.301 -1.517 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.756 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.4 111.42 3.26 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.142 1.895 . . . . 0.0 108.863 173.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -111.42 155.58 22.94 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.978 0.418 . . . . 0.0 111.664 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.3 -177.49 3.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -75.96 107.55 8.23 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.439 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -96.03 114.56 26.28 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tt -93.82 125.6 46.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.457 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -79.62 116.06 19.6 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.527 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.21 141.92 86.65 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.12 123.49 11.06 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.071 2.514 . . . . 0.0 113.083 -175.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 86.7 mt -114.79 88.42 2.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 22.2 t70 162.79 134.59 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 126.109 1.764 . . . . 0.0 106.515 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -113.67 105.66 54.6 Favored Pre-proline 0 CA--C 1.466 -2.259 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.822 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -60.32 126.51 20.27 Favored 'Trans proline' 0 N--CA 1.426 -2.488 0 N-CA-C 107.315 -1.84 . . . . 0.0 107.315 167.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 pt -129.73 103.15 8.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-O 122.603 1.192 . . . . 0.0 108.81 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.449 ' H ' ' CD ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -87.39 109.16 19.36 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 113.719 -1.582 . . . . 0.0 108.107 -171.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -126.89 145.79 50.54 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.445 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -133.67 136.55 44.82 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 34.4 m -80.65 130.28 36.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.316 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 t -69.56 135.47 50.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.798 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.51 -45.17 85.27 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.622 0.576 . . . . 0.0 112.401 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.12 -47.23 16.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.846 0.355 . . . . 0.0 111.671 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.9 m -80.37 -36.75 33.57 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.99 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 5.24 90.11 Favored Glycine 0 N--CA 1.46 0.261 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.468 -176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -101.24 130.79 24.15 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 51.7 Cg_endo -71.65 123.08 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.525 2.817 . . . . 0.0 112.698 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.95 149.39 30.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 150.93 33.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.6 mt -58.5 -28.76 65.7 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m -81.08 -7.21 59.51 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 121.676 0.75 . . . . 0.0 110.354 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.45 7.17 22.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.476 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.0 tp -52.77 -50.5 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.64 -47.5 76.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.062 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.76 -48.07 78.67 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.799 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.562 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 49.8 t60 -62.1 -55.94 23.89 Favored 'General case' 0 C--O 1.198 -1.648 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.086 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.8 pp -60.73 -27.8 68.2 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.841 -0.743 . . . . 0.0 112.863 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.06 -42.65 59.89 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.997 0.427 . . . . 0.0 111.057 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -98.66 -6.02 30.54 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.189 0.519 . . . . 0.0 111.115 -169.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -74.61 158.98 32.74 Favored 'General case' 0 N--CA 1.413 -2.304 0 C-N-CA 118.546 -1.262 . . . . 0.0 113.095 -172.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.5 t -55.12 110.96 0.75 Allowed 'General case' 0 C--O 1.248 0.996 0 O-C-N 124.353 1.033 . . . . 0.0 111.754 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.76 158.02 25.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.351 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.45 13.48 35.41 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.29 113.6 9.5 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 123.299 0.64 . . . . 0.0 110.119 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 C--N 1.292 -1.903 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -62.71 -44.05 18.6 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.32 2.013 . . . . 0.0 112.553 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -97.51 164.99 12.21 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.58 5.6 6.19 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.639 0.733 . . . . 0.0 109.497 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -76.47 140.98 41.46 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.702 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -76.87 126.46 31.01 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -66.71 131.65 32.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.987 0.422 . . . . 0.0 110.027 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -85.01 166.38 16.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.798 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -84.08 147.12 50.09 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.25 124.49 14.88 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.224 1.95 . . . . 0.0 111.039 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.43 116.46 19.67 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -97.63 -164.04 1.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.598 -174.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -97.72 132.75 24.43 Favored Pre-proline 0 CA--C 1.475 -1.91 0 C-N-CA 124.147 0.979 . . . . 0.0 111.612 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -89.13 127.64 1.78 Allowed 'Trans proline' 0 N--CA 1.41 -3.395 0 C-N-CA 121.503 1.468 . . . . 0.0 108.564 169.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.6 mt -116.46 114.06 44.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-O 122.256 1.027 . . . . 0.0 109.448 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -89.98 111.04 21.99 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.872 -171.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.43 143.27 47.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -150.32 129.58 12.83 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 27.3 m -73.94 142.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.821 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.2 t -67.92 137.34 55.14 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.379 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -57.46 -38.82 75.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.324 1.015 . . . . 0.0 111.382 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -104.5 -37.6 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.5 m -80.11 -22.52 42.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 119.764 -0.775 . . . . 0.0 112.326 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.18 -27.85 3.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.737 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -63.46 138.83 97.47 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 69.1 Cg_endo -78.33 128.45 8.89 Favored 'Trans proline' 0 C--O 1.249 1.04 0 C-N-CA 122.926 2.418 . . . . 0.0 111.63 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.98 164.06 26.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.271 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.25 147.04 26.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 16' ' ' GLN . 4.5 mm? -63.37 -18.45 63.69 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.006 0.431 . . . . 0.0 112.126 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.85 -1.85 44.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.32 6.65 5.32 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.423 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 16.6 tt -67.93 -36.74 76.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.24 -54.03 40.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.217 0 CA-C-O 120.739 0.304 . . . . 0.0 110.211 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.99 -49.51 71.28 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.078 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.22 -50.15 75.13 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.362 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.5 pp -66.43 -24.26 66.42 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.253 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -84.77 -26.25 27.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.915 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -91.6 -22.45 20.3 Favored 'General case' 0 CA--C 1.471 -2.067 0 C-N-CA 122.75 0.42 . . . . 0.0 110.394 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER -75.92 164.54 26.09 Favored 'General case' 0 N--CA 1.396 -3.142 0 C-N-CA 118.322 -1.351 . . . . 0.0 112.842 -172.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.8 p -55.77 118.94 5.02 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.765 0.666 . . . . 0.0 112.123 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.2 113.5 27.13 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.902 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.43 -33.44 6.58 Favored Glycine 0 C--N 1.293 -1.832 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.3 163.4 16.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 C--N 1.296 -1.74 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.875 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 32.0 p30 . . . . . 0 C--O 1.221 -0.396 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -69.64 -41.73 4.16 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.902 1.735 . . . . 0.0 109.53 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -143.12 155.4 44.57 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.1 78.67 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.88 108.17 7.3 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.505 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp -74.15 115.39 13.59 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.9 mt -122.92 102.03 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 120.953 0.406 . . . . 0.0 110.915 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -98.2 126.86 43.86 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.15 118.1 70.58 Favored Pre-proline 0 C--N 1.3 -1.577 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.223 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.32 132.69 22.93 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.318 2.012 . . . . 0.0 111.072 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.2 tp -92.36 124.07 36.14 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.34 -41.12 96.52 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 123.334 0.396 . . . . 0.0 110.538 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -64.99 131.32 95.18 Favored Pre-proline 0 CA--C 1.489 -1.399 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -84.23 125.98 3.62 Favored 'Trans proline' 1 N--CA 1.398 -4.103 0 CA-C-O 122.096 0.79 . . . . 0.0 110.435 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.0 pt -125.15 144.2 36.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.451 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.656 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -122.93 107.92 12.38 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 -175.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -136.13 136.48 40.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.075 -171.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -131.85 147.42 52.48 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 20.3 m -92.07 145.0 8.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.66 142.4 29.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -61.46 -65.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.14 0.427 . . . . 0.0 112.108 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HB3' ' HZ1' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -67.23 -37.75 84.08 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.8 m -86.5 -21.99 26.67 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.349 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.99 61.37 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 121.068 0.26 . . . . 0.0 112.591 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 32.1 mmtp -87.22 123.24 70.3 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-O 119.335 -0.364 . . . . 0.0 110.91 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -86.35 114.49 1.27 Allowed 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 121.827 1.685 . . . . 0.0 108.988 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -133.14 164.02 27.97 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -58.44 140.85 53.15 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.864 0.727 . . . . 0.0 111.224 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.4 pp -61.47 -14.62 30.26 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -85.59 -31.51 22.59 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.422 0.629 . . . . 0.0 109.863 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -14.29 50.95 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 29' ' ' LEU . 10.2 tp -62.14 -28.71 45.0 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.794 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.57 -53.51 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.352 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.31 -41.71 93.76 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.972 0.415 . . . . 0.0 110.161 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.27 -57.31 13.36 Favored 'General case' 0 C--O 1.205 -1.24 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -62.89 -29.1 70.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.087 0.47 . . . . 0.0 109.997 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.68 -36.49 65.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.549 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -111.25 4.83 19.47 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 121.462 -0.774 . . . . 0.0 110.546 -170.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.98 165.4 24.1 Favored 'General case' 0 N--CA 1.419 -2.015 0 C-N-CA 118.322 -1.351 . . . . 0.0 109.702 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 78.7 m -71.53 114.36 9.52 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.442 0.639 . . . . 0.0 111.719 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.97 126.95 52.8 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.666 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.94 -34.11 4.85 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.9 150.23 40.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--N 1.291 -1.973 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.22 103.98 0.69 Allowed 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.684 2.256 . . . . 0.0 113.305 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -116.42 129.18 56.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.69 -50.44 8.17 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -98.75 106.46 18.73 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -138.12 124.5 20.59 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.5 pt -76.13 132.0 33.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 123.333 0.396 . . . . 0.0 110.086 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -79.58 138.7 37.55 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.76 118.75 73.32 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.76 126.27 13.12 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.056 1.837 . . . . 0.0 110.624 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -130.75 158.76 39.23 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.756 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.59 -51.43 42.57 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 123.611 0.569 . . . . 0.0 111.353 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -138.28 128.06 14.94 Favored Pre-proline 0 CA--C 1.471 -2.094 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -87.55 126.14 2.18 Favored 'Trans proline' 1 N--CA 1.397 -4.153 0 CA-C-O 122.714 1.048 . . . . 0.0 111.848 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.7 mt -116.42 114.46 46.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.78 110.02 9.51 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.438 -170.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -136.03 146.52 47.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.359 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 45.6 ptt85 -145.58 159.35 43.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 33.7 m -79.35 145.51 9.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 120.134 -0.627 . . . . 0.0 112.049 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 t -83.38 144.55 29.57 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.48 176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.84 -64.23 0.89 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.59 1.156 . . . . 0.0 112.0 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -71.51 -51.92 21.09 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.8 m -75.7 -30.23 59.26 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.03 11.32 74.48 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -99.67 129.48 28.74 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 37.9 Cg_endo -68.02 115.74 3.96 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.859 2.373 . . . . 0.0 112.521 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 18' ' ' ARG . 2.6 pt? -111.37 154.99 23.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.45 148.94 33.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.16 -19.48 63.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 110.179 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -82.75 -2.12 53.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.95 6.5 10.86 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.058 0.543 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.01 -42.28 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.33 -61.0 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.077 0 O-C-N 123.238 0.337 . . . . 0.0 111.159 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.16 -47.68 84.9 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 123.325 0.65 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 44.2 t60 -59.06 -53.49 57.77 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.858 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.49 -28.7 68.77 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.082 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -77.2 -28.33 53.87 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 122.229 -0.294 . . . . 0.0 111.534 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -100.86 -30.66 11.55 Favored 'General case' 0 CA--C 1.49 -1.359 0 O-C-N 121.497 -0.752 . . . . 0.0 111.165 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.524 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.34 0.2 OUTLIER -45.78 122.18 3.57 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -165.261 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.8 t -65.72 122.29 16.94 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.49 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.36 152.44 42.06 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.72 18.81 59.29 Favored Glycine 0 C--N 1.298 -1.534 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.556 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.33 115.82 17.42 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--N 1.294 -1.834 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.549 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.55 88.63 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.254 1.969 . . . . 0.0 113.345 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -121.72 91.77 3.59 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.23 133.94 22.23 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.749 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -135.01 111.89 10.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.28 115.12 20.51 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -89.7 96.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.875 0.845 . . . . 0.0 111.195 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -98.59 112.83 24.75 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.187 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.75 119.73 77.74 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.87 124.0 12.47 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.77 1.647 . . . . 0.0 110.664 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.3 tp -84.01 108.96 17.27 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.15 -58.3 8.31 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 123.687 0.617 . . . . 0.0 111.61 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -129.01 100.01 21.27 Favored Pre-proline 0 CA--C 1.46 -2.513 0 CA-C-O 120.988 0.423 . . . . 0.0 110.74 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -64.45 126.47 16.98 Favored 'Trans proline' 0 N--CA 1.423 -2.634 0 N-CA-C 107.096 -1.925 . . . . 0.0 107.096 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.0 pt -120.23 95.39 3.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-O 122.347 1.07 . . . . 0.0 111.799 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.468 ' H ' HD21 ' A' ' 29' ' ' LEU . 25.7 mm-40 -99.39 152.33 20.08 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.395 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.84 115.35 30.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -101.25 124.87 47.63 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.343 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.83 129.57 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -64.87 131.56 47.05 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.861 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -57.39 -37.21 72.32 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.148 0.979 . . . . 0.0 111.686 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.09 -47.69 10.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.33 0.586 . . . . 0.0 111.809 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.0 m -90.41 -21.15 22.08 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.07 33.9 87.23 Favored Glycine 0 N--CA 1.476 1.356 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -118.45 121.03 31.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -82.75 135.92 8.08 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 123.049 2.5 . . . . 0.0 113.697 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -146.79 169.28 19.42 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.752 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 137.07 43.27 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.86 0.362 . . . . 0.0 110.366 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.468 HD21 ' H ' ' A' ' 16' ' ' GLN . 1.2 pt? -59.07 -14.63 10.42 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.922 0.889 . . . . 0.0 113.027 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -82.35 -9.19 59.56 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.105 0.479 . . . . 0.0 110.816 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 6.45 5.24 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.097 0.475 . . . . 0.0 110.704 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.427 ' O ' HD12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -63.5 -35.63 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 -174.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.92 -46.96 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.313 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.95 -48.03 82.96 Favored 'General case' 0 C--O 1.273 2.329 0 CA-C-O 121.461 0.648 . . . . 0.0 110.061 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.562 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 28.6 t60 -54.97 -56.76 16.11 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.911 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.45 -35.48 72.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.831 0.348 . . . . 0.0 110.655 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -66.45 -37.97 86.33 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.162 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -117.41 4.73 12.5 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 118.72 -1.192 . . . . 0.0 113.202 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.303 0.5 OUTLIER -54.5 115.88 2.36 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -169.702 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.5 m -106.32 110.09 22.21 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.2 137.13 58.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.726 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.81 15.27 13.47 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.37 130.55 38.02 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.8 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 CA--C 1.5 -0.981 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -71.8 110.17 2.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.31 2.007 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -70.99 -56.39 6.28 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.384 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.9 -42.98 0.21 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -110.42 153.9 24.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.9 mt -78.49 114.76 17.68 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.9 mm -109.83 98.18 6.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -102.37 124.24 47.6 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -87.39 144.32 35.61 Favored Pre-proline 0 C--N 1.29 -1.979 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.39 132.28 43.95 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 122.948 2.432 . . . . 0.0 111.212 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.64 91.9 2.38 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.981 0.895 . . . . 0.0 109.195 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -115.24 -167.91 1.31 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -106.88 116.61 58.39 Favored Pre-proline 0 CA--C 1.481 -1.676 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -89.07 128.89 1.94 Allowed 'Trans proline' 0 N--CA 1.412 -3.284 0 C-N-CA 122.236 1.957 . . . . 0.0 109.07 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.45 137.95 54.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.455 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -114.68 107.63 15.73 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 121.85 0.833 . . . . 0.0 109.502 -171.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -139.89 137.22 34.68 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.844 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -128.92 144.71 51.26 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.1 m -85.91 136.92 21.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.136 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -67.98 120.41 14.19 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -54.37 -45.08 72.71 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 123.843 0.715 . . . . 0.0 111.027 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -69.18 -38.58 78.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.157 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 60.8 m -98.62 -22.91 15.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.2 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.12 25.3 69.18 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -103.45 111.61 65.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.641 -173.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.87 121.35 7.27 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.79 1.66 . . . . 0.0 110.278 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 pp -126.06 148.69 49.28 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.987 -176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.23 149.96 49.73 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.59 0.556 . . . . 0.0 109.736 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' A' ' 16' ' ' GLN . 1.9 pt? -52.62 -32.68 42.94 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.803 0.689 . . . . 0.0 111.682 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -77.4 -21.48 53.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.915 0.486 . . . . 0.0 111.118 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 3.22 40.59 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -50.5 78.3 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.48 -41.04 90.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.8 -56.25 24.61 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.304 0.573 . . . . 0.0 109.512 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -60.66 -48.26 82.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.43 -27.12 68.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.883 0.373 . . . . 0.0 110.546 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.95 -34.37 22.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.234 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -103.15 4.65 37.17 Favored 'General case' 0 CA--C 1.478 -1.822 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.477 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.54 161.74 22.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 118.013 -1.475 . . . . 0.0 109.605 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 69.2 m -86.8 110.64 20.07 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.718 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.4 132.93 37.18 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.56 -33.38 5.9 Favored Glycine 0 C--N 1.31 -0.887 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.57 131.2 41.46 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.293 -1.863 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.131 -179.629 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.509 -0.599 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -86.21 87.51 0.83 Allowed 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.167 1.911 . . . . 0.0 111.447 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -129.72 4.9 5.04 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.977 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.51 161.87 41.95 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -88.27 119.59 28.83 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.0 mt -67.14 135.29 53.32 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.6 pt -76.44 161.84 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.767 170.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.2 130.21 45.52 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -47.55 114.47 3.14 Favored Pre-proline 0 C--O 1.243 0.758 0 O-C-N 124.649 1.218 . . . . 0.0 110.931 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.32 131.0 12.41 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.182 1.922 . . . . 0.0 111.288 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.0 tp -136.4 89.07 2.43 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -170.51 170.15 7.02 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -132.91 97.86 16.5 Favored Pre-proline 0 CA--C 1.466 -2.288 0 CA-C-O 121.427 0.632 . . . . 0.0 110.243 170.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -70.01 127.17 14.02 Favored 'Trans proline' 0 N--CA 1.424 -2.612 0 N-CA-C 107.665 -1.706 . . . . 0.0 107.665 167.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -105.55 123.63 60.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 14.2 mm100 -74.05 144.29 45.11 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -108.86 129.69 55.41 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.392 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -122.5 128.1 50.39 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.7 m -74.6 131.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.108 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.4 t -65.63 117.73 8.51 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.44 -19.75 62.32 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -52.3 4.97 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.736 0.303 . . . . 0.0 110.478 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.7 m -87.38 -16.65 34.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.24 38.97 95.74 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -117.26 129.08 25.58 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.31 114.94 3.62 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.705 2.27 . . . . 0.0 111.632 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -109.72 124.81 51.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 123.302 0.641 . . . . 0.0 110.61 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -72.33 146.85 46.84 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 16' ' ' GLN . 6.6 mp -50.28 -18.79 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -174.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -89.6 -37.22 14.82 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.988 1.267 . . . . 0.0 110.33 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.3 -12.57 43.16 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.75 -38.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.03 -48.19 89.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.074 0.234 . . . . 0.0 110.943 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.26 -56.78 16.8 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 31.5 t60 -54.83 -56.16 22.47 Favored 'General case' 0 C--O 1.204 -1.335 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.47 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.68 -28.02 69.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.081 0.467 . . . . 0.0 110.519 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -77.72 -36.96 50.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.5 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -108.44 0.13 20.87 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.497 -1.281 . . . . 0.0 111.454 -172.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.463 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -67.87 165.46 17.55 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.164 -173.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.0 p -55.82 122.68 12.05 Favored 'General case' 0 C--O 1.258 1.543 0 O-C-N 124.127 0.892 . . . . 0.0 111.956 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 157.7 28.07 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.28 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.51 20.6 7.68 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.51 97.35 10.09 Favored 'General case' 0 N--CA 1.433 -1.288 0 O-C-N 122.619 -0.342 . . . . 0.0 110.501 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 59.7 m . . . . . 0 C--N 1.303 -1.454 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 175.787 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.72 -44.3 50.95 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.84 2.36 . . . . 0.0 110.753 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -111.55 109.67 19.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.05 147.23 50.51 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -82.82 152.95 25.43 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.671 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.94 129.53 41.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.654 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.34 101.58 2.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.44 152.96 31.87 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.519 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -108.58 112.4 60.72 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 171.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -44.53 137.43 8.39 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 124.115 3.21 . . . . 0.0 115.316 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.4 tp -92.09 117.02 29.44 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.85 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 69.6 -51.26 0.62 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.593 1.557 . . . . 0.0 113.138 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -69.76 128.5 91.9 Favored Pre-proline 0 CA--C 1.471 -2.063 0 CA-C-O 120.997 0.427 . . . . 0.0 110.685 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -90.42 127.34 1.37 Allowed 'Trans proline' 0 N--CA 1.404 -3.769 0 N-CA-C 108.416 -1.417 . . . . 0.0 108.416 168.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.88 118.34 44.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.21 110.41 22.46 Favored 'General case' 0 C--N 1.261 -3.241 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -162.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -131.41 154.54 48.54 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.183 -1.372 . . . . 0.0 108.604 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -145.71 137.75 25.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -86.31 154.75 3.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.61 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.96 142.08 29.06 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.705 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.08 -46.88 72.95 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.188 0.305 . . . . 0.0 110.635 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.508 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 68.9 mttm -73.76 -52.13 14.19 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 16.5 m -86.29 -25.32 25.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -172.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.81 -33.19 3.32 Favored Glycine 0 N--CA 1.469 0.847 0 O-C-N 121.86 -0.525 . . . . 0.0 113.314 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -52.34 135.88 41.42 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 123.93 0.892 . . . . 0.0 113.024 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.81 123.49 8.52 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.568 2.178 . . . . 0.0 110.143 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 mt -104.01 156.45 17.85 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.44 139.69 58.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -44.53 -54.33 6.14 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 124.078 0.951 . . . . 0.0 113.439 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -90.77 6.12 45.49 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.36 0.6 . . . . 0.0 111.929 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.46 -2.74 57.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.53 0.681 . . . . 0.0 109.757 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -33.57 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.6 -61.01 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 122.873 0.469 . . . . 0.0 110.36 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.155 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.505 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 47.6 t60 -57.89 -52.88 63.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.752 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.25 -35.17 74.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.17 -34.5 77.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -113.0 -1.95 14.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.391 -0.924 . . . . 0.0 113.023 -172.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.508 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -70.0 145.71 51.59 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.2 t -95.19 142.23 27.87 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.83 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.35 148.52 29.32 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.39 20.06 75.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.847 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 23' ' ' CYS . . . -107.09 141.56 38.13 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.294 -1.831 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.644 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.97 -64.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 121.784 1.656 . . . . 0.0 112.021 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -136.01 -8.94 2.06 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.281 0.563 . . . . 0.0 110.328 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.48 171.55 8.91 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -75.2 107.74 7.5 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.5 tp -109.7 116.23 31.32 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.874 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.83 97.82 5.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 171.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.12 114.81 3.05 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 124.209 0.943 . . . . 0.0 110.17 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -75.02 114.69 37.46 Favored Pre-proline 0 C--N 1.308 -1.226 0 O-C-N 124.521 1.138 . . . . 0.0 111.989 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -82.31 142.32 11.91 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.523 2.149 . . . . 0.0 109.275 172.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -78.5 103.92 8.76 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.71 144.18 57.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.164 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.67 128.25 92.99 Favored Pre-proline 0 CA--C 1.485 -1.528 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -86.3 125.66 2.61 Favored 'Trans proline' 0 N--CA 1.406 -3.66 0 CA-C-O 122.395 0.914 . . . . 0.0 111.829 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.57 135.24 60.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.83 146.71 33.22 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.57 0.224 . . . . 0.0 110.703 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.91 131.74 51.05 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.061 0.851 . . . . 0.0 109.849 -174.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -115.99 131.12 57.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.98 134.78 29.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.676 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.407 ' HB2' HD11 ' A' ' 27' ' ' LEU . 43.1 t -67.95 126.05 28.25 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.38 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.1 mp0 -59.03 -29.47 67.31 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.677 0.791 . . . . 0.0 110.762 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -87.92 -52.54 5.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.151 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.0 m -93.46 -14.51 26.62 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.66 99.8 Favored Glycine 0 N--CA 1.463 0.456 0 CA-C-O 121.432 0.462 . . . . 0.0 112.433 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -125.45 140.33 36.06 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.02 115.03 4.15 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.667 2.245 . . . . 0.0 112.128 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 20' ' ' CYS . 16.2 mt -99.81 120.7 40.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.05 150.45 45.55 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.438 ' O ' HG21 ' A' ' 32' ' ' ILE . 93.4 mt -56.43 -27.17 55.84 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.768 0.794 . . . . 0.0 110.874 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -71.43 -27.14 63.08 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.609 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.64 5.96 15.55 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.4 tp -60.58 -42.4 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.89 -47.0 71.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.82 -51.58 68.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.035 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.44 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 32.1 t60 -62.94 -54.05 44.6 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.028 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -62.36 -26.83 68.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.311 0.96 . . . . 0.0 112.764 -176.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -79.41 -36.37 39.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.072 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.5 -1.24 21.56 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.348 -169.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -73.72 154.07 39.79 Favored 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.195 -176.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 43' ' ' ALA . 40.9 t -62.5 110.63 1.74 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.648 0.593 . . . . 0.0 111.848 -177.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.01 128.59 53.94 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.105 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.59 -28.24 11.94 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.201 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -117.58 134.33 54.99 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.297 -1.695 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.556 -177.869 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.14 -40.05 54.04 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.711 2.274 . . . . 0.0 112.485 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -152.91 128.17 9.84 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.37 -46.85 25.55 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -120.2 154.63 34.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 tp -82.55 118.65 23.42 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -104.29 130.2 55.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 120.926 0.393 . . . . 0.0 110.036 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.17 153.18 34.39 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.377 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.07 144.45 67.54 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.14 124.17 14.68 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 121.773 1.648 . . . . 0.0 110.854 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.2 mt -113.02 113.97 26.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.062 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.72 -49.94 64.41 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.887 0.851 . . . . 0.0 109.149 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -81.17 141.74 50.41 Favored Pre-proline 0 CA--C 1.465 -2.294 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.528 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -82.16 125.93 4.79 Favored 'Trans proline' 0 N--CA 1.403 -3.803 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.2 mt -116.83 103.21 14.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.553 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.408 ' H ' HD22 ' A' ' 29' ' ' LEU . 12.6 mm100 -91.33 159.78 15.83 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.01 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -120.36 138.08 53.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -124.99 135.39 52.75 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -98.98 142.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.147 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -86.88 133.74 33.59 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -50.61 72.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 44' ' ' SER . 9.0 ptpp? -66.17 -47.87 72.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.008 0.432 . . . . 0.0 111.846 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 m -79.51 -32.91 42.44 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.676 -175.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 21.36 76.33 Favored Glycine 0 N--CA 1.461 0.345 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -95.79 123.24 56.47 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -83.81 121.56 2.89 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.467 2.111 . . . . 0.0 110.986 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.53 164.55 14.42 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.364 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 150.6 37.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.408 HD22 ' H ' ' A' ' 16' ' ' GLN . 1.7 pt? -55.89 -25.61 43.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.071 0.548 . . . . 0.0 111.869 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -86.09 -33.65 20.87 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.837 0.855 . . . . 0.0 111.517 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.57 6.19 42.22 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.158 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 tp -55.1 -43.44 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.444 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.83 -39.13 84.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.26 -51.99 60.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 37.1 t60 -57.83 -53.17 61.21 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.419 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.41 -31.76 71.69 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.891 0.377 . . . . 0.0 110.812 -174.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -72.98 -41.09 64.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -110.18 5.46 21.92 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.151 -170.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.483 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -68.71 149.81 48.63 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.367 -176.28 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.3 m -76.95 110.86 11.92 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.073 0.463 . . . . 0.0 109.867 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.59 125.46 37.24 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.05 -16.87 57.89 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.03 98.82 6.52 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 5.3 p . . . . . 0 N--CA 1.426 -1.631 0 CA-C-O 118.478 -0.773 . . . . 0.0 110.473 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.74 58.43 4.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.933 2.422 . . . . 0.0 111.829 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.7 m120 72.92 174.32 0.29 Allowed 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 125.531 1.532 . . . . 0.0 109.271 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.88 113.3 20.41 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.166 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.02 117.34 21.54 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.2 pt? -119.07 124.66 47.45 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.998 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 pt -97.04 160.78 2.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.35 155.49 18.92 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -78.7 116.7 61.67 Favored Pre-proline 0 C--N 1.302 -1.482 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.177 -173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.76 126.02 8.55 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.093 1.862 . . . . 0.0 111.613 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.13 118.52 27.76 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.749 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -104.93 130.13 53.17 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -115.89 120.69 35.23 Favored Pre-proline 0 CA--C 1.482 -1.664 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -61.48 127.69 22.57 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.104 1.869 . . . . 0.0 107.797 164.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.2 mm -118.92 134.56 62.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -105.31 156.15 18.42 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.687 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 61.3 m-85 -120.66 148.26 44.16 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.999 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -147.12 138.48 24.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.06 131.61 34.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.867 0.841 . . . . 0.0 111.225 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -76.8 138.37 39.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.137 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.6 -49.65 74.29 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 124.271 1.028 . . . . 0.0 111.231 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.527 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 62.5 mttp -78.34 -11.28 59.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.6 m -128.07 -34.35 2.12 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.849 -1.14 . . . . 0.0 113.86 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.98 89.19 Favored Glycine 0 C--O 1.226 -0.358 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.27 124.85 82.33 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 123.962 0.905 . . . . 0.0 109.523 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.32 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.923 1.749 . . . . 0.0 109.111 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -109.96 157.55 19.16 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.026 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.58 142.28 29.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 124.1 0.875 . . . . 0.0 109.408 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 32' ' ' ILE . 82.3 mt -56.28 -34.07 66.09 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 m -77.74 6.18 7.95 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.835 0.826 . . . . 0.0 111.206 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.45 6.79 4.14 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.72 -0.613 . . . . 0.0 110.795 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 11.3 tt -62.07 -43.37 97.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -174.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.27 -41.39 92.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.106 0.479 . . . . 0.0 110.278 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.88 -56.72 18.62 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.835 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -58.07 -52.78 64.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.599 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -63.18 -21.67 66.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.608 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.48 -34.42 21.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.168 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -109.06 4.11 22.75 Favored 'General case' 0 CA--C 1.476 -1.885 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.246 -171.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.527 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -76.66 151.9 35.98 Favored 'General case' 0 N--CA 1.411 -2.412 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.639 -176.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.9 t -89.49 127.98 35.92 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.05 114.66 11.46 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.673 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.53 20.07 42.45 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.746 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.26 106.25 0.22 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.395 0.617 . . . . 0.0 112.032 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.3 m . . . . . 0 C--N 1.306 -1.31 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.34 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.435 ' H3 ' ' HD2' ' A' ' 2' ' ' PRO . 8.1 t30 . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.435 ' HD2' ' H3 ' ' A' ' 1' ' ' ASN . 72.6 Cg_endo -74.7 -23.02 14.91 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 121.44 1.427 . . . . 0.0 114.853 -176.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -113.83 129.28 56.61 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.577 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.54 91.5 8.26 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -70.11 113.89 7.73 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.887 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.1 mt -103.46 145.18 30.39 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.4 pt -84.15 139.6 17.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 120.936 0.398 . . . . 0.0 111.569 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -90.39 117.88 29.45 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -111.08 127.3 27.1 Favored Pre-proline 0 C--N 1.288 -2.099 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.008 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.33 148.56 55.35 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.272 1.981 . . . . 0.0 111.658 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.3 mt -77.33 144.01 38.35 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.02 174.3 12.05 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -138.19 127.11 14.52 Favored Pre-proline 0 CA--C 1.467 -2.221 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -81.08 128.01 6.28 Favored 'Trans proline' 0 N--CA 1.403 -3.849 0 C-N-CA 120.857 1.038 . . . . 0.0 109.606 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.6 mm -73.89 95.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-O 122.689 1.233 . . . . 0.0 108.132 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -91.0 164.31 14.02 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.828 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.94 156.75 22.46 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.1 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -141.71 129.12 21.24 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.939 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.0 m -73.87 143.91 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.5 t -79.14 143.06 35.83 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.246 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -45.16 -55.57 5.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.755 1.622 . . . . 0.0 111.821 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.47 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -100.94 -34.63 9.7 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.459 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.8 m -82.52 -20.14 37.28 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.131 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.42 -36.12 1.56 Allowed Glycine 0 N--CA 1.473 1.108 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.579 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -51.89 139.53 31.96 Favored Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 124.581 1.152 . . . . 0.0 112.462 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.3 125.9 4.69 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.941 2.428 . . . . 0.0 112.531 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.53 150.86 27.53 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.234 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.95 45.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 32' ' ' ILE . 2.0 pt? -54.69 -30.11 54.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -82.26 -25.53 34.0 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.778 -0.576 . . . . 0.0 110.832 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.84 -9.71 39.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 29' ' ' LEU . 7.4 tp -61.82 -34.68 63.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.93 -52.41 59.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.45 -48.79 80.3 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -57.37 -52.79 63.93 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -25.86 68.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -72.71 -43.48 62.94 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.683 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -110.42 4.94 21.05 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.264 -0.898 . . . . 0.0 112.705 -170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.97 115.91 7.23 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 119.27 -0.972 . . . . 0.0 112.462 -176.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.4 m -97.31 137.81 35.74 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.134 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.77 133.91 55.49 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.36 -21.91 21.08 Favored Glycine 0 C--N 1.297 -1.602 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -175.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.18 140.75 40.24 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.241 0.652 0 C-N-CA 124.007 0.923 . . . . 0.0 112.016 -174.342 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.505 -0.75 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -47.53 -32.52 15.88 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 124.102 3.202 . . . . 0.0 115.11 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -65.39 -30.47 71.28 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 122.427 -0.171 . . . . 0.0 111.299 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 69.72 145.83 0.06 Allowed 'General case' 0 C--O 1.246 0.883 0 C-N-CA 125.141 1.376 . . . . 0.0 112.404 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -78.92 110.19 13.9 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.6 tp -128.36 132.72 48.57 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.473 0.654 . . . . 0.0 111.676 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.7 tt -123.08 128.38 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 171.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.5 138.16 58.06 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -78.52 138.51 59.0 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.02 154.8 59.52 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 123.032 2.488 . . . . 0.0 112.051 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -89.73 88.38 7.36 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-O 122.301 1.048 . . . . 0.0 111.498 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -123.75 7.77 8.79 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -80.53 151.73 72.02 Favored Pre-proline 0 CA--C 1.464 -2.359 0 CA-C-N 112.14 -2.3 . . . . 0.0 109.594 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.75 126.17 2.93 Favored 'Trans proline' 0 N--CA 1.402 -3.901 0 N-CA-C 107.898 -1.616 . . . . 0.0 107.898 170.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.4 mm -131.16 146.78 33.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.415 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 15.9 mm100 -67.62 162.05 24.39 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.051 0.453 . . . . 0.0 111.41 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -122.2 151.96 40.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 111.103 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.434 ' O ' HD21 ' A' ' 27' ' ' LEU . 16.2 ptt180 -135.53 154.32 51.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -92.35 136.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.737 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.2 t -66.19 132.61 48.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.623 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -51.03 -43.52 60.89 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.037 1.335 . . . . 0.0 110.631 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 40' ' ' CYS . 58.8 tttp -82.55 -52.11 7.15 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.018 -174.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.93 -22.23 18.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.58 8.62 86.12 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.037 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -87.06 128.3 56.23 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.88 114.93 4.16 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 122.356 2.037 . . . . 0.0 111.581 176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.434 HD21 ' O ' ' A' ' 18' ' ' ARG . 2.0 pt? -113.15 148.82 34.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.58 147.88 50.14 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 16' ' ' GLN . 85.6 mt -54.81 -32.95 60.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.069 0.461 . . . . 0.0 111.942 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -86.58 -12.04 49.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.562 0.745 . . . . 0.0 112.185 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.92 6.43 48.91 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 122.185 -0.322 . . . . 0.0 111.6 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.9 tp -51.92 -43.79 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.203 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.04 -47.86 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 123.084 0.24 . . . . 0.0 111.465 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.58 -54.71 35.67 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.148 0.579 . . . . 0.0 111.104 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -62.5 -45.84 91.18 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.628 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.31 -30.26 70.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -76.27 -27.04 56.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -94.68 -23.69 17.48 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.265 0.1 OUTLIER -81.27 148.03 29.64 Favored 'General case' 0 N--CA 1.393 -3.316 0 C-N-CA 117.633 -1.627 . . . . 0.0 110.473 -177.431 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 13.0 p -86.55 130.99 34.29 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.004 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.43 141.87 33.66 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.72 -33.54 4.15 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.92 160.44 21.44 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.29 -2.021 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.692 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.504 -0.802 0 CA-C-O 120.343 0.116 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.25 3.73 7.37 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.77 2.313 . . . . 0.0 110.819 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -151.12 146.02 25.86 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.67 155.74 21.84 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 123.847 0.717 . . . . 0.0 110.787 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -70.8 136.12 48.58 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.8 114.63 8.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.5 mm -128.17 105.28 13.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.13 136.26 48.09 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -89.65 107.58 19.69 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.51 128.14 9.35 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.666 2.244 . . . . 0.0 113.291 -171.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 11' ' ' LEU . 3.9 pp -113.59 90.02 3.24 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 122.911 1.338 . . . . 0.0 111.606 176.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -106.13 -40.98 5.48 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -92.96 151.91 41.03 Favored Pre-proline 0 CA--C 1.465 -2.298 0 CA-C-N 113.005 -1.907 . . . . 0.0 107.459 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.37 127.27 7.31 Favored 'Trans proline' 0 N--CA 1.404 -3.788 0 N-CA-C 107.525 -1.76 . . . . 0.0 107.525 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.4 mm -93.9 114.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 11.8 mm100 -108.72 153.36 23.56 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.98 -176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.62 122.96 42.72 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -122.42 145.22 48.48 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.0 m -86.86 139.54 17.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.214 0.53 . . . . 0.0 110.484 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.1 t -80.66 145.26 31.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.39 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -47.17 -67.25 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 126.712 2.005 . . . . 0.0 112.998 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -90.39 -11.22 41.17 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.1 m -101.74 -32.06 10.48 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.976 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.76 73.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.73 -176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -87.55 133.91 37.12 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.34 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.31 138.3 15.74 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.982 1.788 . . . . 0.0 110.389 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.37 155.15 45.12 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -81.13 144.31 31.77 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -57.32 -24.91 58.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -69.23 -25.15 64.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 121.708 0.765 . . . . 0.0 110.503 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.46 7.05 37.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.75 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 tp -51.47 -46.28 35.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.84 -40.79 88.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.52 -54.27 34.9 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -57.23 -52.24 66.13 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.674 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.35 -32.53 70.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.149 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 -22.71 27.94 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -110.41 3.03 19.34 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.046 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.303 0.4 OUTLIER -68.13 138.5 55.75 Favored 'General case' 0 N--CA 1.411 -2.424 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.814 -175.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.0 m -106.31 152.43 23.56 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.035 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.82 112.96 19.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.26 18.78 15.94 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -174.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.01 101.23 1.75 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.452 0.644 . . . . 0.0 109.513 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.419 -1.993 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -178.149 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 40.1 t30 . . . . . 0 C--O 1.236 0.382 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.94 135.31 23.08 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.164 1.91 . . . . 0.0 112.295 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -88.99 -34.6 16.78 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.91 95.66 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.747 1.619 . . . . 0.0 114.834 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.595 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -93.33 107.35 19.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.91 128.38 34.39 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -86.89 116.73 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-O 122.197 0.999 . . . . 0.0 110.521 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -99.69 147.86 24.97 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.01 116.02 53.64 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.19 143.96 73.22 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.297 1.998 . . . . 0.0 110.962 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.1 tp -80.63 89.96 5.73 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.56 -39.92 64.33 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.496 -173.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -97.75 122.29 55.43 Favored Pre-proline 0 CA--C 1.465 -2.305 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.59 125.78 7.79 Favored 'Trans proline' 0 N--CA 1.401 -3.945 0 CA-C-O 122.391 0.913 . . . . 0.0 109.993 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.6 mt -99.59 105.58 17.71 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.251 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.434 ' H ' HD22 ' A' ' 29' ' ' LEU . 13.7 mm100 -92.78 155.28 17.76 Favored 'General case' 0 C--N 1.269 -2.893 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.165 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -117.52 121.26 40.52 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.154 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.532 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 17.1 ttp85 -116.17 134.31 55.07 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.72 137.07 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.179 0.514 . . . . 0.0 111.785 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.36 143.46 48.59 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.692 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.42 -42.92 87.03 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.137 0.575 . . . . 0.0 110.474 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -74.11 -52.86 11.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -86.75 -23.37 25.5 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 37.56 94.09 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -122.48 125.54 26.45 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.39 118.71 5.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.936 2.424 . . . . 0.0 111.113 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 18' ' ' ARG . 4.3 pp -113.48 152.34 30.28 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.593 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.32 131.97 46.79 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.434 HD22 ' H ' ' A' ' 16' ' ' GLN . 1.5 pt? -51.18 -29.6 14.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -73.62 -30.22 62.84 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.985 0.514 . . . . 0.0 111.141 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.9 6.54 48.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -172.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.38 -44.64 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.97 -46.32 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.653 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -63.33 -48.95 75.89 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.499 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 15.6 t60 -58.94 -58.31 9.19 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.999 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.95 -22.43 66.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.017 0.437 . . . . 0.0 111.467 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.62 -51.7 12.25 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.422 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -109.3 5.38 23.58 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 117.831 -1.547 . . . . 0.0 113.375 -170.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.499 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.313 0.5 OUTLIER -45.72 134.83 7.24 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.609 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.0 m -52.16 113.26 0.97 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.541 -1.663 . . . . 0.0 114.192 -171.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.67 140.17 29.72 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.12 20.68 58.69 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.463 -175.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.26 143.71 34.0 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.545 -0.327 . . . . 0.0 110.259 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.774 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 88.0 mm-40 . . . . . 0 C--O 1.245 0.855 0 N-CA-C 111.346 0.128 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.95 150.2 50.34 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 123.705 0.628 . . . . 0.0 110.039 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -151.54 147.68 27.1 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.01 140.12 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.376 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.537 ' HB2' HD11 ' A' ' 27' ' ' LEU . 43.4 t -68.2 124.95 24.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -30.83 14.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.7 m -94.8 -30.52 14.18 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.917 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.44 3.13 81.82 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.496 0.559 . . . . 0.0 114.496 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 11.8 mptt -93.58 141.45 23.87 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 122.205 -0.585 . . . . 0.0 110.934 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.82 117.1 4.97 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.816 2.344 . . . . 0.0 110.96 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 20' ' ' CYS . 17.3 mt -105.59 125.77 51.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.215 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.08 152.76 23.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.493 ' O ' HG22 ' A' ' 32' ' ' ILE . 5.5 mp -56.56 -24.31 46.21 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -75.82 -28.18 58.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.782 -0.574 . . . . 0.0 110.678 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.6 -2.95 19.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 29' ' ' LEU . 7.1 tp -59.12 -42.22 85.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-O 120.423 0.154 . . . . 0.0 110.908 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.82 -51.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.22 -36.34 71.82 Favored 'General case' 0 C--O 1.26 1.608 0 CA-C-O 120.944 0.402 . . . . 0.0 111.1 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -64.17 -51.62 62.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.795 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 tt -58.58 -38.07 77.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.698 0.285 . . . . 0.0 110.339 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -68.64 -39.01 80.91 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -101.39 -6.54 23.91 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.059 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.417 -2.082 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.659 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 . . . . . 0 N--CA 1.439 -1.007 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 48.7 m-85 -111.77 121.39 44.96 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -129.9 150.78 51.04 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -86.78 132.4 32.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.471 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.08 139.48 58.72 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.726 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -53.16 -49.5 66.5 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.16 0.984 . . . . 0.0 112.057 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -88.1 -51.78 5.6 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.439 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 m -79.28 -18.24 53.09 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.471 -172.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.08 66.43 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-O 121.347 0.415 . . . . 0.0 112.445 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -96.76 141.36 22.97 Favored Pre-proline 0 N--CA 1.429 -1.52 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.56 119.28 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.185 2.59 . . . . 0.0 110.39 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 3.1 mm? -115.76 130.66 56.93 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.939 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.18 133.8 34.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -48.98 -30.69 6.32 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -67.96 -22.0 65.05 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 122.158 -0.339 . . . . 0.0 111.578 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.35 -0.8 10.88 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.262 0.554 . . . . 0.0 111.017 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.464 HD13 ' HG ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -66.87 -33.27 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.057 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 46.4 t -63.06 -58.14 8.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.757 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.407 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 4.2 p30 -63.26 -32.84 74.36 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.284 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 39.3 t60 -56.26 -55.06 37.99 Favored 'General case' 0 C--O 1.199 -1.557 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 32' ' ' ILE . 91.8 mt -56.89 -37.12 70.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.633 0.254 . . . . 0.0 111.247 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 55.1 mt-10 -69.99 -32.56 70.82 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -117.6 5.26 12.38 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.565 -0.709 . . . . 0.0 111.478 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.573 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.969 -176.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -115.34 138.09 51.34 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.049 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -115.81 132.65 56.58 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.14 120.62 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.886 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.38 118.98 10.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -51.67 -50.02 61.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -74.0 -33.08 63.68 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.205 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.3 m -89.12 -29.67 19.2 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.848 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.08 28.28 71.86 Favored Glycine 0 N--CA 1.463 0.494 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.18 129.18 24.42 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.844 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -85.01 115.17 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.577 2.185 . . . . 0.0 111.047 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -121.73 153.87 37.66 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.066 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.94 37.15 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.11 -15.68 35.84 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -72.73 -23.6 60.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.093 0.473 . . . . 0.0 111.196 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.06 6.88 9.75 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.565 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.438 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -52.7 -47.4 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 122.728 0.411 . . . . 0.0 111.682 -176.31 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 12.6 p -67.15 -38.69 81.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.306 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.92 -52.48 65.22 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.586 0.708 . . . . 0.0 110.308 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 25.8 t60 -61.03 -46.71 89.64 Favored 'General case' 0 C--O 1.201 -1.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.022 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tt -57.78 -39.47 77.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 24.7 mm-40 -76.82 -27.83 55.32 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.64 5.02 12.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.276 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.225 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -133.75 145.9 50.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.207 1.003 . . . . 0.0 109.931 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 38.4 ttm180 -141.95 137.06 30.99 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.74 123.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.268 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 t -61.21 140.37 57.94 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.61 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.86 -49.63 76.71 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.718 0.636 . . . . 0.0 110.541 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -78.82 -31.99 46.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.8 m -104.58 -36.62 7.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -171.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.57 -8.18 80.21 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.105 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -73.94 133.29 79.09 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 117.208 0.504 . . . . 0.0 111.654 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 43.6 Cg_endo -80.23 113.97 3.01 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.932 1.755 . . . . 0.0 110.071 171.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 154.12 30.9 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -74.87 146.01 42.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 123.402 0.439 . . . . 0.0 109.863 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' ILE . 4.3 mm? -65.04 -10.71 32.07 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.407 0.622 . . . . 0.0 111.842 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.24 -14.65 59.72 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.558 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.29 7.12 9.06 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.961 -0.462 . . . . 0.0 111.608 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 29' ' ' LEU . 8.0 tp -57.47 -48.56 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.96 -44.19 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.215 0.461 . . . . 0.0 111.186 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.38 -55.91 28.78 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.997 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -59.38 -50.22 74.79 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.829 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.22 -29.69 69.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.6 0.238 . . . . 0.0 111.49 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.39 -25.51 22.65 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.18 -10.65 21.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 O-C-N 121.822 -0.549 . . . . 0.0 111.459 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.316 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.028 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -169.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 . . . . . 0 N--CA 1.431 -1.388 0 CA-C-O 120.924 0.393 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -108.43 115.35 29.94 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.659 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -107.89 130.85 54.98 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.455 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 26.8 m -79.8 123.07 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.51 173.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.1 t -58.57 133.74 56.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.499 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -49.49 -56.55 9.42 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.932 1.395 . . . . 0.0 111.887 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.08 -38.21 18.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 119.189 -1.004 . . . . 0.0 113.508 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.03 -27.92 43.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.34 25.99 74.84 Favored Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.378 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 30.8 mmtm -103.29 128.31 27.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 123.474 0.709 . . . . 0.0 110.436 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -82.24 114.9 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.124 1.882 . . . . 0.0 110.906 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 157.35 36.77 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 140.81 45.26 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 32' ' ' ILE . 90.1 mt -56.36 -24.2 42.58 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -75.41 -10.13 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.94 -0.475 . . . . 0.0 112.101 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.3 5.97 12.67 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 120.878 0.371 . . . . 0.0 111.055 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 29' ' ' LEU . 10.9 tt -67.83 -44.35 85.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.29 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.97 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.1 -51.89 66.08 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.048 0.452 . . . . 0.0 110.096 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -59.12 -56.21 25.13 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.927 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.69 -21.66 66.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.973 0.416 . . . . 0.0 111.815 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.38 -34.01 20.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.568 175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -104.2 -7.49 20.07 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 121.301 -0.874 . . . . 0.0 111.827 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.412 -2.374 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -126.89 145.79 50.54 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.445 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 75.0 mtp180 -133.67 136.55 44.82 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 34.4 m -80.65 130.28 36.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.316 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 t -69.56 135.47 50.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.798 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.51 -45.17 85.27 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.622 0.576 . . . . 0.0 112.401 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.12 -47.23 16.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.846 0.355 . . . . 0.0 111.671 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.9 m -80.37 -36.75 33.57 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.99 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 5.24 90.11 Favored Glycine 0 N--CA 1.46 0.261 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.468 -176.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -101.24 130.79 24.15 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 51.7 Cg_endo -71.65 123.08 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.525 2.817 . . . . 0.0 112.698 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.95 149.39 30.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 150.93 33.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.6 mt -58.5 -28.76 65.7 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m -81.08 -7.21 59.51 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 121.676 0.75 . . . . 0.0 110.354 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.45 7.17 22.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.0 tp -52.77 -50.5 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.64 -47.5 76.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.062 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.76 -48.07 78.67 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.799 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.517 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 49.8 t60 -62.1 -55.94 23.89 Favored 'General case' 0 C--O 1.198 -1.648 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.086 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.8 pp -60.73 -27.8 68.2 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.841 -0.743 . . . . 0.0 112.863 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.06 -42.65 59.89 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.997 0.427 . . . . 0.0 111.057 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -98.66 -6.02 30.54 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.189 0.519 . . . . 0.0 111.115 -169.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.517 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.413 -2.304 0 C-N-CA 118.546 -1.262 . . . . 0.0 113.095 -172.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.545 ' HB2' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.028 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.43 143.27 47.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -150.32 129.58 12.83 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 27.3 m -73.94 142.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.821 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.2 t -67.92 137.34 55.14 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.379 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -57.46 -38.82 75.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.324 1.015 . . . . 0.0 111.382 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -104.5 -37.6 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.5 m -80.11 -22.52 42.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 119.764 -0.775 . . . . 0.0 112.326 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.18 -27.85 3.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.737 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -63.46 138.83 97.47 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 69.1 Cg_endo -78.33 128.45 8.89 Favored 'Trans proline' 0 C--O 1.249 1.04 0 C-N-CA 122.926 2.418 . . . . 0.0 111.63 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.98 164.06 26.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.271 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.25 147.04 26.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 16' ' ' GLN . 4.5 mm? -63.37 -18.45 63.69 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.006 0.431 . . . . 0.0 112.126 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.85 -1.85 44.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.32 6.65 5.32 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 16.6 tt -67.93 -36.74 76.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.24 -54.03 40.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.217 0 CA-C-O 120.739 0.304 . . . . 0.0 110.211 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.99 -49.51 71.28 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.078 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.22 -50.15 75.13 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.362 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.5 pp -66.43 -24.26 66.42 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.253 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -84.77 -26.25 27.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.915 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -91.6 -22.45 20.3 Favored 'General case' 0 CA--C 1.471 -2.067 0 C-N-CA 122.75 0.42 . . . . 0.0 110.394 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER . . . . . 0 N--CA 1.396 -3.142 0 C-N-CA 118.322 -1.351 . . . . 0.0 112.842 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 10.0 mp0 . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -136.13 136.48 40.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.075 -171.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -131.85 147.42 52.48 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 20.3 m -92.07 145.0 8.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.66 142.4 29.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -61.46 -65.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.14 0.427 . . . . 0.0 112.108 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.23 -37.75 84.08 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.8 m -86.5 -21.99 26.67 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.349 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.99 61.37 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 121.068 0.26 . . . . 0.0 112.591 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 32.1 mmtp -87.22 123.24 70.3 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-O 119.335 -0.364 . . . . 0.0 110.91 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -86.35 114.49 1.27 Allowed 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 121.827 1.685 . . . . 0.0 108.988 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -133.14 164.02 27.97 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -58.44 140.85 53.15 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.864 0.727 . . . . 0.0 111.224 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.472 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.4 pp -61.47 -14.62 30.26 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -85.59 -31.51 22.59 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.422 0.629 . . . . 0.0 109.863 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -14.29 50.95 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 29' ' ' LEU . 10.2 tp -62.14 -28.71 45.0 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.794 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.57 -53.51 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.352 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.31 -41.71 93.76 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.972 0.415 . . . . 0.0 110.161 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.27 -57.31 13.36 Favored 'General case' 0 C--O 1.205 -1.24 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -62.89 -29.1 70.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.087 0.47 . . . . 0.0 109.997 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.68 -36.49 65.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.549 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -111.25 4.83 19.47 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 121.462 -0.774 . . . . 0.0 110.546 -170.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.419 -2.015 0 C-N-CA 118.322 -1.351 . . . . 0.0 109.702 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.402 -2.827 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -136.03 146.52 47.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.359 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 45.6 ptt85 -145.58 159.35 43.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 33.7 m -79.35 145.51 9.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 120.134 -0.627 . . . . 0.0 112.049 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HB2' HD22 ' A' ' 27' ' ' LEU . 15.7 t -83.38 144.55 29.57 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.48 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.84 -64.23 0.89 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.59 1.156 . . . . 0.0 112.0 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -71.51 -51.92 21.09 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.8 m -75.7 -30.23 59.26 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.03 11.32 74.48 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -99.67 129.48 28.74 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 37.9 Cg_endo -68.02 115.74 3.96 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.859 2.373 . . . . 0.0 112.521 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 27' ' ' LEU . 2.6 pt? -111.37 154.99 23.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -78.45 148.94 33.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.16 -19.48 63.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 110.179 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -82.75 -2.12 53.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.95 6.5 10.86 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.058 0.543 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.01 -42.28 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.33 -61.0 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.077 0 O-C-N 123.238 0.337 . . . . 0.0 111.159 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.16 -47.68 84.9 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 123.325 0.65 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.443 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 44.2 t60 -59.06 -53.49 57.77 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.858 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.49 -28.7 68.77 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.082 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -77.2 -28.33 53.87 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 122.229 -0.294 . . . . 0.0 111.534 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -100.86 -30.66 11.55 Favored 'General case' 0 CA--C 1.49 -1.359 0 O-C-N 121.497 -0.752 . . . . 0.0 111.165 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.34 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.39 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -165.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.84 115.35 30.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -101.25 124.87 47.63 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.343 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.83 129.57 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -64.87 131.56 47.05 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.861 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -57.39 -37.21 72.32 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.148 0.979 . . . . 0.0 111.686 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.09 -47.69 10.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.33 0.586 . . . . 0.0 111.809 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.0 m -90.41 -21.15 22.08 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.07 33.9 87.23 Favored Glycine 0 N--CA 1.476 1.356 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -118.45 121.03 31.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -82.75 135.92 8.08 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 123.049 2.5 . . . . 0.0 113.697 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.481 HD11 ' HA ' ' A' ' 32' ' ' ILE . 1.7 pt? -146.79 169.28 19.42 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.752 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 137.07 43.27 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.86 0.362 . . . . 0.0 110.366 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -59.07 -14.63 10.42 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.922 0.889 . . . . 0.0 113.027 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -82.35 -9.19 59.56 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.105 0.479 . . . . 0.0 110.816 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 6.45 5.24 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.097 0.475 . . . . 0.0 110.704 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HA ' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -63.5 -35.63 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 -174.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.92 -46.96 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.313 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.95 -48.03 82.96 Favored 'General case' 0 C--O 1.273 2.329 0 CA-C-O 121.461 0.648 . . . . 0.0 110.061 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.5 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 28.6 t60 -54.97 -56.76 16.11 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.911 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.45 -35.48 72.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.831 0.348 . . . . 0.0 110.655 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -66.45 -37.97 86.33 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.162 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -117.41 4.73 12.5 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 118.72 -1.192 . . . . 0.0 113.202 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.303 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -169.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.506 ' HB2' HD22 ' A' ' 29' ' ' LEU . 8.2 mp0 . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 121.85 0.833 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -139.89 137.22 34.68 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.844 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -128.92 144.71 51.26 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 23.1 m -85.91 136.92 21.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.136 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -67.98 120.41 14.19 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 28.0 mp0 -54.37 -45.08 72.71 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 123.843 0.715 . . . . 0.0 111.027 -175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -69.18 -38.58 78.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.157 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 60.8 m -98.62 -22.91 15.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.2 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.12 25.3 69.18 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -103.45 111.61 65.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.641 -173.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -72.87 121.35 7.27 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.79 1.66 . . . . 0.0 110.278 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 32' ' ' ILE . 3.3 pp -126.06 148.69 49.28 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.987 -176.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.23 149.96 49.73 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.59 0.556 . . . . 0.0 109.736 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 16' ' ' GLN . 1.9 pt? -52.62 -32.68 42.94 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.803 0.689 . . . . 0.0 111.682 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -77.4 -21.48 53.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.915 0.486 . . . . 0.0 111.118 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 3.22 40.59 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -58.3 -50.5 78.3 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.48 -41.04 90.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.8 -56.25 24.61 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.304 0.573 . . . . 0.0 109.512 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -60.66 -48.26 82.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.43 -27.12 68.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.883 0.373 . . . . 0.0 110.546 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.95 -34.37 22.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.234 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -103.15 4.65 37.17 Favored 'General case' 0 CA--C 1.478 -1.822 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.477 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.409 -2.48 0 C-N-CA 118.013 -1.475 . . . . 0.0 109.605 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 80.7 mm-40 . . . . . 0 N--CA 1.425 -1.722 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -108.86 129.69 55.41 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.392 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -122.5 128.1 50.39 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.7 m -74.6 131.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.108 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.4 t -65.63 117.73 8.51 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.44 -19.75 62.32 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -52.3 4.97 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.736 0.303 . . . . 0.0 110.478 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.7 m -87.38 -16.65 34.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.24 38.97 95.74 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 47.1 mmtm -117.26 129.08 25.58 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 16.2 Cg_exo -68.31 114.94 3.62 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.705 2.27 . . . . 0.0 111.632 177.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -109.72 124.81 51.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 123.302 0.641 . . . . 0.0 110.61 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -72.33 146.85 46.84 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 16' ' ' GLN . 6.6 mp -50.28 -18.79 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -174.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -89.6 -37.22 14.82 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.988 1.267 . . . . 0.0 110.33 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.3 -12.57 43.16 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.75 -38.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.03 -48.19 89.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.074 0.234 . . . . 0.0 110.943 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.26 -56.78 16.8 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 31.5 t60 -54.83 -56.16 22.47 Favored 'General case' 0 C--O 1.204 -1.335 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.47 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.68 -28.02 69.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.081 0.467 . . . . 0.0 110.519 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -77.72 -36.96 50.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.5 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -108.44 0.13 20.87 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.497 -1.281 . . . . 0.0 111.454 -172.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.412 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.426 -1.664 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.164 -173.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.419 -1.981 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -131.41 154.54 48.54 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.183 -1.372 . . . . 0.0 108.604 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -145.71 137.75 25.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 33.1 m -86.31 154.75 3.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.61 -176.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.96 142.08 29.06 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.705 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.08 -46.88 72.95 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.188 0.305 . . . . 0.0 110.635 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -73.76 -52.13 14.19 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 16.5 m -86.29 -25.32 25.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -172.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.81 -33.19 3.32 Favored Glycine 0 N--CA 1.469 0.847 0 O-C-N 121.86 -0.525 . . . . 0.0 113.314 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 40.1 mmtm -52.34 135.88 41.42 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 123.93 0.892 . . . . 0.0 113.024 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 5.2 Cg_exo -73.81 123.49 8.52 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.568 2.178 . . . . 0.0 110.143 172.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 mt -104.01 156.45 17.85 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.44 139.69 58.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 1.1 tm? -44.53 -54.33 6.14 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 124.078 0.951 . . . . 0.0 113.439 -171.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -90.77 6.12 45.49 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.36 0.6 . . . . 0.0 111.929 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.46 -2.74 57.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.53 0.681 . . . . 0.0 109.757 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -33.57 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.6 -61.01 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 122.873 0.469 . . . . 0.0 110.36 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.155 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 47.6 t60 -57.89 -52.88 63.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.752 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.25 -35.17 74.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.17 -34.5 77.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -113.0 -1.95 14.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.391 -0.924 . . . . 0.0 113.023 -172.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.441 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 120.57 0.224 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.91 131.74 51.05 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.061 0.851 . . . . 0.0 109.849 -174.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -115.99 131.12 57.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.98 134.78 29.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.676 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.445 ' HB2' HD11 ' A' ' 27' ' ' LEU . 43.1 t -67.95 126.05 28.25 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.38 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.1 mp0 -59.03 -29.47 67.31 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.677 0.791 . . . . 0.0 110.762 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HD2' ' SG ' ' A' ' 23' ' ' CYS . 12.9 tmtt? -87.92 -52.54 5.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.151 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 22' ' ' LYS . 18.0 m -93.46 -14.51 26.62 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.66 99.8 Favored Glycine 0 N--CA 1.463 0.456 0 CA-C-O 121.432 0.462 . . . . 0.0 112.433 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -125.45 140.33 36.06 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.02 115.03 4.15 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.667 2.245 . . . . 0.0 112.128 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 20' ' ' CYS . 16.2 mt -99.81 120.7 40.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.05 150.45 45.55 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.441 ' O ' HG22 ' A' ' 32' ' ' ILE . 93.4 mt -56.43 -27.17 55.84 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.768 0.794 . . . . 0.0 110.874 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -71.43 -27.14 63.08 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.609 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.64 5.96 15.55 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.4 tp -60.58 -42.4 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.89 -47.0 71.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.82 -51.58 68.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.035 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -62.94 -54.05 44.6 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.028 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -62.36 -26.83 68.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.311 0.96 . . . . 0.0 112.764 -176.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -79.41 -36.37 39.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.072 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.5 -1.24 21.56 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.348 -169.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.416 -2.15 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.195 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -120.36 138.08 53.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -124.99 135.39 52.75 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -98.98 142.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.147 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -86.88 133.74 33.59 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -50.61 72.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -66.17 -47.87 72.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.008 0.432 . . . . 0.0 111.846 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 m -79.51 -32.91 42.44 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.676 -175.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 21.36 76.33 Favored Glycine 0 N--CA 1.461 0.345 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -95.79 123.24 56.47 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -83.81 121.56 2.89 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.467 2.111 . . . . 0.0 110.986 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.53 164.55 14.42 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.364 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 150.6 37.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -55.89 -25.61 43.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.071 0.548 . . . . 0.0 111.869 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -86.09 -33.65 20.87 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.837 0.855 . . . . 0.0 111.517 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.57 6.19 42.22 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.158 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 tp -55.1 -43.44 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.444 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.83 -39.13 84.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.26 -51.99 60.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 37.1 t60 -57.83 -53.17 61.21 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.419 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.41 -31.76 71.69 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.891 0.377 . . . . 0.0 110.812 -174.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -72.98 -41.09 64.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -110.18 5.46 21.92 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.151 -170.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.427 -1.586 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.367 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 120.918 0.39 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 61.3 m-85 -120.66 148.26 44.16 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.999 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -147.12 138.48 24.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.06 131.61 34.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.867 0.841 . . . . 0.0 111.225 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -76.8 138.37 39.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.137 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.6 -49.65 74.29 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 124.271 1.028 . . . . 0.0 111.231 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -78.34 -11.28 59.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.6 m -128.07 -34.35 2.12 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.849 -1.14 . . . . 0.0 113.86 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.98 89.19 Favored Glycine 0 C--O 1.226 -0.358 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.27 124.85 82.33 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 123.962 0.905 . . . . 0.0 109.523 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.32 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.923 1.749 . . . . 0.0 109.111 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -109.96 157.55 19.16 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.026 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.58 142.28 29.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 124.1 0.875 . . . . 0.0 109.408 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HG22 ' A' ' 32' ' ' ILE . 82.3 mt -56.28 -34.07 66.09 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 m -77.74 6.18 7.95 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.835 0.826 . . . . 0.0 111.206 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.45 6.79 4.14 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.72 -0.613 . . . . 0.0 110.795 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 11.3 tt -62.07 -43.37 97.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -174.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.27 -41.39 92.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.106 0.479 . . . . 0.0 110.278 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.88 -56.72 18.62 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.835 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -58.07 -52.78 64.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.599 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -63.18 -21.67 66.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.608 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.48 -34.42 21.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.168 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -109.06 4.11 22.75 Favored 'General case' 0 CA--C 1.476 -1.885 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.246 -171.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.411 -2.412 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.639 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 N--CA 1.43 -1.435 0 CA-C-O 121.114 0.483 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.94 156.75 22.46 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.1 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -141.71 129.12 21.24 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.939 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.0 m -73.87 143.91 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.5 t -79.14 143.06 35.83 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.246 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -45.16 -55.57 5.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.755 1.622 . . . . 0.0 111.821 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -100.94 -34.63 9.7 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.459 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.8 m -82.52 -20.14 37.28 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.131 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.42 -36.12 1.56 Allowed Glycine 0 N--CA 1.473 1.108 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.579 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -51.89 139.53 31.96 Favored Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 124.581 1.152 . . . . 0.0 112.462 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.3 125.9 4.69 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.941 2.428 . . . . 0.0 112.531 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.53 150.86 27.53 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.234 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.95 45.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.482 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.0 pt? -54.69 -30.11 54.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -82.26 -25.53 34.0 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.778 -0.576 . . . . 0.0 110.832 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.84 -9.71 39.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 29' ' ' LEU . 7.4 tp -61.82 -34.68 63.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.93 -52.41 59.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.45 -48.79 80.3 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -57.37 -52.79 63.93 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -25.86 68.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -72.71 -43.48 62.94 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.683 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -110.42 4.94 21.05 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.264 -0.898 . . . . 0.0 112.705 -170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.972 0 C-N-CA 119.27 -0.972 . . . . 0.0 112.462 -176.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.425 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 88.6 mm-40 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 121.051 0.453 . . . . 0.0 111.41 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -122.2 151.96 40.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 111.103 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.43 ' O ' HD23 ' A' ' 27' ' ' LEU . 16.2 ptt180 -135.53 154.32 51.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -92.35 136.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.737 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.2 t -66.19 132.61 48.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.623 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -51.03 -43.52 60.89 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.037 1.335 . . . . 0.0 110.631 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -82.55 -52.11 7.15 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.018 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.93 -22.23 18.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.58 8.62 86.12 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.037 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -87.06 128.3 56.23 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.88 114.93 4.16 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 122.356 2.037 . . . . 0.0 111.581 176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 27' ' ' LEU . 2.0 pt? -113.15 148.82 34.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.58 147.88 50.14 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 16' ' ' GLN . 85.6 mt -54.81 -32.95 60.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.069 0.461 . . . . 0.0 111.942 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -86.58 -12.04 49.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.562 0.745 . . . . 0.0 112.185 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.92 6.43 48.91 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 122.185 -0.322 . . . . 0.0 111.6 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.9 tp -51.92 -43.79 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.203 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.04 -47.86 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 123.084 0.24 . . . . 0.0 111.465 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.58 -54.71 35.67 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.148 0.579 . . . . 0.0 111.104 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -62.5 -45.84 91.18 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.628 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.31 -30.26 70.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -76.27 -27.04 56.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -94.68 -23.69 17.48 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.265 0.0 OUTLIER . . . . . 0 N--CA 1.393 -3.316 0 C-N-CA 117.633 -1.627 . . . . 0.0 110.473 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 64.2 mm-40 . . . . . 0 N--CA 1.424 -1.731 0 CA-C-O 120.956 0.408 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.62 122.96 42.72 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -122.42 145.22 48.48 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.0 m -86.86 139.54 17.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.214 0.53 . . . . 0.0 110.484 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.1 t -80.66 145.26 31.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.39 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -47.17 -67.25 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 126.712 2.005 . . . . 0.0 112.998 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -90.39 -11.22 41.17 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.1 m -101.74 -32.06 10.48 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.976 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.76 73.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.73 -176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -87.55 133.91 37.12 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.34 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.31 138.3 15.74 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.982 1.788 . . . . 0.0 110.389 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.37 155.15 45.12 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -81.13 144.31 31.77 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -57.32 -24.91 58.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -69.23 -25.15 64.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 121.708 0.765 . . . . 0.0 110.503 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.46 7.05 37.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.75 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 tp -51.47 -46.28 35.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.84 -40.79 88.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.52 -54.27 34.9 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -57.23 -52.24 66.13 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.674 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.35 -32.53 70.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.149 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 -22.71 27.94 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -110.41 3.03 19.34 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.046 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.303 0.4 OUTLIER . . . . . 0 N--CA 1.411 -2.424 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.814 -175.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 . . . . . 0 N--CA 1.427 -1.592 0 CA-C-O 120.995 0.426 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 29.9 m-85 -117.52 121.26 40.52 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.154 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 17.1 ttp85 -116.17 134.31 55.07 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.72 137.07 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.179 0.514 . . . . 0.0 111.785 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.36 143.46 48.59 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.692 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.42 -42.92 87.03 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.137 0.575 . . . . 0.0 110.474 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -74.11 -52.86 11.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -86.75 -23.37 25.5 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 37.56 94.09 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -122.48 125.54 26.45 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.39 118.71 5.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.936 2.424 . . . . 0.0 111.113 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 18' ' ' ARG . 4.3 pp -113.48 152.34 30.28 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.593 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.32 131.97 46.79 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -51.18 -29.6 14.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -73.62 -30.22 62.84 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.985 0.514 . . . . 0.0 111.141 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.9 6.54 48.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -172.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.38 -44.64 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.97 -46.32 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.653 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -63.33 -48.95 75.89 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.427 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.6 t-80 -58.94 -58.31 9.19 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.999 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.95 -22.43 66.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.017 0.437 . . . . 0.0 111.467 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.62 -51.7 12.25 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.422 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -109.3 5.38 23.58 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 117.831 -1.547 . . . . 0.0 113.375 -170.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.313 0.5 OUTLIER . . . . . 0 C--O 1.245 0.843 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 . . . . . 0 C--O 1.238 0.455 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.24 89.58 1.31 Allowed 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 121.473 1.448 . . . . 0.0 111.61 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -87.16 -42.57 12.9 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.971 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.89 -0.19 9.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.735 0.778 . . . . 0.0 108.982 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -81.3 127.02 32.27 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.649 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.6 tp -117.54 119.89 36.42 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.115 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mm -85.78 100.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.56 130.98 44.73 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.157 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.15 128.53 93.89 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.08 122.74 7.84 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 120.581 0.854 . . . . 0.0 112.256 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.8 tp -105.07 89.92 3.29 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -104.8 51.63 0.76 Allowed 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 122.344 1.069 . . . . 0.0 109.005 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -121.33 98.94 46.24 Favored Pre-proline 0 CA--C 1.47 -2.134 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.26 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -63.86 127.23 19.04 Favored 'Trans proline' 0 N--CA 1.428 -2.372 0 N-CA-C 107.218 -1.878 . . . . 0.0 107.218 166.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.6 mt -97.54 130.13 46.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 88.0 mm-40 -87.31 158.63 19.01 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 123.296 0.372 . . . . 0.0 111.346 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.95 150.2 50.34 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 123.705 0.628 . . . . 0.0 110.039 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -151.54 147.68 27.1 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.01 140.12 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.376 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.537 ' HB2' HD11 ' A' ' 27' ' ' LEU . 43.4 t -68.2 124.95 24.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -30.83 14.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.7 m -94.8 -30.52 14.18 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.917 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.44 3.13 81.82 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.496 0.559 . . . . 0.0 114.496 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 11.8 mptt -93.58 141.45 23.87 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 122.205 -0.585 . . . . 0.0 110.934 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.82 117.1 4.97 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.816 2.344 . . . . 0.0 110.96 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 20' ' ' CYS . 17.3 mt -105.59 125.77 51.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.215 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.08 152.76 23.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.493 ' O ' HG22 ' A' ' 32' ' ' ILE . 5.5 mp -56.56 -24.31 46.21 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -75.82 -28.18 58.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.782 -0.574 . . . . 0.0 110.678 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.6 -2.95 19.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 29' ' ' LEU . 7.1 tp -59.12 -42.22 85.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-O 120.423 0.154 . . . . 0.0 110.908 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.82 -51.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.22 -36.34 71.82 Favored 'General case' 0 C--O 1.26 1.608 0 CA-C-O 120.944 0.402 . . . . 0.0 111.1 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -64.17 -51.62 62.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.795 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 tt -58.58 -38.07 77.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.698 0.285 . . . . 0.0 110.339 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -68.64 -39.01 80.91 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -101.39 -6.54 23.91 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.059 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.67 154.17 39.8 Favored 'General case' 0 N--CA 1.417 -2.082 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.659 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.1 m -106.82 143.86 34.29 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.57 113.57 17.82 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.36 18.4 12.05 Favored Glycine 0 C--N 1.301 -1.377 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.76 115.39 11.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.29 -2.011 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 . . . . . 0 C--O 1.205 -1.239 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.27 -10.06 15.01 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.253 1.969 . . . . 0.0 111.289 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -95.94 6.75 48.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.01 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.45 114.09 7.17 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -54.76 121.72 9.16 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.42 127.94 34.81 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.0 tt -138.12 131.08 40.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.719 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.74 113.41 16.79 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.17 152.6 42.74 Favored Pre-proline 0 C--N 1.296 -1.744 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.794 -174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.21 124.42 16.22 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.526 2.817 . . . . 0.0 113.104 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.4 pt? -131.13 162.37 30.05 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.5 -11.95 50.27 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.039 0.447 . . . . 0.0 111.093 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -85.61 130.39 51.29 Favored Pre-proline 0 CA--C 1.479 -1.763 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.66 175.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -87.3 127.72 2.5 Favored 'Trans proline' 0 N--CA 1.408 -3.52 0 C-N-CA 121.369 1.38 . . . . 0.0 108.739 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.48 104.28 13.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 122.354 1.073 . . . . 0.0 110.106 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -100.66 164.77 11.72 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.021 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 48.7 m-85 -111.77 121.39 44.96 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -129.9 150.78 51.04 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -86.78 132.4 32.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.471 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.08 139.48 58.72 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.726 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -53.16 -49.5 66.5 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.16 0.984 . . . . 0.0 112.057 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -88.1 -51.78 5.6 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.439 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 m -79.28 -18.24 53.09 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.471 -172.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.08 66.43 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-O 121.347 0.415 . . . . 0.0 112.445 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -96.76 141.36 22.97 Favored Pre-proline 0 N--CA 1.429 -1.52 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.56 119.28 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.185 2.59 . . . . 0.0 110.39 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 3.1 mm? -115.76 130.66 56.93 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.939 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.18 133.8 34.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -48.98 -30.69 6.32 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -67.96 -22.0 65.05 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 122.158 -0.339 . . . . 0.0 111.578 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.35 -0.8 10.88 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.262 0.554 . . . . 0.0 111.017 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.464 HD13 ' HG ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -66.87 -33.27 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.057 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 46.4 t -63.06 -58.14 8.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.757 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.407 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 4.2 p30 -63.26 -32.84 74.36 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.284 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 39.3 t60 -56.26 -55.06 37.99 Favored 'General case' 0 C--O 1.199 -1.557 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 32' ' ' ILE . 91.8 mt -56.89 -37.12 70.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.633 0.254 . . . . 0.0 111.247 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 55.1 mt-10 -69.99 -32.56 70.82 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -117.6 5.26 12.38 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.565 -0.709 . . . . 0.0 111.478 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -77.69 163.23 26.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.969 -176.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 5.0 p -93.39 116.71 29.26 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.706 0.765 . . . . 0.0 112.43 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.23 142.05 39.74 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.15 3.74 65.17 Favored Glycine 0 C--N 1.302 -1.307 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.96 110.86 1.12 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.185 0.594 . . . . 0.0 110.501 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.414 -2.256 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.984 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.2 t30 . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.8 131.75 17.54 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 121.861 1.707 . . . . 0.0 112.151 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -84.33 -45.07 13.17 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.88 -164.38 1.04 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -76.92 138.66 39.85 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.979 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.66 114.58 10.95 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 tt -134.53 136.92 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.408 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.94 120.18 33.0 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.82 119.3 68.97 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.12 145.43 96.43 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.449 2.099 . . . . 0.0 110.553 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.73 90.41 5.81 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.641 0.734 . . . . 0.0 109.136 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -103.15 125.48 49.87 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.417 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -70.66 119.75 74.72 Favored Pre-proline 0 CA--C 1.471 -2.09 0 O-C-N 123.718 0.636 . . . . 0.0 112.061 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -65.68 126.83 16.74 Favored 'Trans proline' 0 N--CA 1.426 -2.466 0 C-N-CA 121.77 1.647 . . . . 0.0 108.794 170.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mm -95.43 126.13 47.99 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -88.62 148.68 23.94 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.338 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -115.34 138.09 51.34 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.049 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -115.81 132.65 56.58 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.14 120.62 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.886 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.38 118.98 10.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -51.67 -50.02 61.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 5.4 ptpp? -74.0 -33.08 63.68 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.205 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.3 m -89.12 -29.67 19.2 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.848 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.08 28.28 71.86 Favored Glycine 0 N--CA 1.463 0.494 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.18 129.18 24.42 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.844 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -85.01 115.17 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.577 2.185 . . . . 0.0 111.047 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -121.73 153.87 37.66 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.066 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.94 37.15 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.11 -15.68 35.84 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -72.73 -23.6 60.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.093 0.473 . . . . 0.0 111.196 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.06 6.88 9.75 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.565 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.438 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -52.7 -47.4 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 122.728 0.411 . . . . 0.0 111.682 -176.31 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 12.6 p -67.15 -38.69 81.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.306 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.92 -52.48 65.22 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.586 0.708 . . . . 0.0 110.308 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 25.8 t60 -61.03 -46.71 89.64 Favored 'General case' 0 C--O 1.201 -1.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.022 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tt -57.78 -39.47 77.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 24.7 mm-40 -76.82 -27.83 55.32 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.64 5.02 12.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.276 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -72.86 163.1 28.65 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.2 t -88.76 126.98 35.58 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.385 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.11 151.47 22.2 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.54 20.58 21.85 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.815 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.53 111.46 19.1 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.408 0.623 . . . . 0.0 110.291 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--N 1.3 -1.577 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.9 170.42 16.73 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.463 2.109 . . . . 0.0 112.746 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -103.7 -66.82 0.92 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.56 -48.67 0.05 OUTLIER 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -78.81 158.3 28.21 Favored 'General case' 0 C--O 1.259 1.587 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 168.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.91 148.29 38.35 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.0 mm -82.67 102.69 8.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.249 0.547 . . . . 0.0 109.681 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -98.29 111.97 24.13 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.128 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -113.76 130.59 23.65 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.51 124.56 16.58 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.826 2.351 . . . . 0.0 113.497 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 pp -103.97 147.24 27.59 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.073 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 66.62 -61.63 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.45 1.5 . . . . 0.0 111.436 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -92.09 122.16 65.49 Favored Pre-proline 0 CA--C 1.475 -1.937 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -88.01 126.58 2.07 Favored 'Trans proline' 0 N--CA 1.401 -3.945 0 CA-C-O 121.952 0.73 . . . . 0.0 111.07 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.3 mm -94.38 100.1 10.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.514 ' H ' ' CD ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -83.61 110.18 18.04 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 113.023 -1.899 . . . . 0.0 112.142 -169.392 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -133.75 145.9 50.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.207 1.003 . . . . 0.0 109.931 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 38.4 ttm180 -141.95 137.06 30.99 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.74 123.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.268 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 t -61.21 140.37 57.94 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.61 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.86 -49.63 76.71 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.718 0.636 . . . . 0.0 110.541 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -78.82 -31.99 46.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.602 ' HB3' ' OXT' ' A' ' 44' ' ' SER . 35.8 m -104.58 -36.62 7.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -171.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.57 -8.18 80.21 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.105 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.55 ' HG3' ' OXT' ' A' ' 44' ' ' SER . 30.9 mtmm -73.94 133.29 79.09 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 117.208 0.504 . . . . 0.0 111.654 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 43.6 Cg_endo -80.23 113.97 3.01 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.932 1.755 . . . . 0.0 110.071 171.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 154.12 30.9 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -74.87 146.01 42.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 123.402 0.439 . . . . 0.0 109.863 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' ILE . 4.3 mm? -65.04 -10.71 32.07 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.407 0.622 . . . . 0.0 111.842 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.24 -14.65 59.72 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.558 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.29 7.12 9.06 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.961 -0.462 . . . . 0.0 111.608 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 29' ' ' LEU . 8.0 tp -57.47 -48.56 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.96 -44.19 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.215 0.461 . . . . 0.0 111.186 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.38 -55.91 28.78 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.997 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -59.38 -50.22 74.79 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.829 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.22 -29.69 69.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.6 0.238 . . . . 0.0 111.49 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.39 -25.51 22.65 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.18 -10.65 21.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 O-C-N 121.822 -0.549 . . . . 0.0 111.459 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.316 0.3 OUTLIER -64.37 120.95 13.2 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -169.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.9 t -105.94 142.21 36.03 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.396 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.05 144.07 57.51 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.04 -33.16 6.03 Favored Glycine 0 C--N 1.297 -1.626 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.96 101.79 13.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.602 ' OXT' ' HB3' ' A' ' 23' ' ' CYS . 16.8 t . . . . . 0 N--CA 1.422 -1.864 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.492 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 50.2 t30 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 1' ' ' ASN . 53.2 Cg_endo -92.83 48.92 0.42 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 121.664 1.576 . . . . 0.0 112.237 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 74.74 -60.12 0.53 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.236 1.414 . . . . 0.0 111.886 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.61 -70.98 0.28 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.09 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -99.04 158.65 15.52 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.426 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.88 121.36 19.87 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 tt -83.55 131.66 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 169.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.99 114.67 24.83 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.25 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 34.6 t70 -64.13 122.72 79.23 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.164 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 9' ' ' ASP . 23.7 Cg_exo -64.49 164.61 22.89 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.244 2.629 . . . . 0.0 113.955 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.5 tp -70.73 150.1 46.26 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.741 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.54 96.49 2.43 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.418 0.627 . . . . 0.0 110.204 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -113.57 124.73 30.7 Favored Pre-proline 0 C--N 1.277 -2.581 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.921 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -88.64 126.98 1.89 Allowed 'Trans proline' 0 N--CA 1.402 -3.867 0 C-N-CA 120.892 1.061 . . . . 0.0 110.22 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.5 mt -107.47 126.68 63.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -91.34 155.75 18.28 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.493 0.495 . . . . 0.0 110.73 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -108.43 115.35 29.94 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.659 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -107.89 130.85 54.98 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.455 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 26.8 m -79.8 123.07 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.51 173.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.1 t -58.57 133.74 56.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.499 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -49.49 -56.55 9.42 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.932 1.395 . . . . 0.0 111.887 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.08 -38.21 18.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 119.189 -1.004 . . . . 0.0 113.508 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.03 -27.92 43.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.34 25.99 74.84 Favored Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.378 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 30.8 mmtm -103.29 128.31 27.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 123.474 0.709 . . . . 0.0 110.436 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -82.24 114.9 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.124 1.882 . . . . 0.0 110.906 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 157.35 36.77 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 140.81 45.26 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 32' ' ' ILE . 90.1 mt -56.36 -24.2 42.58 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -75.41 -10.13 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.94 -0.475 . . . . 0.0 112.101 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.3 5.97 12.67 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 120.878 0.371 . . . . 0.0 111.055 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 29' ' ' LEU . 10.9 tt -67.83 -44.35 85.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.29 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.97 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.1 -51.89 66.08 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.048 0.452 . . . . 0.0 110.096 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -59.12 -56.21 25.13 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.927 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 39' ' ' HIS . 28.0 tp -63.69 -21.66 66.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.973 0.416 . . . . 0.0 111.815 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.38 -34.01 20.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.568 175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -104.2 -7.49 20.07 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 121.301 -0.874 . . . . 0.0 111.827 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.421 ' CE1' HD12 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -62.53 133.43 54.94 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.9 t -81.91 111.18 17.87 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.666 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.15 131.75 47.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.04 -30.96 7.59 Favored Glycine 0 C--N 1.298 -1.557 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.48 98.94 11.21 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.301 -1.517 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.756 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.4 111.42 3.26 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.142 1.895 . . . . 0.0 108.863 173.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -111.42 155.58 22.94 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.978 0.418 . . . . 0.0 111.664 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.3 -177.49 3.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -75.96 107.55 8.23 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.439 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -96.03 114.56 26.28 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tt -93.82 125.6 46.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.457 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -79.62 116.06 19.6 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.527 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.21 141.92 86.65 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.12 123.49 11.06 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.071 2.514 . . . . 0.0 113.083 -175.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 86.7 mt -114.79 88.42 2.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 22.2 t70 162.79 134.59 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 126.109 1.764 . . . . 0.0 106.515 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -113.67 105.66 54.6 Favored Pre-proline 0 CA--C 1.466 -2.259 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.822 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -60.32 126.51 20.27 Favored 'Trans proline' 0 N--CA 1.426 -2.488 0 N-CA-C 107.315 -1.84 . . . . 0.0 107.315 167.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 pt -129.73 103.15 8.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-O 122.603 1.192 . . . . 0.0 108.81 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.543 ' H ' ' CD ' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -87.39 109.16 19.36 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 113.719 -1.582 . . . . 0.0 108.107 -171.118 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -126.89 145.79 50.54 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.445 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 75.0 mtp180 -133.67 136.55 44.82 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 34.4 m -80.65 130.28 36.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.316 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 t -69.56 135.47 50.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.798 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.51 -45.17 85.27 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.622 0.576 . . . . 0.0 112.401 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.12 -47.23 16.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.846 0.355 . . . . 0.0 111.671 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.9 m -80.37 -36.75 33.57 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.99 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 5.24 90.11 Favored Glycine 0 N--CA 1.46 0.261 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.468 -176.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -101.24 130.79 24.15 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 51.7 Cg_endo -71.65 123.08 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.525 2.817 . . . . 0.0 112.698 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.95 149.39 30.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 150.93 33.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.6 mt -58.5 -28.76 65.7 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m -81.08 -7.21 59.51 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 121.676 0.75 . . . . 0.0 110.354 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.45 7.17 22.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.0 tp -52.77 -50.5 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.64 -47.5 76.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.062 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.76 -48.07 78.67 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.799 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.517 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 49.8 t60 -62.1 -55.94 23.89 Favored 'General case' 0 C--O 1.198 -1.648 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.086 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.8 pp -60.73 -27.8 68.2 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.841 -0.743 . . . . 0.0 112.863 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.06 -42.65 59.89 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.997 0.427 . . . . 0.0 111.057 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -98.66 -6.02 30.54 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.189 0.519 . . . . 0.0 111.115 -169.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.517 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -74.61 158.98 32.74 Favored 'General case' 0 N--CA 1.413 -2.304 0 C-N-CA 118.546 -1.262 . . . . 0.0 113.095 -172.253 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.5 t -55.12 110.96 0.75 Allowed 'General case' 0 C--O 1.248 0.996 0 O-C-N 124.353 1.033 . . . . 0.0 111.754 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.76 158.02 25.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.351 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.45 13.48 35.41 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.29 113.6 9.5 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 123.299 0.64 . . . . 0.0 110.119 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 C--N 1.292 -1.903 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.913 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -62.71 -44.05 18.6 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.32 2.013 . . . . 0.0 112.553 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -97.51 164.99 12.21 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.58 5.6 6.19 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.639 0.733 . . . . 0.0 109.497 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -76.47 140.98 41.46 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.702 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -76.87 126.46 31.01 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -66.71 131.65 32.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.987 0.422 . . . . 0.0 110.027 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -85.01 166.38 16.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.798 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -84.08 147.12 50.09 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.25 124.49 14.88 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.224 1.95 . . . . 0.0 111.039 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.43 116.46 19.67 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -97.63 -164.04 1.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.598 -174.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -97.72 132.75 24.43 Favored Pre-proline 0 CA--C 1.475 -1.91 0 C-N-CA 124.147 0.979 . . . . 0.0 111.612 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -89.13 127.64 1.78 Allowed 'Trans proline' 0 N--CA 1.41 -3.395 0 C-N-CA 121.503 1.468 . . . . 0.0 108.564 169.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.6 mt -116.46 114.06 44.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-O 122.256 1.027 . . . . 0.0 109.448 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.545 ' HB2' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -89.98 111.04 21.99 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.872 -171.509 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.43 143.27 47.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -150.32 129.58 12.83 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 27.3 m -73.94 142.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.821 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.2 t -67.92 137.34 55.14 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.379 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -57.46 -38.82 75.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.324 1.015 . . . . 0.0 111.382 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -104.5 -37.6 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.5 m -80.11 -22.52 42.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 119.764 -0.775 . . . . 0.0 112.326 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.18 -27.85 3.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.737 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -63.46 138.83 97.47 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 69.1 Cg_endo -78.33 128.45 8.89 Favored 'Trans proline' 0 C--O 1.249 1.04 0 C-N-CA 122.926 2.418 . . . . 0.0 111.63 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.98 164.06 26.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.271 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.25 147.04 26.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 16' ' ' GLN . 4.5 mm? -63.37 -18.45 63.69 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.006 0.431 . . . . 0.0 112.126 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.85 -1.85 44.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.32 6.65 5.32 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 16.6 tt -67.93 -36.74 76.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.24 -54.03 40.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.217 0 CA-C-O 120.739 0.304 . . . . 0.0 110.211 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.99 -49.51 71.28 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.078 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.22 -50.15 75.13 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.362 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.5 pp -66.43 -24.26 66.42 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.253 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -84.77 -26.25 27.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.915 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -91.6 -22.45 20.3 Favored 'General case' 0 CA--C 1.471 -2.067 0 C-N-CA 122.75 0.42 . . . . 0.0 110.394 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER -75.92 164.54 26.09 Favored 'General case' 0 N--CA 1.396 -3.142 0 C-N-CA 118.322 -1.351 . . . . 0.0 112.842 -172.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.8 p -55.77 118.94 5.02 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.765 0.666 . . . . 0.0 112.123 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.2 113.5 27.13 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.902 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.43 -33.44 6.58 Favored Glycine 0 C--N 1.293 -1.832 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.3 163.4 16.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 C--N 1.296 -1.74 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.875 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 32.0 p30 . . . . . 0 C--O 1.221 -0.396 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -69.64 -41.73 4.16 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.902 1.735 . . . . 0.0 109.53 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -143.12 155.4 44.57 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.1 78.67 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.88 108.17 7.3 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.505 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp -74.15 115.39 13.59 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.9 mt -122.92 102.03 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 120.953 0.406 . . . . 0.0 110.915 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -98.2 126.86 43.86 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.15 118.1 70.58 Favored Pre-proline 0 C--N 1.3 -1.577 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.223 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.32 132.69 22.93 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.318 2.012 . . . . 0.0 111.072 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.2 tp -92.36 124.07 36.14 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.34 -41.12 96.52 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 123.334 0.396 . . . . 0.0 110.538 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -64.99 131.32 95.18 Favored Pre-proline 0 CA--C 1.489 -1.399 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -84.23 125.98 3.62 Favored 'Trans proline' 1 N--CA 1.398 -4.103 0 CA-C-O 122.096 0.79 . . . . 0.0 110.435 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.0 pt -125.15 144.2 36.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.451 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 10.0 mp0 -122.93 107.92 12.38 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -136.13 136.48 40.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.075 -171.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -131.85 147.42 52.48 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 20.3 m -92.07 145.0 8.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.66 142.4 29.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -61.46 -65.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.14 0.427 . . . . 0.0 112.108 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -67.23 -37.75 84.08 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.8 m -86.5 -21.99 26.67 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.349 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.99 61.37 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 121.068 0.26 . . . . 0.0 112.591 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 32.1 mmtp -87.22 123.24 70.3 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-O 119.335 -0.364 . . . . 0.0 110.91 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -86.35 114.49 1.27 Allowed 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 121.827 1.685 . . . . 0.0 108.988 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -133.14 164.02 27.97 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -58.44 140.85 53.15 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.864 0.727 . . . . 0.0 111.224 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.472 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.4 pp -61.47 -14.62 30.26 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -85.59 -31.51 22.59 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.422 0.629 . . . . 0.0 109.863 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -14.29 50.95 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 29' ' ' LEU . 10.2 tp -62.14 -28.71 45.0 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.794 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.57 -53.51 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.352 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.31 -41.71 93.76 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.972 0.415 . . . . 0.0 110.161 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.27 -57.31 13.36 Favored 'General case' 0 C--O 1.205 -1.24 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -62.89 -29.1 70.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.087 0.47 . . . . 0.0 109.997 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.68 -36.49 65.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.549 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -111.25 4.83 19.47 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 121.462 -0.774 . . . . 0.0 110.546 -170.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.98 165.4 24.1 Favored 'General case' 0 N--CA 1.419 -2.015 0 C-N-CA 118.322 -1.351 . . . . 0.0 109.702 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 78.7 m -71.53 114.36 9.52 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.442 0.639 . . . . 0.0 111.719 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.97 126.95 52.8 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.666 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.94 -34.11 4.85 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.9 150.23 40.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--N 1.291 -1.973 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.22 103.98 0.69 Allowed 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.684 2.256 . . . . 0.0 113.305 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -116.42 129.18 56.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.69 -50.44 8.17 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -98.75 106.46 18.73 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -138.12 124.5 20.59 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.5 pt -76.13 132.0 33.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 123.333 0.396 . . . . 0.0 110.086 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -79.58 138.7 37.55 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.76 118.75 73.32 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.76 126.27 13.12 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.056 1.837 . . . . 0.0 110.624 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -130.75 158.76 39.23 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.756 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.59 -51.43 42.57 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 123.611 0.569 . . . . 0.0 111.353 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -138.28 128.06 14.94 Favored Pre-proline 0 CA--C 1.471 -2.094 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -87.55 126.14 2.18 Favored 'Trans proline' 1 N--CA 1.397 -4.153 0 CA-C-O 122.714 1.048 . . . . 0.0 111.848 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.7 mt -116.42 114.46 46.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -133.78 110.02 9.51 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.438 -170.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -136.03 146.52 47.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.359 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 45.6 ptt85 -145.58 159.35 43.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 33.7 m -79.35 145.51 9.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 120.134 -0.627 . . . . 0.0 112.049 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HB2' HD22 ' A' ' 27' ' ' LEU . 15.7 t -83.38 144.55 29.57 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.48 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.84 -64.23 0.89 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.59 1.156 . . . . 0.0 112.0 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -71.51 -51.92 21.09 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.8 m -75.7 -30.23 59.26 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.03 11.32 74.48 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -99.67 129.48 28.74 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 37.9 Cg_endo -68.02 115.74 3.96 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.859 2.373 . . . . 0.0 112.521 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 27' ' ' LEU . 2.6 pt? -111.37 154.99 23.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -78.45 148.94 33.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.16 -19.48 63.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 110.179 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -82.75 -2.12 53.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.95 6.5 10.86 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.058 0.543 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.01 -42.28 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.33 -61.0 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.077 0 O-C-N 123.238 0.337 . . . . 0.0 111.159 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.16 -47.68 84.9 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 123.325 0.65 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.443 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 44.2 t60 -59.06 -53.49 57.77 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.858 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.49 -28.7 68.77 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.082 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -77.2 -28.33 53.87 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 122.229 -0.294 . . . . 0.0 111.534 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -100.86 -30.66 11.55 Favored 'General case' 0 CA--C 1.49 -1.359 0 O-C-N 121.497 -0.752 . . . . 0.0 111.165 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.34 0.2 OUTLIER -45.78 122.18 3.57 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -165.261 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.8 t -65.72 122.29 16.94 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.49 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.36 152.44 42.06 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.72 18.81 59.29 Favored Glycine 0 C--N 1.298 -1.534 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.556 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.33 115.82 17.42 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--N 1.294 -1.834 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.549 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.55 88.63 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.254 1.969 . . . . 0.0 113.345 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -121.72 91.77 3.59 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.23 133.94 22.23 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.749 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -135.01 111.89 10.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.28 115.12 20.51 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -89.7 96.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.875 0.845 . . . . 0.0 111.195 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -98.59 112.83 24.75 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.187 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.75 119.73 77.74 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.87 124.0 12.47 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.77 1.647 . . . . 0.0 110.664 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.3 tp -84.01 108.96 17.27 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.15 -58.3 8.31 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 123.687 0.617 . . . . 0.0 111.61 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -129.01 100.01 21.27 Favored Pre-proline 0 CA--C 1.46 -2.513 0 CA-C-O 120.988 0.423 . . . . 0.0 110.74 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -64.45 126.47 16.98 Favored 'Trans proline' 0 N--CA 1.423 -2.634 0 N-CA-C 107.096 -1.925 . . . . 0.0 107.096 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.0 pt -120.23 95.39 3.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-O 122.347 1.07 . . . . 0.0 111.799 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.546 ' H ' HD22 ' A' ' 29' ' ' LEU . 25.7 mm-40 -99.39 152.33 20.08 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.395 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.84 115.35 30.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -101.25 124.87 47.63 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.343 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.83 129.57 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -64.87 131.56 47.05 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.861 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -57.39 -37.21 72.32 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.148 0.979 . . . . 0.0 111.686 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.09 -47.69 10.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.33 0.586 . . . . 0.0 111.809 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.0 m -90.41 -21.15 22.08 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.07 33.9 87.23 Favored Glycine 0 N--CA 1.476 1.356 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -118.45 121.03 31.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -82.75 135.92 8.08 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 123.049 2.5 . . . . 0.0 113.697 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.481 HD11 ' HA ' ' A' ' 32' ' ' ILE . 1.7 pt? -146.79 169.28 19.42 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.752 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 137.07 43.27 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.86 0.362 . . . . 0.0 110.366 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.546 HD22 ' H ' ' A' ' 16' ' ' GLN . 1.2 pt? -59.07 -14.63 10.42 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.922 0.889 . . . . 0.0 113.027 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -82.35 -9.19 59.56 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.105 0.479 . . . . 0.0 110.816 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 6.45 5.24 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.097 0.475 . . . . 0.0 110.704 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HA ' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -63.5 -35.63 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 -174.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.92 -46.96 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.313 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.95 -48.03 82.96 Favored 'General case' 0 C--O 1.273 2.329 0 CA-C-O 121.461 0.648 . . . . 0.0 110.061 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.5 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 28.6 t60 -54.97 -56.76 16.11 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.911 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.45 -35.48 72.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.831 0.348 . . . . 0.0 110.655 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -66.45 -37.97 86.33 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.162 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -117.41 4.73 12.5 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 118.72 -1.192 . . . . 0.0 113.202 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.303 0.5 OUTLIER -54.5 115.88 2.36 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -169.702 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.5 m -106.32 110.09 22.21 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.2 137.13 58.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.726 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.81 15.27 13.47 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.37 130.55 38.02 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.8 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 CA--C 1.5 -0.981 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -71.8 110.17 2.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.31 2.007 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -70.99 -56.39 6.28 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.384 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.9 -42.98 0.21 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -110.42 153.9 24.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.9 mt -78.49 114.76 17.68 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.9 mm -109.83 98.18 6.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -102.37 124.24 47.6 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -87.39 144.32 35.61 Favored Pre-proline 0 C--N 1.29 -1.979 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.39 132.28 43.95 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 122.948 2.432 . . . . 0.0 111.212 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.64 91.9 2.38 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.981 0.895 . . . . 0.0 109.195 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -115.24 -167.91 1.31 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -106.88 116.61 58.39 Favored Pre-proline 0 CA--C 1.481 -1.676 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -89.07 128.89 1.94 Allowed 'Trans proline' 0 N--CA 1.412 -3.284 0 C-N-CA 122.236 1.957 . . . . 0.0 109.07 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.405 HG22 ' CD1' ' A' ' 17' ' ' TYR . 45.4 mt -122.45 137.95 54.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.506 ' HB2' HD22 ' A' ' 29' ' ' LEU . 8.2 mp0 -114.68 107.63 15.73 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 121.85 0.833 . . . . 0.0 109.502 -171.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' CD1' HG22 ' A' ' 15' ' ' ILE . 7.0 m-85 -139.89 137.22 34.68 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.844 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -128.92 144.71 51.26 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 23.1 m -85.91 136.92 21.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.136 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -67.98 120.41 14.19 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 28.0 mp0 -54.37 -45.08 72.71 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 123.843 0.715 . . . . 0.0 111.027 -175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -69.18 -38.58 78.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.157 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 60.8 m -98.62 -22.91 15.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.2 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.12 25.3 69.18 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -103.45 111.61 65.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.641 -173.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -72.87 121.35 7.27 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.79 1.66 . . . . 0.0 110.278 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 32' ' ' ILE . 3.3 pp -126.06 148.69 49.28 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.987 -176.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.23 149.96 49.73 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.59 0.556 . . . . 0.0 109.736 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 16' ' ' GLN . 1.9 pt? -52.62 -32.68 42.94 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.803 0.689 . . . . 0.0 111.682 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -77.4 -21.48 53.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.915 0.486 . . . . 0.0 111.118 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 3.22 40.59 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -58.3 -50.5 78.3 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.48 -41.04 90.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.8 -56.25 24.61 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.304 0.573 . . . . 0.0 109.512 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -60.66 -48.26 82.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.43 -27.12 68.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.883 0.373 . . . . 0.0 110.546 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.95 -34.37 22.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.234 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -103.15 4.65 37.17 Favored 'General case' 0 CA--C 1.478 -1.822 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.477 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.54 161.74 22.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 118.013 -1.475 . . . . 0.0 109.605 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 69.2 m -86.8 110.64 20.07 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.718 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.4 132.93 37.18 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.56 -33.38 5.9 Favored Glycine 0 C--N 1.31 -0.887 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.57 131.2 41.46 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.293 -1.863 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.131 -179.629 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.509 -0.599 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -86.21 87.51 0.83 Allowed 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.167 1.911 . . . . 0.0 111.447 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -129.72 4.9 5.04 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.977 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.51 161.87 41.95 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -88.27 119.59 28.83 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.0 mt -67.14 135.29 53.32 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.6 pt -76.44 161.84 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.767 170.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.2 130.21 45.52 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 18.8 t70 -47.55 114.47 3.14 Favored Pre-proline 0 C--O 1.243 0.758 0 O-C-N 124.649 1.218 . . . . 0.0 110.931 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' ASP . 4.1 Cg_exo -76.32 131.0 12.41 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.182 1.922 . . . . 0.0 111.288 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.0 tp -136.4 89.07 2.43 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -170.51 170.15 7.02 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -132.91 97.86 16.5 Favored Pre-proline 0 CA--C 1.466 -2.288 0 CA-C-O 121.427 0.632 . . . . 0.0 110.243 170.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -70.01 127.17 14.02 Favored 'Trans proline' 0 N--CA 1.424 -2.612 0 N-CA-C 107.665 -1.706 . . . . 0.0 107.665 167.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -105.55 123.63 60.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 80.7 mm-40 -74.05 144.29 45.11 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -108.86 129.69 55.41 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.392 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -122.5 128.1 50.39 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.7 m -74.6 131.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.108 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.4 t -65.63 117.73 8.51 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.44 -19.75 62.32 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -52.3 4.97 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.736 0.303 . . . . 0.0 110.478 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.7 m -87.38 -16.65 34.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.24 38.97 95.74 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 47.1 mmtm -117.26 129.08 25.58 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 16.2 Cg_exo -68.31 114.94 3.62 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.705 2.27 . . . . 0.0 111.632 177.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -109.72 124.81 51.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 123.302 0.641 . . . . 0.0 110.61 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -72.33 146.85 46.84 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 16' ' ' GLN . 6.6 mp -50.28 -18.79 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -174.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -89.6 -37.22 14.82 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.988 1.267 . . . . 0.0 110.33 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.3 -12.57 43.16 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.75 -38.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.03 -48.19 89.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.074 0.234 . . . . 0.0 110.943 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.26 -56.78 16.8 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 31.5 t60 -54.83 -56.16 22.47 Favored 'General case' 0 C--O 1.204 -1.335 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.47 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.68 -28.02 69.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.081 0.467 . . . . 0.0 110.519 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -77.72 -36.96 50.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.5 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -108.44 0.13 20.87 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.497 -1.281 . . . . 0.0 111.454 -172.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.412 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -67.87 165.46 17.55 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.164 -173.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.0 p -55.82 122.68 12.05 Favored 'General case' 0 C--O 1.258 1.543 0 O-C-N 124.127 0.892 . . . . 0.0 111.956 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 157.7 28.07 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.28 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.51 20.6 7.68 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.51 97.35 10.09 Favored 'General case' 0 N--CA 1.433 -1.288 0 O-C-N 122.619 -0.342 . . . . 0.0 110.501 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 59.7 m . . . . . 0 C--N 1.303 -1.454 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 175.787 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.72 -44.3 50.95 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.84 2.36 . . . . 0.0 110.753 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -111.55 109.67 19.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.05 147.23 50.51 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -82.82 152.95 25.43 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.671 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.94 129.53 41.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.654 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.34 101.58 2.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.44 152.96 31.87 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.519 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -108.58 112.4 60.72 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 171.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -44.53 137.43 8.39 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 124.115 3.21 . . . . 0.0 115.316 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.4 tp -92.09 117.02 29.44 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.85 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 69.6 -51.26 0.62 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.593 1.557 . . . . 0.0 113.138 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -69.76 128.5 91.9 Favored Pre-proline 0 CA--C 1.471 -2.063 0 CA-C-O 120.997 0.427 . . . . 0.0 110.685 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -90.42 127.34 1.37 Allowed 'Trans proline' 0 N--CA 1.404 -3.769 0 N-CA-C 108.416 -1.417 . . . . 0.0 108.416 168.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.88 118.34 44.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -107.21 110.41 22.46 Favored 'General case' 0 C--N 1.261 -3.241 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -162.143 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -131.41 154.54 48.54 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.183 -1.372 . . . . 0.0 108.604 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -145.71 137.75 25.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 33.1 m -86.31 154.75 3.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.61 -176.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.96 142.08 29.06 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.705 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.08 -46.88 72.95 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.188 0.305 . . . . 0.0 110.635 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.521 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 68.9 mttm -73.76 -52.13 14.19 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 16.5 m -86.29 -25.32 25.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -172.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.81 -33.19 3.32 Favored Glycine 0 N--CA 1.469 0.847 0 O-C-N 121.86 -0.525 . . . . 0.0 113.314 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 40.1 mmtm -52.34 135.88 41.42 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 123.93 0.892 . . . . 0.0 113.024 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 5.2 Cg_exo -73.81 123.49 8.52 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.568 2.178 . . . . 0.0 110.143 172.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 mt -104.01 156.45 17.85 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.44 139.69 58.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 1.1 tm? -44.53 -54.33 6.14 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 124.078 0.951 . . . . 0.0 113.439 -171.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -90.77 6.12 45.49 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.36 0.6 . . . . 0.0 111.929 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.46 -2.74 57.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.53 0.681 . . . . 0.0 109.757 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -33.57 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.6 -61.01 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 122.873 0.469 . . . . 0.0 110.36 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.155 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 47.6 t60 -57.89 -52.88 63.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.752 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.25 -35.17 74.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.17 -34.5 77.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -113.0 -1.95 14.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.391 -0.924 . . . . 0.0 113.023 -172.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.521 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -70.0 145.71 51.59 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.2 t -95.19 142.23 27.87 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.83 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.35 148.52 29.32 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.39 20.06 75.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.847 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 23' ' ' CYS . . . -107.09 141.56 38.13 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.294 -1.831 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.644 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.97 -64.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 121.784 1.656 . . . . 0.0 112.021 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -136.01 -8.94 2.06 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.281 0.563 . . . . 0.0 110.328 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.48 171.55 8.91 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -75.2 107.74 7.5 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.5 tp -109.7 116.23 31.32 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.874 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.83 97.82 5.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 171.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.12 114.81 3.05 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 124.209 0.943 . . . . 0.0 110.17 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -75.02 114.69 37.46 Favored Pre-proline 0 C--N 1.308 -1.226 0 O-C-N 124.521 1.138 . . . . 0.0 111.989 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -82.31 142.32 11.91 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.523 2.149 . . . . 0.0 109.275 172.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -78.5 103.92 8.76 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.71 144.18 57.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.164 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.67 128.25 92.99 Favored Pre-proline 0 CA--C 1.485 -1.528 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -86.3 125.66 2.61 Favored 'Trans proline' 0 N--CA 1.406 -3.66 0 CA-C-O 122.395 0.914 . . . . 0.0 111.829 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.57 135.24 60.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.83 146.71 33.22 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.57 0.224 . . . . 0.0 110.703 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.91 131.74 51.05 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.061 0.851 . . . . 0.0 109.849 -174.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -115.99 131.12 57.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.98 134.78 29.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.676 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.445 ' HB2' HD11 ' A' ' 27' ' ' LEU . 43.1 t -67.95 126.05 28.25 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.38 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.1 mp0 -59.03 -29.47 67.31 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.677 0.791 . . . . 0.0 110.762 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HD2' ' SG ' ' A' ' 23' ' ' CYS . 12.9 tmtt? -87.92 -52.54 5.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.151 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 22' ' ' LYS . 18.0 m -93.46 -14.51 26.62 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.66 99.8 Favored Glycine 0 N--CA 1.463 0.456 0 CA-C-O 121.432 0.462 . . . . 0.0 112.433 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -125.45 140.33 36.06 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.02 115.03 4.15 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.667 2.245 . . . . 0.0 112.128 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 20' ' ' CYS . 16.2 mt -99.81 120.7 40.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.05 150.45 45.55 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.441 ' O ' HG22 ' A' ' 32' ' ' ILE . 93.4 mt -56.43 -27.17 55.84 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.768 0.794 . . . . 0.0 110.874 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -71.43 -27.14 63.08 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.609 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.64 5.96 15.55 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.4 tp -60.58 -42.4 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.89 -47.0 71.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.82 -51.58 68.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.035 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -62.94 -54.05 44.6 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.028 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -62.36 -26.83 68.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.311 0.96 . . . . 0.0 112.764 -176.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -79.41 -36.37 39.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.072 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.5 -1.24 21.56 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.348 -169.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.72 154.07 39.79 Favored 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.195 -176.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 43' ' ' ALA . 40.9 t -62.5 110.63 1.74 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.648 0.593 . . . . 0.0 111.848 -177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.01 128.59 53.94 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.105 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.59 -28.24 11.94 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.201 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.497 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -117.58 134.33 54.99 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.297 -1.695 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.556 -177.869 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.14 -40.05 54.04 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.711 2.274 . . . . 0.0 112.485 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -152.91 128.17 9.84 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.37 -46.85 25.55 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -120.2 154.63 34.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 tp -82.55 118.65 23.42 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -104.29 130.2 55.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 120.926 0.393 . . . . 0.0 110.036 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.17 153.18 34.39 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.377 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.07 144.45 67.54 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.14 124.17 14.68 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 121.773 1.648 . . . . 0.0 110.854 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.2 mt -113.02 113.97 26.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.062 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.72 -49.94 64.41 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.887 0.851 . . . . 0.0 109.149 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -81.17 141.74 50.41 Favored Pre-proline 0 CA--C 1.465 -2.294 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.528 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -82.16 125.93 4.79 Favored 'Trans proline' 0 N--CA 1.403 -3.803 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.2 mt -116.83 103.21 14.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.553 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' H ' HD22 ' A' ' 29' ' ' LEU . 69.0 mm-40 -91.33 159.78 15.83 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.01 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -120.36 138.08 53.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -124.99 135.39 52.75 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -98.98 142.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.147 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -86.88 133.74 33.59 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -50.61 72.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 44' ' ' SER . 9.0 ptpp? -66.17 -47.87 72.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.008 0.432 . . . . 0.0 111.846 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 m -79.51 -32.91 42.44 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.676 -175.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 21.36 76.33 Favored Glycine 0 N--CA 1.461 0.345 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -95.79 123.24 56.47 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -83.81 121.56 2.89 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.467 2.111 . . . . 0.0 110.986 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.53 164.55 14.42 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.364 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 150.6 37.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 16' ' ' GLN . 1.7 pt? -55.89 -25.61 43.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.071 0.548 . . . . 0.0 111.869 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -86.09 -33.65 20.87 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.837 0.855 . . . . 0.0 111.517 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.57 6.19 42.22 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.158 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 tp -55.1 -43.44 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.444 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.83 -39.13 84.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.26 -51.99 60.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 37.1 t60 -57.83 -53.17 61.21 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.419 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.41 -31.76 71.69 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.891 0.377 . . . . 0.0 110.812 -174.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -72.98 -41.09 64.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -110.18 5.46 21.92 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.151 -170.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -68.71 149.81 48.63 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.367 -176.28 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.3 m -76.95 110.86 11.92 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.073 0.463 . . . . 0.0 109.867 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.59 125.46 37.24 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.05 -16.87 57.89 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.03 98.82 6.52 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 5.3 p . . . . . 0 N--CA 1.426 -1.631 0 CA-C-O 118.478 -0.773 . . . . 0.0 110.473 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 2.3 m-20 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 1' ' ' ASN . 7.1 Cg_exo -74.74 58.43 4.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.933 2.422 . . . . 0.0 111.829 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.7 m120 72.92 174.32 0.29 Allowed 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 125.531 1.532 . . . . 0.0 109.271 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.88 113.3 20.41 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.166 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.02 117.34 21.54 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.2 pt? -119.07 124.66 47.45 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.998 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 pt -97.04 160.78 2.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.35 155.49 18.92 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -78.7 116.7 61.67 Favored Pre-proline 0 C--N 1.302 -1.482 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.177 -173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.76 126.02 8.55 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.093 1.862 . . . . 0.0 111.613 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.13 118.52 27.76 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.749 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -104.93 130.13 53.17 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -115.89 120.69 35.23 Favored Pre-proline 0 CA--C 1.482 -1.664 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -61.48 127.69 22.57 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.104 1.869 . . . . 0.0 107.797 164.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.2 mm -118.92 134.56 62.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -105.31 156.15 18.42 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.687 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 61.3 m-85 -120.66 148.26 44.16 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.999 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -147.12 138.48 24.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.06 131.61 34.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.867 0.841 . . . . 0.0 111.225 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -76.8 138.37 39.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.137 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.6 -49.65 74.29 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 124.271 1.028 . . . . 0.0 111.231 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 62.5 mttp -78.34 -11.28 59.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.6 m -128.07 -34.35 2.12 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.849 -1.14 . . . . 0.0 113.86 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.98 89.19 Favored Glycine 0 C--O 1.226 -0.358 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.27 124.85 82.33 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 123.962 0.905 . . . . 0.0 109.523 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.32 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.923 1.749 . . . . 0.0 109.111 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -109.96 157.55 19.16 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.026 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.58 142.28 29.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 124.1 0.875 . . . . 0.0 109.408 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HG22 ' A' ' 32' ' ' ILE . 82.3 mt -56.28 -34.07 66.09 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 m -77.74 6.18 7.95 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.835 0.826 . . . . 0.0 111.206 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.45 6.79 4.14 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.72 -0.613 . . . . 0.0 110.795 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 11.3 tt -62.07 -43.37 97.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -174.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.27 -41.39 92.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.106 0.479 . . . . 0.0 110.278 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.88 -56.72 18.62 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.835 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -58.07 -52.78 64.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.599 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -63.18 -21.67 66.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.608 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.48 -34.42 21.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.168 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -109.06 4.11 22.75 Favored 'General case' 0 CA--C 1.476 -1.885 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.246 -171.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.541 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -76.66 151.9 35.98 Favored 'General case' 0 N--CA 1.411 -2.412 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.639 -176.519 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.9 t -89.49 127.98 35.92 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.05 114.66 11.46 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.673 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.53 20.07 42.45 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.746 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.26 106.25 0.22 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.395 0.617 . . . . 0.0 112.032 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.3 m . . . . . 0 C--N 1.306 -1.31 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.34 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.7 -23.02 14.91 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 121.44 1.427 . . . . 0.0 114.853 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -113.83 129.28 56.61 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.577 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.54 91.5 8.26 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -70.11 113.89 7.73 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.887 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.1 mt -103.46 145.18 30.39 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.4 pt -84.15 139.6 17.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 120.936 0.398 . . . . 0.0 111.569 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -90.39 117.88 29.45 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -111.08 127.3 27.1 Favored Pre-proline 0 C--N 1.288 -2.099 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.008 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.33 148.56 55.35 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.272 1.981 . . . . 0.0 111.658 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.3 mt -77.33 144.01 38.35 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.02 174.3 12.05 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -138.19 127.11 14.52 Favored Pre-proline 0 CA--C 1.467 -2.221 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -81.08 128.01 6.28 Favored 'Trans proline' 0 N--CA 1.403 -3.849 0 C-N-CA 120.857 1.038 . . . . 0.0 109.606 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.6 mm -73.89 95.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-O 122.689 1.233 . . . . 0.0 108.132 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -91.0 164.31 14.02 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.828 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.94 156.75 22.46 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.1 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -141.71 129.12 21.24 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.939 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.0 m -73.87 143.91 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.5 t -79.14 143.06 35.83 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.246 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -45.16 -55.57 5.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.755 1.622 . . . . 0.0 111.821 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -100.94 -34.63 9.7 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.459 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.8 m -82.52 -20.14 37.28 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.131 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.42 -36.12 1.56 Allowed Glycine 0 N--CA 1.473 1.108 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.579 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -51.89 139.53 31.96 Favored Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 124.581 1.152 . . . . 0.0 112.462 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.3 125.9 4.69 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.941 2.428 . . . . 0.0 112.531 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.53 150.86 27.53 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.234 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.95 45.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.482 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.0 pt? -54.69 -30.11 54.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -82.26 -25.53 34.0 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.778 -0.576 . . . . 0.0 110.832 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.84 -9.71 39.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 29' ' ' LEU . 7.4 tp -61.82 -34.68 63.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.93 -52.41 59.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.45 -48.79 80.3 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -57.37 -52.79 63.93 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -25.86 68.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -72.71 -43.48 62.94 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.683 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -110.42 4.94 21.05 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.264 -0.898 . . . . 0.0 112.705 -170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.97 115.91 7.23 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 119.27 -0.972 . . . . 0.0 112.462 -176.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.4 m -97.31 137.81 35.74 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.134 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.77 133.91 55.49 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.36 -21.91 21.08 Favored Glycine 0 C--N 1.297 -1.602 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -175.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.18 140.75 40.24 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.241 0.652 0 C-N-CA 124.007 0.923 . . . . 0.0 112.016 -174.342 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.505 -0.75 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -47.53 -32.52 15.88 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 124.102 3.202 . . . . 0.0 115.11 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -65.39 -30.47 71.28 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 122.427 -0.171 . . . . 0.0 111.299 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 69.72 145.83 0.06 Allowed 'General case' 0 C--O 1.246 0.883 0 C-N-CA 125.141 1.376 . . . . 0.0 112.404 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -78.92 110.19 13.9 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.6 tp -128.36 132.72 48.57 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.473 0.654 . . . . 0.0 111.676 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.7 tt -123.08 128.38 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 171.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.5 138.16 58.06 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -78.52 138.51 59.0 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.02 154.8 59.52 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 123.032 2.488 . . . . 0.0 112.051 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -89.73 88.38 7.36 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-O 122.301 1.048 . . . . 0.0 111.498 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -123.75 7.77 8.79 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -80.53 151.73 72.02 Favored Pre-proline 0 CA--C 1.464 -2.359 0 CA-C-N 112.14 -2.3 . . . . 0.0 109.594 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.75 126.17 2.93 Favored 'Trans proline' 0 N--CA 1.402 -3.901 0 N-CA-C 107.898 -1.616 . . . . 0.0 107.898 170.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.4 mm -131.16 146.78 33.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.425 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 88.6 mm-40 -67.62 162.05 24.39 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.051 0.453 . . . . 0.0 111.41 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -122.2 151.96 40.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 111.103 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.43 ' O ' HD23 ' A' ' 27' ' ' LEU . 16.2 ptt180 -135.53 154.32 51.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -92.35 136.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.737 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.2 t -66.19 132.61 48.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.623 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -51.03 -43.52 60.89 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.037 1.335 . . . . 0.0 110.631 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 40' ' ' CYS . 58.8 tttp -82.55 -52.11 7.15 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.018 -174.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.93 -22.23 18.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.58 8.62 86.12 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.037 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -87.06 128.3 56.23 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.88 114.93 4.16 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 122.356 2.037 . . . . 0.0 111.581 176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 27' ' ' LEU . 2.0 pt? -113.15 148.82 34.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.58 147.88 50.14 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 16' ' ' GLN . 85.6 mt -54.81 -32.95 60.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.069 0.461 . . . . 0.0 111.942 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -86.58 -12.04 49.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.562 0.745 . . . . 0.0 112.185 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.92 6.43 48.91 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 122.185 -0.322 . . . . 0.0 111.6 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.9 tp -51.92 -43.79 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.203 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.04 -47.86 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 123.084 0.24 . . . . 0.0 111.465 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.58 -54.71 35.67 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.148 0.579 . . . . 0.0 111.104 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -62.5 -45.84 91.18 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.628 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.31 -30.26 70.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -76.27 -27.04 56.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -94.68 -23.69 17.48 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.265 0.1 OUTLIER -81.27 148.03 29.64 Favored 'General case' 0 N--CA 1.393 -3.316 0 C-N-CA 117.633 -1.627 . . . . 0.0 110.473 -177.431 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 13.0 p -86.55 130.99 34.29 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.004 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.43 141.87 33.66 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.72 -33.54 4.15 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.92 160.44 21.44 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.29 -2.021 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.692 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.504 -0.802 0 CA-C-O 120.343 0.116 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.25 3.73 7.37 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.77 2.313 . . . . 0.0 110.819 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -151.12 146.02 25.86 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.67 155.74 21.84 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 123.847 0.717 . . . . 0.0 110.787 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -70.8 136.12 48.58 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.8 114.63 8.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.5 mm -128.17 105.28 13.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.13 136.26 48.09 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -89.65 107.58 19.69 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.51 128.14 9.35 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.666 2.244 . . . . 0.0 113.291 -171.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 11' ' ' LEU . 3.9 pp -113.59 90.02 3.24 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 122.911 1.338 . . . . 0.0 111.606 176.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -106.13 -40.98 5.48 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -92.96 151.91 41.03 Favored Pre-proline 0 CA--C 1.465 -2.298 0 CA-C-N 113.005 -1.907 . . . . 0.0 107.459 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.37 127.27 7.31 Favored 'Trans proline' 0 N--CA 1.404 -3.788 0 N-CA-C 107.525 -1.76 . . . . 0.0 107.525 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.4 mm -93.9 114.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 11.8 mm100 -108.72 153.36 23.56 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.98 -176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.62 122.96 42.72 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -122.42 145.22 48.48 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.0 m -86.86 139.54 17.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.214 0.53 . . . . 0.0 110.484 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.1 t -80.66 145.26 31.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.39 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -47.17 -67.25 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 126.712 2.005 . . . . 0.0 112.998 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -90.39 -11.22 41.17 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.1 m -101.74 -32.06 10.48 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.976 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.76 73.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.73 -176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -87.55 133.91 37.12 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.34 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.31 138.3 15.74 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.982 1.788 . . . . 0.0 110.389 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.37 155.15 45.12 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -81.13 144.31 31.77 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -57.32 -24.91 58.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -69.23 -25.15 64.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 121.708 0.765 . . . . 0.0 110.503 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.46 7.05 37.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.75 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 tp -51.47 -46.28 35.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.84 -40.79 88.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.52 -54.27 34.9 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -57.23 -52.24 66.13 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.674 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.35 -32.53 70.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.149 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 -22.71 27.94 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -110.41 3.03 19.34 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.046 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.303 0.4 OUTLIER -68.13 138.5 55.75 Favored 'General case' 0 N--CA 1.411 -2.424 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.814 -175.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.0 m -106.31 152.43 23.56 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.035 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.82 112.96 19.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.26 18.78 15.94 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -174.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.01 101.23 1.75 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.452 0.644 . . . . 0.0 109.513 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.419 -1.993 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -178.149 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 40.1 t30 . . . . . 0 C--O 1.236 0.382 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.94 135.31 23.08 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.164 1.91 . . . . 0.0 112.295 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -88.99 -34.6 16.78 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.91 95.66 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.747 1.619 . . . . 0.0 114.834 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -93.33 107.35 19.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.91 128.38 34.39 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -86.89 116.73 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-O 122.197 0.999 . . . . 0.0 110.521 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -99.69 147.86 24.97 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.01 116.02 53.64 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.19 143.96 73.22 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.297 1.998 . . . . 0.0 110.962 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.1 tp -80.63 89.96 5.73 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.56 -39.92 64.33 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.496 -173.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -97.75 122.29 55.43 Favored Pre-proline 0 CA--C 1.465 -2.305 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.59 125.78 7.79 Favored 'Trans proline' 0 N--CA 1.401 -3.945 0 CA-C-O 122.391 0.913 . . . . 0.0 109.993 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.6 mt -99.59 105.58 17.71 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.251 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.468 ' H ' HD22 ' A' ' 29' ' ' LEU . 13.7 mm100 -92.78 155.28 17.76 Favored 'General case' 0 C--N 1.269 -2.893 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.165 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 29.9 m-85 -117.52 121.26 40.52 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.154 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 17.1 ttp85 -116.17 134.31 55.07 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.72 137.07 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.179 0.514 . . . . 0.0 111.785 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.36 143.46 48.59 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.692 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.42 -42.92 87.03 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.137 0.575 . . . . 0.0 110.474 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -74.11 -52.86 11.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -86.75 -23.37 25.5 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 37.56 94.09 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -122.48 125.54 26.45 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.39 118.71 5.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.936 2.424 . . . . 0.0 111.113 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 18' ' ' ARG . 4.3 pp -113.48 152.34 30.28 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.593 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.32 131.97 46.79 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.468 HD22 ' H ' ' A' ' 16' ' ' GLN . 1.5 pt? -51.18 -29.6 14.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -73.62 -30.22 62.84 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.985 0.514 . . . . 0.0 111.141 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.9 6.54 48.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -172.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.38 -44.64 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.97 -46.32 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.653 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -63.33 -48.95 75.89 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.427 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 15.6 t60 -58.94 -58.31 9.19 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.999 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.95 -22.43 66.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.017 0.437 . . . . 0.0 111.467 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.62 -51.7 12.25 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.422 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -109.3 5.38 23.58 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 117.831 -1.547 . . . . 0.0 113.375 -170.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.313 0.5 OUTLIER -45.72 134.83 7.24 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.609 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.0 m -52.16 113.26 0.97 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.541 -1.663 . . . . 0.0 114.192 -171.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.67 140.17 29.72 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.12 20.68 58.69 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.463 -175.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.26 143.71 34.0 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.545 -0.327 . . . . 0.0 110.259 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.774 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 16.7 mm100 . . . . . 0 C--O 1.245 0.855 0 N-CA-C 111.346 0.128 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.95 150.2 50.34 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 123.705 0.628 . . . . 0.0 110.039 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -151.54 147.68 27.1 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.01 140.12 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.376 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.537 ' HB2' HD11 ' A' ' 27' ' ' LEU . 43.4 t -68.2 124.95 24.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -30.83 14.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.7 m -94.8 -30.52 14.18 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.917 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.44 3.13 81.82 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.496 0.559 . . . . 0.0 114.496 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 11.8 mptt -93.58 141.45 23.87 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 122.205 -0.585 . . . . 0.0 110.934 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.82 117.1 4.97 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.816 2.344 . . . . 0.0 110.96 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 20' ' ' CYS . 17.3 mt -105.59 125.77 51.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.215 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.08 152.76 23.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.493 ' O ' HG22 ' A' ' 32' ' ' ILE . 5.5 mp -56.56 -24.31 46.21 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -75.82 -28.18 58.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.782 -0.574 . . . . 0.0 110.678 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.6 -2.95 19.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 29' ' ' LEU . 7.1 tp -59.12 -42.22 85.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-O 120.423 0.154 . . . . 0.0 110.908 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.82 -51.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.22 -36.34 71.82 Favored 'General case' 0 C--O 1.26 1.608 0 CA-C-O 120.944 0.402 . . . . 0.0 111.1 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -64.17 -51.62 62.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.795 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 tt -58.58 -38.07 77.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.698 0.285 . . . . 0.0 110.339 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -68.64 -39.01 80.91 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -101.39 -6.54 23.91 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.059 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.417 -2.082 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.659 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 . . . . . 0 N--CA 1.439 -1.007 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 48.7 m-85 -111.77 121.39 44.96 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -129.9 150.78 51.04 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -86.78 132.4 32.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.471 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.08 139.48 58.72 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.726 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -53.16 -49.5 66.5 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.16 0.984 . . . . 0.0 112.057 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -88.1 -51.78 5.6 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.439 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 m -79.28 -18.24 53.09 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.471 -172.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.08 66.43 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-O 121.347 0.415 . . . . 0.0 112.445 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -96.76 141.36 22.97 Favored Pre-proline 0 N--CA 1.429 -1.52 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.56 119.28 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.185 2.59 . . . . 0.0 110.39 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 3.1 mm? -115.76 130.66 56.93 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.939 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.18 133.8 34.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -48.98 -30.69 6.32 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -67.96 -22.0 65.05 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 122.158 -0.339 . . . . 0.0 111.578 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.35 -0.8 10.88 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.262 0.554 . . . . 0.0 111.017 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.464 HD13 ' HG ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -66.87 -33.27 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.057 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 46.4 t -63.06 -58.14 8.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.757 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.407 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 4.2 p30 -63.26 -32.84 74.36 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.284 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 39.3 t60 -56.26 -55.06 37.99 Favored 'General case' 0 C--O 1.199 -1.557 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 32' ' ' ILE . 91.8 mt -56.89 -37.12 70.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.633 0.254 . . . . 0.0 111.247 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 55.1 mt-10 -69.99 -32.56 70.82 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -117.6 5.26 12.38 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.565 -0.709 . . . . 0.0 111.478 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.573 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.969 -176.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 N--CA 1.443 -0.816 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -115.34 138.09 51.34 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.049 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -115.81 132.65 56.58 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.14 120.62 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.886 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.38 118.98 10.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -51.67 -50.02 61.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 5.4 ptpp? -74.0 -33.08 63.68 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.205 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.3 m -89.12 -29.67 19.2 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.848 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.08 28.28 71.86 Favored Glycine 0 N--CA 1.463 0.494 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.18 129.18 24.42 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.844 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -85.01 115.17 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.577 2.185 . . . . 0.0 111.047 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -121.73 153.87 37.66 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.066 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.94 37.15 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.11 -15.68 35.84 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -72.73 -23.6 60.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.093 0.473 . . . . 0.0 111.196 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.06 6.88 9.75 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.565 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.438 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -52.7 -47.4 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 122.728 0.411 . . . . 0.0 111.682 -176.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 12.6 p -67.15 -38.69 81.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.306 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.92 -52.48 65.22 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.586 0.708 . . . . 0.0 110.308 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 25.8 t60 -61.03 -46.71 89.64 Favored 'General case' 0 C--O 1.201 -1.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.022 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tt -57.78 -39.47 77.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 24.7 mm-40 -76.82 -27.83 55.32 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.64 5.02 12.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.276 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.225 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -133.75 145.9 50.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.207 1.003 . . . . 0.0 109.931 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 38.4 ttm180 -141.95 137.06 30.99 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.74 123.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.268 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 t -61.21 140.37 57.94 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.61 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.86 -49.63 76.71 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.718 0.636 . . . . 0.0 110.541 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -78.82 -31.99 46.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.8 m -104.58 -36.62 7.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -171.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.57 -8.18 80.21 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.105 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -73.94 133.29 79.09 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 117.208 0.504 . . . . 0.0 111.654 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 43.6 Cg_endo -80.23 113.97 3.01 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.932 1.755 . . . . 0.0 110.071 171.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 154.12 30.9 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -74.87 146.01 42.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 123.402 0.439 . . . . 0.0 109.863 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' ILE . 4.3 mm? -65.04 -10.71 32.07 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.407 0.622 . . . . 0.0 111.842 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.24 -14.65 59.72 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.558 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.29 7.12 9.06 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.961 -0.462 . . . . 0.0 111.608 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 29' ' ' LEU . 8.0 tp -57.47 -48.56 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.96 -44.19 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.215 0.461 . . . . 0.0 111.186 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.38 -55.91 28.78 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.997 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -59.38 -50.22 74.79 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.829 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.22 -29.69 69.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.6 0.238 . . . . 0.0 111.49 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.39 -25.51 22.65 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.18 -10.65 21.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 O-C-N 121.822 -0.549 . . . . 0.0 111.459 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.316 0.3 OUTLIER . . . . . 0 N--CA 1.418 -2.028 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -169.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 . . . . . 0 N--CA 1.431 -1.388 0 CA-C-O 120.924 0.393 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -108.43 115.35 29.94 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.659 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -107.89 130.85 54.98 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.455 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 26.8 m -79.8 123.07 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.51 173.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.1 t -58.57 133.74 56.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.499 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -49.49 -56.55 9.42 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.932 1.395 . . . . 0.0 111.887 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.08 -38.21 18.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 119.189 -1.004 . . . . 0.0 113.508 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.03 -27.92 43.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.34 25.99 74.84 Favored Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.378 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 30.8 mmtm -103.29 128.31 27.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 123.474 0.709 . . . . 0.0 110.436 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -82.24 114.9 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.124 1.882 . . . . 0.0 110.906 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 157.35 36.77 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 140.81 45.26 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 32' ' ' ILE . 90.1 mt -56.36 -24.2 42.58 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -75.41 -10.13 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.94 -0.475 . . . . 0.0 112.101 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.3 5.97 12.67 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 120.878 0.371 . . . . 0.0 111.055 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 29' ' ' LEU . 10.9 tt -67.83 -44.35 85.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.29 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.97 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.1 -51.89 66.08 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.048 0.452 . . . . 0.0 110.096 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -59.12 -56.21 25.13 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.927 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 39' ' ' HIS . 28.0 tp -63.69 -21.66 66.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.973 0.416 . . . . 0.0 111.815 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.38 -34.01 20.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.568 175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -104.2 -7.49 20.07 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 121.301 -0.874 . . . . 0.0 111.827 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.421 ' CE1' HD12 ' A' ' 36' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.412 -2.374 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -126.89 145.79 50.54 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.445 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 75.0 mtp180 -133.67 136.55 44.82 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 34.4 m -80.65 130.28 36.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.316 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 t -69.56 135.47 50.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.798 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.51 -45.17 85.27 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.622 0.576 . . . . 0.0 112.401 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.12 -47.23 16.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.846 0.355 . . . . 0.0 111.671 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.9 m -80.37 -36.75 33.57 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.99 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 5.24 90.11 Favored Glycine 0 N--CA 1.46 0.261 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.468 -176.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -101.24 130.79 24.15 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 51.7 Cg_endo -71.65 123.08 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.525 2.817 . . . . 0.0 112.698 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.95 149.39 30.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 150.93 33.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.6 mt -58.5 -28.76 65.7 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m -81.08 -7.21 59.51 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 121.676 0.75 . . . . 0.0 110.354 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.45 7.17 22.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.0 tp -52.77 -50.5 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.64 -47.5 76.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.062 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.76 -48.07 78.67 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.799 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.517 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 49.8 t60 -62.1 -55.94 23.89 Favored 'General case' 0 C--O 1.198 -1.648 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.086 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.8 pp -60.73 -27.8 68.2 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.841 -0.743 . . . . 0.0 112.863 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.06 -42.65 59.89 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.997 0.427 . . . . 0.0 111.057 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -98.66 -6.02 30.54 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.189 0.519 . . . . 0.0 111.115 -169.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.517 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.413 -2.304 0 C-N-CA 118.546 -1.262 . . . . 0.0 113.095 -172.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.545 ' HB2' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.028 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.43 143.27 47.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -150.32 129.58 12.83 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 27.3 m -73.94 142.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.821 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.2 t -67.92 137.34 55.14 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.379 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -57.46 -38.82 75.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.324 1.015 . . . . 0.0 111.382 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -104.5 -37.6 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.5 m -80.11 -22.52 42.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 119.764 -0.775 . . . . 0.0 112.326 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.18 -27.85 3.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.737 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -63.46 138.83 97.47 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 69.1 Cg_endo -78.33 128.45 8.89 Favored 'Trans proline' 0 C--O 1.249 1.04 0 C-N-CA 122.926 2.418 . . . . 0.0 111.63 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.98 164.06 26.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.271 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.25 147.04 26.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 16' ' ' GLN . 4.5 mm? -63.37 -18.45 63.69 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.006 0.431 . . . . 0.0 112.126 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.85 -1.85 44.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.32 6.65 5.32 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 16.6 tt -67.93 -36.74 76.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.24 -54.03 40.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.217 0 CA-C-O 120.739 0.304 . . . . 0.0 110.211 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.99 -49.51 71.28 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.078 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.22 -50.15 75.13 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.362 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.5 pp -66.43 -24.26 66.42 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.253 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -84.77 -26.25 27.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.915 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -91.6 -22.45 20.3 Favored 'General case' 0 CA--C 1.471 -2.067 0 C-N-CA 122.75 0.42 . . . . 0.0 110.394 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER . . . . . 0 N--CA 1.396 -3.142 0 C-N-CA 118.322 -1.351 . . . . 0.0 112.842 -172.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -136.13 136.48 40.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.075 -171.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -131.85 147.42 52.48 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 20.3 m -92.07 145.0 8.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.66 142.4 29.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -61.46 -65.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.14 0.427 . . . . 0.0 112.108 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.23 -37.75 84.08 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.8 m -86.5 -21.99 26.67 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.349 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.99 61.37 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 121.068 0.26 . . . . 0.0 112.591 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 32.1 mmtp -87.22 123.24 70.3 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-O 119.335 -0.364 . . . . 0.0 110.91 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -86.35 114.49 1.27 Allowed 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 121.827 1.685 . . . . 0.0 108.988 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -133.14 164.02 27.97 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -58.44 140.85 53.15 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.864 0.727 . . . . 0.0 111.224 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.472 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.4 pp -61.47 -14.62 30.26 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -85.59 -31.51 22.59 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.422 0.629 . . . . 0.0 109.863 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -14.29 50.95 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 29' ' ' LEU . 10.2 tp -62.14 -28.71 45.0 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.794 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.57 -53.51 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.352 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.31 -41.71 93.76 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.972 0.415 . . . . 0.0 110.161 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.27 -57.31 13.36 Favored 'General case' 0 C--O 1.205 -1.24 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -62.89 -29.1 70.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.087 0.47 . . . . 0.0 109.997 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.68 -36.49 65.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.549 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -111.25 4.83 19.47 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 121.462 -0.774 . . . . 0.0 110.546 -170.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.419 -2.015 0 C-N-CA 118.322 -1.351 . . . . 0.0 109.702 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.402 -2.827 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -136.03 146.52 47.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.359 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 45.6 ptt85 -145.58 159.35 43.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 33.7 m -79.35 145.51 9.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 120.134 -0.627 . . . . 0.0 112.049 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HB2' HD22 ' A' ' 27' ' ' LEU . 15.7 t -83.38 144.55 29.57 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.48 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.84 -64.23 0.89 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.59 1.156 . . . . 0.0 112.0 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -71.51 -51.92 21.09 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.8 m -75.7 -30.23 59.26 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.03 11.32 74.48 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -99.67 129.48 28.74 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 37.9 Cg_endo -68.02 115.74 3.96 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.859 2.373 . . . . 0.0 112.521 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 27' ' ' LEU . 2.6 pt? -111.37 154.99 23.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -78.45 148.94 33.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.16 -19.48 63.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 110.179 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -82.75 -2.12 53.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.95 6.5 10.86 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.058 0.543 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.01 -42.28 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.33 -61.0 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.077 0 O-C-N 123.238 0.337 . . . . 0.0 111.159 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.16 -47.68 84.9 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 123.325 0.65 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.443 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 44.2 t60 -59.06 -53.49 57.77 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.858 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.49 -28.7 68.77 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.082 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -77.2 -28.33 53.87 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 122.229 -0.294 . . . . 0.0 111.534 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -100.86 -30.66 11.55 Favored 'General case' 0 CA--C 1.49 -1.359 0 O-C-N 121.497 -0.752 . . . . 0.0 111.165 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.34 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.39 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -165.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.84 115.35 30.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -101.25 124.87 47.63 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.343 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.83 129.57 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -64.87 131.56 47.05 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.861 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -57.39 -37.21 72.32 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.148 0.979 . . . . 0.0 111.686 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.09 -47.69 10.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.33 0.586 . . . . 0.0 111.809 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.0 m -90.41 -21.15 22.08 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.07 33.9 87.23 Favored Glycine 0 N--CA 1.476 1.356 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -118.45 121.03 31.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -82.75 135.92 8.08 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 123.049 2.5 . . . . 0.0 113.697 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.481 HD11 ' HA ' ' A' ' 32' ' ' ILE . 1.7 pt? -146.79 169.28 19.42 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.752 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 137.07 43.27 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.86 0.362 . . . . 0.0 110.366 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -59.07 -14.63 10.42 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.922 0.889 . . . . 0.0 113.027 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -82.35 -9.19 59.56 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.105 0.479 . . . . 0.0 110.816 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 6.45 5.24 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.097 0.475 . . . . 0.0 110.704 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HA ' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -63.5 -35.63 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 -174.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.92 -46.96 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.313 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.95 -48.03 82.96 Favored 'General case' 0 C--O 1.273 2.329 0 CA-C-O 121.461 0.648 . . . . 0.0 110.061 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.5 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 28.6 t60 -54.97 -56.76 16.11 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.911 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.45 -35.48 72.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.831 0.348 . . . . 0.0 110.655 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -66.45 -37.97 86.33 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.162 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -117.41 4.73 12.5 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 118.72 -1.192 . . . . 0.0 113.202 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.303 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -169.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.506 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 121.85 0.833 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -139.89 137.22 34.68 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.844 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -128.92 144.71 51.26 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 23.1 m -85.91 136.92 21.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.136 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -67.98 120.41 14.19 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 28.0 mp0 -54.37 -45.08 72.71 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 123.843 0.715 . . . . 0.0 111.027 -175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -69.18 -38.58 78.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.157 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 60.8 m -98.62 -22.91 15.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.2 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.12 25.3 69.18 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -103.45 111.61 65.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.641 -173.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -72.87 121.35 7.27 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.79 1.66 . . . . 0.0 110.278 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 32' ' ' ILE . 3.3 pp -126.06 148.69 49.28 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.987 -176.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.23 149.96 49.73 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.59 0.556 . . . . 0.0 109.736 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 16' ' ' GLN . 1.9 pt? -52.62 -32.68 42.94 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.803 0.689 . . . . 0.0 111.682 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -77.4 -21.48 53.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.915 0.486 . . . . 0.0 111.118 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 3.22 40.59 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -58.3 -50.5 78.3 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.48 -41.04 90.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.8 -56.25 24.61 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.304 0.573 . . . . 0.0 109.512 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -60.66 -48.26 82.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.43 -27.12 68.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.883 0.373 . . . . 0.0 110.546 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.95 -34.37 22.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.234 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -103.15 4.65 37.17 Favored 'General case' 0 CA--C 1.478 -1.822 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.477 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.409 -2.48 0 C-N-CA 118.013 -1.475 . . . . 0.0 109.605 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 14.2 mm100 . . . . . 0 N--CA 1.425 -1.722 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -108.86 129.69 55.41 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.392 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -122.5 128.1 50.39 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.7 m -74.6 131.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.108 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.4 t -65.63 117.73 8.51 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.44 -19.75 62.32 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -52.3 4.97 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.736 0.303 . . . . 0.0 110.478 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.7 m -87.38 -16.65 34.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.24 38.97 95.74 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 47.1 mmtm -117.26 129.08 25.58 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 16.2 Cg_exo -68.31 114.94 3.62 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.705 2.27 . . . . 0.0 111.632 177.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -109.72 124.81 51.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 123.302 0.641 . . . . 0.0 110.61 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -72.33 146.85 46.84 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 16' ' ' GLN . 6.6 mp -50.28 -18.79 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -174.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -89.6 -37.22 14.82 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.988 1.267 . . . . 0.0 110.33 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.3 -12.57 43.16 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.75 -38.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.03 -48.19 89.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.074 0.234 . . . . 0.0 110.943 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.26 -56.78 16.8 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 31.5 t60 -54.83 -56.16 22.47 Favored 'General case' 0 C--O 1.204 -1.335 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.47 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.68 -28.02 69.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.081 0.467 . . . . 0.0 110.519 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -77.72 -36.96 50.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.5 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -108.44 0.13 20.87 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.497 -1.281 . . . . 0.0 111.454 -172.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.412 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.426 -1.664 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.164 -173.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.419 -1.981 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -131.41 154.54 48.54 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.183 -1.372 . . . . 0.0 108.604 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -145.71 137.75 25.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 33.1 m -86.31 154.75 3.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.61 -176.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.96 142.08 29.06 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.705 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.08 -46.88 72.95 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.188 0.305 . . . . 0.0 110.635 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.521 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 68.9 mttm -73.76 -52.13 14.19 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 16.5 m -86.29 -25.32 25.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -172.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.81 -33.19 3.32 Favored Glycine 0 N--CA 1.469 0.847 0 O-C-N 121.86 -0.525 . . . . 0.0 113.314 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 40.1 mmtm -52.34 135.88 41.42 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 123.93 0.892 . . . . 0.0 113.024 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 5.2 Cg_exo -73.81 123.49 8.52 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.568 2.178 . . . . 0.0 110.143 172.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 mt -104.01 156.45 17.85 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.44 139.69 58.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 1.1 tm? -44.53 -54.33 6.14 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 124.078 0.951 . . . . 0.0 113.439 -171.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -90.77 6.12 45.49 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.36 0.6 . . . . 0.0 111.929 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.46 -2.74 57.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.53 0.681 . . . . 0.0 109.757 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -33.57 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.6 -61.01 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 122.873 0.469 . . . . 0.0 110.36 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.155 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 47.6 t60 -57.89 -52.88 63.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.752 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.25 -35.17 74.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.17 -34.5 77.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -113.0 -1.95 14.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.391 -0.924 . . . . 0.0 113.023 -172.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.521 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 120.57 0.224 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.91 131.74 51.05 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.061 0.851 . . . . 0.0 109.849 -174.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -115.99 131.12 57.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.98 134.78 29.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.676 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.445 ' HB2' HD11 ' A' ' 27' ' ' LEU . 43.1 t -67.95 126.05 28.25 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.38 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.1 mp0 -59.03 -29.47 67.31 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.677 0.791 . . . . 0.0 110.762 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HD2' ' SG ' ' A' ' 23' ' ' CYS . 12.9 tmtt? -87.92 -52.54 5.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.151 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 22' ' ' LYS . 18.0 m -93.46 -14.51 26.62 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.66 99.8 Favored Glycine 0 N--CA 1.463 0.456 0 CA-C-O 121.432 0.462 . . . . 0.0 112.433 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -125.45 140.33 36.06 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.02 115.03 4.15 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.667 2.245 . . . . 0.0 112.128 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 20' ' ' CYS . 16.2 mt -99.81 120.7 40.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.05 150.45 45.55 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.441 ' O ' HG22 ' A' ' 32' ' ' ILE . 93.4 mt -56.43 -27.17 55.84 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.768 0.794 . . . . 0.0 110.874 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -71.43 -27.14 63.08 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.609 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.64 5.96 15.55 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.4 tp -60.58 -42.4 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.89 -47.0 71.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.82 -51.58 68.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.035 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -62.94 -54.05 44.6 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.028 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -62.36 -26.83 68.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.311 0.96 . . . . 0.0 112.764 -176.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -79.41 -36.37 39.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.072 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.5 -1.24 21.56 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.348 -169.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.416 -2.15 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.195 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -120.36 138.08 53.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -124.99 135.39 52.75 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -98.98 142.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.147 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -86.88 133.74 33.59 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -50.61 72.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -66.17 -47.87 72.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.008 0.432 . . . . 0.0 111.846 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 m -79.51 -32.91 42.44 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.676 -175.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 21.36 76.33 Favored Glycine 0 N--CA 1.461 0.345 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -95.79 123.24 56.47 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -83.81 121.56 2.89 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.467 2.111 . . . . 0.0 110.986 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.53 164.55 14.42 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.364 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 150.6 37.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -55.89 -25.61 43.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.071 0.548 . . . . 0.0 111.869 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -86.09 -33.65 20.87 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.837 0.855 . . . . 0.0 111.517 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.57 6.19 42.22 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.158 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 tp -55.1 -43.44 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.444 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.83 -39.13 84.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.26 -51.99 60.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 37.1 t60 -57.83 -53.17 61.21 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.419 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.41 -31.76 71.69 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.891 0.377 . . . . 0.0 110.812 -174.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -72.98 -41.09 64.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -110.18 5.46 21.92 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.151 -170.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.427 -1.586 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.367 -176.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 120.918 0.39 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 61.3 m-85 -120.66 148.26 44.16 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.999 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -147.12 138.48 24.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.06 131.61 34.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.867 0.841 . . . . 0.0 111.225 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -76.8 138.37 39.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.137 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.6 -49.65 74.29 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 124.271 1.028 . . . . 0.0 111.231 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 62.5 mttp -78.34 -11.28 59.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.6 m -128.07 -34.35 2.12 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.849 -1.14 . . . . 0.0 113.86 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.98 89.19 Favored Glycine 0 C--O 1.226 -0.358 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.27 124.85 82.33 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 123.962 0.905 . . . . 0.0 109.523 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.32 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.923 1.749 . . . . 0.0 109.111 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -109.96 157.55 19.16 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.026 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.58 142.28 29.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 124.1 0.875 . . . . 0.0 109.408 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HG22 ' A' ' 32' ' ' ILE . 82.3 mt -56.28 -34.07 66.09 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 m -77.74 6.18 7.95 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.835 0.826 . . . . 0.0 111.206 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.45 6.79 4.14 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.72 -0.613 . . . . 0.0 110.795 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 11.3 tt -62.07 -43.37 97.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -174.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.27 -41.39 92.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.106 0.479 . . . . 0.0 110.278 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.88 -56.72 18.62 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.835 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -58.07 -52.78 64.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.599 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -63.18 -21.67 66.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.608 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.48 -34.42 21.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.168 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -109.06 4.11 22.75 Favored 'General case' 0 CA--C 1.476 -1.885 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.246 -171.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.541 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.411 -2.412 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.639 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 N--CA 1.43 -1.435 0 CA-C-O 121.114 0.483 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.94 156.75 22.46 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.1 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -141.71 129.12 21.24 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.939 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.0 m -73.87 143.91 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.5 t -79.14 143.06 35.83 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.246 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -45.16 -55.57 5.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.755 1.622 . . . . 0.0 111.821 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.463 ' HB3' ' NZ ' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -100.94 -34.63 9.7 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.8 m -82.52 -20.14 37.28 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.131 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.42 -36.12 1.56 Allowed Glycine 0 N--CA 1.473 1.108 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.579 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -51.89 139.53 31.96 Favored Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 124.581 1.152 . . . . 0.0 112.462 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.3 125.9 4.69 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.941 2.428 . . . . 0.0 112.531 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.53 150.86 27.53 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.234 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.95 45.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.482 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.0 pt? -54.69 -30.11 54.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -82.26 -25.53 34.0 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.778 -0.576 . . . . 0.0 110.832 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.84 -9.71 39.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 29' ' ' LEU . 7.4 tp -61.82 -34.68 63.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.93 -52.41 59.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.45 -48.79 80.3 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -57.37 -52.79 63.93 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -25.86 68.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -72.71 -43.48 62.94 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.683 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -110.42 4.94 21.05 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.264 -0.898 . . . . 0.0 112.705 -170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.42 -1.972 0 C-N-CA 119.27 -0.972 . . . . 0.0 112.462 -176.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.425 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 15.9 mm100 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 121.051 0.453 . . . . 0.0 111.41 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -122.2 151.96 40.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 111.103 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.43 ' O ' HD23 ' A' ' 27' ' ' LEU . 16.2 ptt180 -135.53 154.32 51.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -92.35 136.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.737 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.2 t -66.19 132.61 48.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.623 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -51.03 -43.52 60.89 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.037 1.335 . . . . 0.0 110.631 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -82.55 -52.11 7.15 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.018 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.93 -22.23 18.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.58 8.62 86.12 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.037 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -87.06 128.3 56.23 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.88 114.93 4.16 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 122.356 2.037 . . . . 0.0 111.581 176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 27' ' ' LEU . 2.0 pt? -113.15 148.82 34.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.58 147.88 50.14 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 16' ' ' GLN . 85.6 mt -54.81 -32.95 60.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.069 0.461 . . . . 0.0 111.942 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -86.58 -12.04 49.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.562 0.745 . . . . 0.0 112.185 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.92 6.43 48.91 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 122.185 -0.322 . . . . 0.0 111.6 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.9 tp -51.92 -43.79 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.203 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.04 -47.86 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 123.084 0.24 . . . . 0.0 111.465 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.58 -54.71 35.67 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.148 0.579 . . . . 0.0 111.104 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -62.5 -45.84 91.18 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.628 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.31 -30.26 70.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -76.27 -27.04 56.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -94.68 -23.69 17.48 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.265 0.1 OUTLIER . . . . . 0 N--CA 1.393 -3.316 0 C-N-CA 117.633 -1.627 . . . . 0.0 110.473 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 11.8 mm100 . . . . . 0 N--CA 1.424 -1.731 0 CA-C-O 120.956 0.408 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.62 122.96 42.72 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -122.42 145.22 48.48 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.0 m -86.86 139.54 17.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.214 0.53 . . . . 0.0 110.484 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.1 t -80.66 145.26 31.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.39 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -47.17 -67.25 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 126.712 2.005 . . . . 0.0 112.998 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -90.39 -11.22 41.17 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.1 m -101.74 -32.06 10.48 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.976 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.76 73.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.73 -176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -87.55 133.91 37.12 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.34 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.31 138.3 15.74 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.982 1.788 . . . . 0.0 110.389 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.37 155.15 45.12 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -81.13 144.31 31.77 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -57.32 -24.91 58.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -69.23 -25.15 64.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 121.708 0.765 . . . . 0.0 110.503 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.46 7.05 37.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.75 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 tp -51.47 -46.28 35.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.84 -40.79 88.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.52 -54.27 34.9 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -57.23 -52.24 66.13 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.674 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.35 -32.53 70.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.149 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 -22.71 27.94 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -110.41 3.03 19.34 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.046 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.303 0.4 OUTLIER . . . . . 0 N--CA 1.411 -2.424 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.814 -175.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 . . . . . 0 N--CA 1.427 -1.592 0 CA-C-O 120.995 0.426 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 29.9 m-85 -117.52 121.26 40.52 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.154 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 17.1 ttp85 -116.17 134.31 55.07 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.72 137.07 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.179 0.514 . . . . 0.0 111.785 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.36 143.46 48.59 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.692 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.42 -42.92 87.03 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.137 0.575 . . . . 0.0 110.474 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -74.11 -52.86 11.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -86.75 -23.37 25.5 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 37.56 94.09 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -122.48 125.54 26.45 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.39 118.71 5.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.936 2.424 . . . . 0.0 111.113 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 18' ' ' ARG . 4.3 pp -113.48 152.34 30.28 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.593 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.32 131.97 46.79 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -51.18 -29.6 14.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -73.62 -30.22 62.84 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.985 0.514 . . . . 0.0 111.141 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.9 6.54 48.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -172.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.38 -44.64 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.97 -46.32 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.653 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -63.33 -48.95 75.89 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.427 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 15.6 t60 -58.94 -58.31 9.19 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.999 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.95 -22.43 66.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.017 0.437 . . . . 0.0 111.467 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.62 -51.7 12.25 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.422 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -109.3 5.38 23.58 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 117.831 -1.547 . . . . 0.0 113.375 -170.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.313 0.5 OUTLIER . . . . . 0 C--O 1.245 0.843 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 . . . . . 0 C--O 1.238 0.455 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.24 89.58 1.31 Allowed 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 121.473 1.448 . . . . 0.0 111.61 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -87.16 -42.57 12.9 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.971 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.89 -0.19 9.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.735 0.778 . . . . 0.0 108.982 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.3 127.02 32.27 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.649 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.6 tp -117.54 119.89 36.42 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.115 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 mm -85.78 100.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.56 130.98 44.73 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.157 -174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.15 128.53 93.89 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.08 122.74 7.84 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 120.581 0.854 . . . . 0.0 112.256 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.8 tp -105.07 89.92 3.29 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -104.8 51.63 0.76 Allowed 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 122.344 1.069 . . . . 0.0 109.005 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -121.33 98.94 46.24 Favored Pre-proline 0 CA--C 1.47 -2.134 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.26 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -63.86 127.23 19.04 Favored 'Trans proline' 0 N--CA 1.428 -2.372 0 N-CA-C 107.218 -1.878 . . . . 0.0 107.218 166.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.6 mt -97.54 130.13 46.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 16.7 mm100 -87.31 158.63 19.01 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 123.296 0.372 . . . . 0.0 111.346 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.95 150.2 50.34 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 123.705 0.628 . . . . 0.0 110.039 -174.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -151.54 147.68 27.1 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 169.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.01 140.12 17.21 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.376 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.537 ' HB2' HD11 ' A' ' 27' ' ' LEU . 43.4 t -68.2 124.95 24.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -35.59 69.99 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 -30.83 14.34 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.7 m -94.8 -30.52 14.18 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.917 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.44 3.13 81.82 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 114.496 0.559 . . . . 0.0 114.496 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 11.8 mptt -93.58 141.45 23.87 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 122.205 -0.585 . . . . 0.0 110.934 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.82 117.1 4.97 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.816 2.344 . . . . 0.0 110.96 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 20' ' ' CYS . 17.3 mt -105.59 125.77 51.37 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.215 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.08 152.76 23.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.493 ' O ' HG22 ' A' ' 32' ' ' ILE . 5.5 mp -56.56 -24.31 46.21 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -75.82 -28.18 58.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.782 -0.574 . . . . 0.0 110.678 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.6 -2.95 19.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 29' ' ' LEU . 7.1 tp -59.12 -42.22 85.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-O 120.423 0.154 . . . . 0.0 110.908 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.82 -51.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.22 -36.34 71.82 Favored 'General case' 0 C--O 1.26 1.608 0 CA-C-O 120.944 0.402 . . . . 0.0 111.1 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -64.17 -51.62 62.96 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.795 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.6 tt -58.58 -38.07 77.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.698 0.285 . . . . 0.0 110.339 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -68.64 -39.01 80.91 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -101.39 -6.54 23.91 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.059 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.67 154.17 39.8 Favored 'General case' 0 N--CA 1.417 -2.082 0 C-N-CA 118.516 -1.274 . . . . 0.0 111.659 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.1 m -106.82 143.86 34.29 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.57 113.57 17.82 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.36 18.4 12.05 Favored Glycine 0 C--N 1.301 -1.377 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.76 115.39 11.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.29 -2.011 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 . . . . . 0 C--O 1.205 -1.239 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.27 -10.06 15.01 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.253 1.969 . . . . 0.0 111.289 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -95.94 6.75 48.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.01 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.45 114.09 7.17 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -54.76 121.72 9.16 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.42 127.94 34.81 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.0 tt -138.12 131.08 40.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.719 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -78.74 113.41 16.79 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -92.17 152.6 42.74 Favored Pre-proline 0 C--N 1.296 -1.744 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.794 -174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.21 124.42 16.22 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.526 2.817 . . . . 0.0 113.104 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 11' ' ' LEU . 2.4 pt? -131.13 162.37 30.05 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.5 -11.95 50.27 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.039 0.447 . . . . 0.0 111.093 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -85.61 130.39 51.29 Favored Pre-proline 0 CA--C 1.479 -1.763 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.66 175.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -87.3 127.72 2.5 Favored 'Trans proline' 0 N--CA 1.408 -3.52 0 C-N-CA 121.369 1.38 . . . . 0.0 108.739 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.48 104.28 13.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 122.354 1.073 . . . . 0.0 110.106 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -100.66 164.77 11.72 Favored 'General case' 0 C--N 1.269 -2.907 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.021 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 48.7 m-85 -111.77 121.39 44.96 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.1 ptt85 -129.9 150.78 51.04 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -86.78 132.4 32.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.471 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.08 139.48 58.72 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.726 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -53.16 -49.5 66.5 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.16 0.984 . . . . 0.0 112.057 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -88.1 -51.78 5.6 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.439 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 m -79.28 -18.24 53.09 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.471 -172.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.08 66.43 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-O 121.347 0.415 . . . . 0.0 112.445 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -96.76 141.36 22.97 Favored Pre-proline 0 N--CA 1.429 -1.52 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.56 119.28 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.185 2.59 . . . . 0.0 110.39 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 3.1 mm? -115.76 130.66 56.93 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.939 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.18 133.8 34.59 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -48.98 -30.69 6.32 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -67.96 -22.0 65.05 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 122.158 -0.339 . . . . 0.0 111.578 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.35 -0.8 10.88 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.262 0.554 . . . . 0.0 111.017 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.464 HD13 ' HG ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -66.87 -33.27 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.057 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 46.4 t -63.06 -58.14 8.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.757 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.407 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 4.2 p30 -63.26 -32.84 74.36 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.284 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 39.3 t60 -56.26 -55.06 37.99 Favored 'General case' 0 C--O 1.199 -1.557 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 32' ' ' ILE . 91.8 mt -56.89 -37.12 70.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.633 0.254 . . . . 0.0 111.247 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 55.1 mt-10 -69.99 -32.56 70.82 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -117.6 5.26 12.38 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.565 -0.709 . . . . 0.0 111.478 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -77.69 163.23 26.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.969 -176.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 5.0 p -93.39 116.71 29.26 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.706 0.765 . . . . 0.0 112.43 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.23 142.05 39.74 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.15 3.74 65.17 Favored Glycine 0 C--N 1.302 -1.307 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.96 110.86 1.12 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.185 0.594 . . . . 0.0 110.501 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.414 -2.256 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.2 t30 . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.8 131.75 17.54 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 121.861 1.707 . . . . 0.0 112.151 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -84.33 -45.07 13.17 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.88 -164.38 1.04 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -76.92 138.66 39.85 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.979 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.66 114.58 10.95 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 tt -134.53 136.92 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.408 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.94 120.18 33.0 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.82 119.3 68.97 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.12 145.43 96.43 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.449 2.099 . . . . 0.0 110.553 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.73 90.41 5.81 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.641 0.734 . . . . 0.0 109.136 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -103.15 125.48 49.87 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.417 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -70.66 119.75 74.72 Favored Pre-proline 0 CA--C 1.471 -2.09 0 O-C-N 123.718 0.636 . . . . 0.0 112.061 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -65.68 126.83 16.74 Favored 'Trans proline' 0 N--CA 1.426 -2.466 0 C-N-CA 121.77 1.647 . . . . 0.0 108.794 170.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mm -95.43 126.13 47.99 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -88.62 148.68 23.94 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.338 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -115.34 138.09 51.34 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.049 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -115.81 132.65 56.58 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.14 120.62 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.886 172.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -66.38 118.98 10.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -51.67 -50.02 61.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 5.4 ptpp? -74.0 -33.08 63.68 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.617 -0.833 . . . . 0.0 113.205 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.3 m -89.12 -29.67 19.2 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.848 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.08 28.28 71.86 Favored Glycine 0 N--CA 1.463 0.494 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.18 129.18 24.42 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.844 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -85.01 115.17 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.577 2.185 . . . . 0.0 111.047 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -121.73 153.87 37.66 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.066 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.94 37.15 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.11 -15.68 35.84 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -72.73 -23.6 60.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.093 0.473 . . . . 0.0 111.196 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.06 6.88 9.75 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.565 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.438 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -52.7 -47.4 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 122.728 0.411 . . . . 0.0 111.682 -176.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 12.6 p -67.15 -38.69 81.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.306 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.92 -52.48 65.22 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.586 0.708 . . . . 0.0 110.308 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 25.8 t60 -61.03 -46.71 89.64 Favored 'General case' 0 C--O 1.201 -1.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.022 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tt -57.78 -39.47 77.55 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 24.7 mm-40 -76.82 -27.83 55.32 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.64 5.02 12.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.276 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -72.86 163.1 28.65 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -174.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.2 t -88.76 126.98 35.58 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.385 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.11 151.47 22.2 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.54 20.58 21.85 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.815 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.53 111.46 19.1 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.408 0.623 . . . . 0.0 110.291 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--N 1.3 -1.577 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.9 170.42 16.73 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.463 2.109 . . . . 0.0 112.746 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -103.7 -66.82 0.92 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.56 -48.67 0.05 OUTLIER 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -78.81 158.3 28.21 Favored 'General case' 0 C--O 1.259 1.587 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 168.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.91 148.29 38.35 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.0 mm -82.67 102.69 8.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.249 0.547 . . . . 0.0 109.681 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -98.29 111.97 24.13 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.128 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -113.76 130.59 23.65 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.51 124.56 16.58 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 122.826 2.351 . . . . 0.0 113.497 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 pp -103.97 147.24 27.59 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.073 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 66.62 -61.63 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.45 1.5 . . . . 0.0 111.436 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -92.09 122.16 65.49 Favored Pre-proline 0 CA--C 1.475 -1.937 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -88.01 126.58 2.07 Favored 'Trans proline' 0 N--CA 1.401 -3.945 0 CA-C-O 121.952 0.73 . . . . 0.0 111.07 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.3 mm -94.38 100.1 10.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.514 ' H ' ' CD ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -83.61 110.18 18.04 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 113.023 -1.899 . . . . 0.0 112.142 -169.392 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -133.75 145.9 50.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 124.207 1.003 . . . . 0.0 109.931 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 38.4 ttm180 -141.95 137.06 30.99 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.74 123.2 38.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.268 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 t -61.21 140.37 57.94 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.61 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.86 -49.63 76.71 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.718 0.636 . . . . 0.0 110.541 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -78.82 -31.99 46.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.602 ' HB3' ' OXT' ' A' ' 44' ' ' SER . 35.8 m -104.58 -36.62 7.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -171.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.57 -8.18 80.21 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.105 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.55 ' HG3' ' OXT' ' A' ' 44' ' ' SER . 30.9 mtmm -73.94 133.29 79.09 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 117.208 0.504 . . . . 0.0 111.654 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 43.6 Cg_endo -80.23 113.97 3.01 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 121.932 1.755 . . . . 0.0 110.071 171.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 154.12 30.9 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -74.87 146.01 42.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 123.402 0.439 . . . . 0.0 109.863 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' ILE . 4.3 mm? -65.04 -10.71 32.07 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.407 0.622 . . . . 0.0 111.842 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -77.24 -14.65 59.72 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.558 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.29 7.12 9.06 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.961 -0.462 . . . . 0.0 111.608 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 29' ' ' LEU . 8.0 tp -57.47 -48.56 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.96 -44.19 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.215 0.461 . . . . 0.0 111.186 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.38 -55.91 28.78 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.997 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -59.38 -50.22 74.79 Favored 'General case' 0 C--O 1.202 -1.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.829 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.22 -29.69 69.98 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.6 0.238 . . . . 0.0 111.49 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.39 -25.51 22.65 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.18 -10.65 21.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 O-C-N 121.822 -0.549 . . . . 0.0 111.459 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.316 0.3 OUTLIER -64.37 120.95 13.2 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -169.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.9 t -105.94 142.21 36.03 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.396 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.05 144.07 57.51 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.04 -33.16 6.03 Favored Glycine 0 C--N 1.297 -1.626 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.96 101.79 13.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.602 ' OXT' ' HB3' ' A' ' 23' ' ' CYS . 16.8 t . . . . . 0 N--CA 1.422 -1.864 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.492 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 50.2 t30 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 1' ' ' ASN . 53.2 Cg_endo -92.83 48.92 0.42 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 121.664 1.576 . . . . 0.0 112.237 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 74.74 -60.12 0.53 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.236 1.414 . . . . 0.0 111.886 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.61 -70.98 0.28 Allowed 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.09 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -99.04 158.65 15.52 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.426 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.88 121.36 19.87 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.3 tt -83.55 131.66 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 169.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -87.99 114.67 24.83 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.25 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 34.6 t70 -64.13 122.72 79.23 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.164 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 9' ' ' ASP . 23.7 Cg_exo -64.49 164.61 22.89 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.244 2.629 . . . . 0.0 113.955 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.5 tp -70.73 150.1 46.26 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.741 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.54 96.49 2.43 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.418 0.627 . . . . 0.0 110.204 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -113.57 124.73 30.7 Favored Pre-proline 0 C--N 1.277 -2.581 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.921 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -88.64 126.98 1.89 Allowed 'Trans proline' 0 N--CA 1.402 -3.867 0 C-N-CA 120.892 1.061 . . . . 0.0 110.22 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.5 mt -107.47 126.68 63.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -91.34 155.75 18.28 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.493 0.495 . . . . 0.0 110.73 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -108.43 115.35 29.94 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.659 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -107.89 130.85 54.98 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.455 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 26.8 m -79.8 123.07 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.51 173.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.1 t -58.57 133.74 56.11 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.499 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -49.49 -56.55 9.42 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.932 1.395 . . . . 0.0 111.887 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.08 -38.21 18.05 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 119.189 -1.004 . . . . 0.0 113.508 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.03 -27.92 43.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.34 25.99 74.84 Favored Glycine 0 C--O 1.217 -0.931 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.378 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 30.8 mmtm -103.29 128.31 27.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 123.474 0.709 . . . . 0.0 110.436 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -82.24 114.9 2.55 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.124 1.882 . . . . 0.0 110.906 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.24 157.35 36.77 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 140.81 45.26 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 32' ' ' ILE . 90.1 mt -56.36 -24.2 42.58 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 p -75.41 -10.13 59.18 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.94 -0.475 . . . . 0.0 112.101 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -117.3 5.97 12.67 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 120.878 0.371 . . . . 0.0 111.055 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 29' ' ' LEU . 10.9 tt -67.83 -44.35 85.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.29 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.97 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.1 -51.89 66.08 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.048 0.452 . . . . 0.0 110.096 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -59.12 -56.21 25.13 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.927 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 39' ' ' HIS . 28.0 tp -63.69 -21.66 66.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.973 0.416 . . . . 0.0 111.815 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.38 -34.01 20.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.568 175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -104.2 -7.49 20.07 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 121.301 -0.874 . . . . 0.0 111.827 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.421 ' CE1' HD12 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -62.53 133.43 54.94 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.9 t -81.91 111.18 17.87 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.666 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.15 131.75 47.35 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.04 -30.96 7.59 Favored Glycine 0 C--N 1.298 -1.557 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.48 98.94 11.21 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.301 -1.517 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.756 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.4 111.42 3.26 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.142 1.895 . . . . 0.0 108.863 173.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -111.42 155.58 22.94 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.978 0.418 . . . . 0.0 111.664 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.3 -177.49 3.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -75.96 107.55 8.23 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.439 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -96.03 114.56 26.28 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tt -93.82 125.6 46.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.457 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -79.62 116.06 19.6 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.527 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.21 141.92 86.65 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.12 123.49 11.06 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.071 2.514 . . . . 0.0 113.083 -175.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 86.7 mt -114.79 88.42 2.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 22.2 t70 162.79 134.59 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 126.109 1.764 . . . . 0.0 106.515 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -113.67 105.66 54.6 Favored Pre-proline 0 CA--C 1.466 -2.259 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.822 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -60.32 126.51 20.27 Favored 'Trans proline' 0 N--CA 1.426 -2.488 0 N-CA-C 107.315 -1.84 . . . . 0.0 107.315 167.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 pt -129.73 103.15 8.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-O 122.603 1.192 . . . . 0.0 108.81 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.543 ' H ' ' CD ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -87.39 109.16 19.36 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 113.719 -1.582 . . . . 0.0 108.107 -171.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -126.89 145.79 50.54 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.445 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 75.0 mtp180 -133.67 136.55 44.82 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 34.4 m -80.65 130.28 36.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.316 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 t -69.56 135.47 50.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.798 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.51 -45.17 85.27 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.622 0.576 . . . . 0.0 112.401 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.12 -47.23 16.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.846 0.355 . . . . 0.0 111.671 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.9 m -80.37 -36.75 33.57 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.99 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.45 5.24 90.11 Favored Glycine 0 N--CA 1.46 0.261 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.468 -176.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -101.24 130.79 24.15 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 51.7 Cg_endo -71.65 123.08 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.525 2.817 . . . . 0.0 112.698 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.95 149.39 30.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 150.93 33.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.6 mt -58.5 -28.76 65.7 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m -81.08 -7.21 59.51 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 121.676 0.75 . . . . 0.0 110.354 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.45 7.17 22.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.771 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.0 tp -52.77 -50.5 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.64 -47.5 76.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 120.955 0.407 . . . . 0.0 110.062 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.76 -48.07 78.67 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.799 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.517 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 49.8 t60 -62.1 -55.94 23.89 Favored 'General case' 0 C--O 1.198 -1.648 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.086 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.8 pp -60.73 -27.8 68.2 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 119.841 -0.743 . . . . 0.0 112.863 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.06 -42.65 59.89 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.997 0.427 . . . . 0.0 111.057 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -98.66 -6.02 30.54 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.189 0.519 . . . . 0.0 111.115 -169.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.517 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -74.61 158.98 32.74 Favored 'General case' 0 N--CA 1.413 -2.304 0 C-N-CA 118.546 -1.262 . . . . 0.0 113.095 -172.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.5 t -55.12 110.96 0.75 Allowed 'General case' 0 C--O 1.248 0.996 0 O-C-N 124.353 1.033 . . . . 0.0 111.754 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.76 158.02 25.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.351 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.45 13.48 35.41 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.29 113.6 9.5 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 123.299 0.64 . . . . 0.0 110.119 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 C--N 1.292 -1.903 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -62.71 -44.05 18.6 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.32 2.013 . . . . 0.0 112.553 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -97.51 164.99 12.21 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.58 5.6 6.19 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.639 0.733 . . . . 0.0 109.497 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -76.47 140.98 41.46 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.702 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -76.87 126.46 31.01 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 tt -66.71 131.65 32.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.987 0.422 . . . . 0.0 110.027 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -85.01 166.38 16.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.798 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -84.08 147.12 50.09 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.25 124.49 14.88 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.224 1.95 . . . . 0.0 111.039 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.4 tp -79.43 116.46 19.67 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -97.63 -164.04 1.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.598 -174.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -97.72 132.75 24.43 Favored Pre-proline 0 CA--C 1.475 -1.91 0 C-N-CA 124.147 0.979 . . . . 0.0 111.612 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -89.13 127.64 1.78 Allowed 'Trans proline' 0 N--CA 1.41 -3.395 0 C-N-CA 121.503 1.468 . . . . 0.0 108.564 169.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.6 mt -116.46 114.06 44.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-O 122.256 1.027 . . . . 0.0 109.448 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.545 ' HB2' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -89.98 111.04 21.99 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.872 -171.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.43 143.27 47.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.955 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -150.32 129.58 12.83 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 27.3 m -73.94 142.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.456 -0.498 . . . . 0.0 109.821 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.2 t -67.92 137.34 55.14 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.379 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -57.46 -38.82 75.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.324 1.015 . . . . 0.0 111.382 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -104.5 -37.6 7.11 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 39.5 m -80.11 -22.52 42.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 119.764 -0.775 . . . . 0.0 112.326 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.18 -27.85 3.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.737 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -63.46 138.83 97.47 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 69.1 Cg_endo -78.33 128.45 8.89 Favored 'Trans proline' 0 C--O 1.249 1.04 0 C-N-CA 122.926 2.418 . . . . 0.0 111.63 175.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.98 164.06 26.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.271 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -85.25 147.04 26.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 16' ' ' GLN . 4.5 mm? -63.37 -18.45 63.69 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.006 0.431 . . . . 0.0 112.126 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.85 -1.85 44.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.32 6.65 5.32 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 16.6 tt -67.93 -36.74 76.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.24 -54.03 40.61 Favored 'Isoleucine or valine' 0 C--O 1.252 1.217 0 CA-C-O 120.739 0.304 . . . . 0.0 110.211 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.99 -49.51 71.28 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.078 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -59.22 -50.15 75.13 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.362 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.5 pp -66.43 -24.26 66.42 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.253 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -84.77 -26.25 27.7 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.915 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -91.6 -22.45 20.3 Favored 'General case' 0 CA--C 1.471 -2.067 0 C-N-CA 122.75 0.42 . . . . 0.0 110.394 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER -75.92 164.54 26.09 Favored 'General case' 0 N--CA 1.396 -3.142 0 C-N-CA 118.322 -1.351 . . . . 0.0 112.842 -172.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.8 p -55.77 118.94 5.02 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 123.765 0.666 . . . . 0.0 112.123 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.2 113.5 27.13 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.902 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.43 -33.44 6.58 Favored Glycine 0 C--N 1.293 -1.832 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.3 163.4 16.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 C--N 1.296 -1.74 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.875 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 32.0 p30 . . . . . 0 C--O 1.221 -0.396 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -69.64 -41.73 4.16 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.902 1.735 . . . . 0.0 109.53 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -143.12 155.4 44.57 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.25 -39.1 78.67 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.88 108.17 7.3 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.505 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mp -74.15 115.39 13.59 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.9 mt -122.92 102.03 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 120.953 0.406 . . . . 0.0 110.915 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -98.2 126.86 43.86 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -79.15 118.1 70.58 Favored Pre-proline 0 C--N 1.3 -1.577 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.223 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.32 132.69 22.93 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.318 2.012 . . . . 0.0 111.072 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.2 tp -92.36 124.07 36.14 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.34 -41.12 96.52 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 123.334 0.396 . . . . 0.0 110.538 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -64.99 131.32 95.18 Favored Pre-proline 0 CA--C 1.489 -1.399 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -84.23 125.98 3.62 Favored 'Trans proline' 1 N--CA 1.398 -4.103 0 CA-C-O 122.096 0.79 . . . . 0.0 110.435 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.0 pt -125.15 144.2 36.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.451 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -122.93 107.92 12.38 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 -175.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -136.13 136.48 40.11 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.075 -171.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -131.85 147.42 52.48 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 20.3 m -92.07 145.0 8.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.66 142.4 29.08 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -61.46 -65.96 0.61 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 118.14 0.427 . . . . 0.0 112.108 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -67.23 -37.75 84.08 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.8 m -86.5 -21.99 26.67 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.349 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.99 61.37 Favored Glycine 0 N--CA 1.474 1.19 0 CA-C-O 121.068 0.26 . . . . 0.0 112.591 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 32.1 mmtp -87.22 123.24 70.3 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-O 119.335 -0.364 . . . . 0.0 110.91 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -86.35 114.49 1.27 Allowed 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 121.827 1.685 . . . . 0.0 108.988 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -133.14 164.02 27.97 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -58.44 140.85 53.15 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.864 0.727 . . . . 0.0 111.224 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.472 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.4 pp -61.47 -14.62 30.26 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -85.59 -31.51 22.59 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.422 0.629 . . . . 0.0 109.863 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 -14.29 50.95 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.451 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 29' ' ' LEU . 10.2 tp -62.14 -28.71 45.0 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.794 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.57 -53.51 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.352 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.31 -41.71 93.76 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.972 0.415 . . . . 0.0 110.161 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.27 -57.31 13.36 Favored 'General case' 0 C--O 1.205 -1.24 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -62.89 -29.1 70.51 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.087 0.47 . . . . 0.0 109.997 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.68 -36.49 65.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.549 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -111.25 4.83 19.47 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 121.462 -0.774 . . . . 0.0 110.546 -170.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.98 165.4 24.1 Favored 'General case' 0 N--CA 1.419 -2.015 0 C-N-CA 118.322 -1.351 . . . . 0.0 109.702 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 78.7 m -71.53 114.36 9.52 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.442 0.639 . . . . 0.0 111.719 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.97 126.95 52.8 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.666 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.94 -34.11 4.85 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.9 150.23 40.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--N 1.291 -1.973 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.22 103.98 0.69 Allowed 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.684 2.256 . . . . 0.0 113.305 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -116.42 129.18 56.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.69 -50.44 8.17 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -98.75 106.46 18.73 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -138.12 124.5 20.59 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.5 pt -76.13 132.0 33.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 123.333 0.396 . . . . 0.0 110.086 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -79.58 138.7 37.55 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.76 118.75 73.32 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.76 126.27 13.12 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.056 1.837 . . . . 0.0 110.624 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -130.75 158.76 39.23 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.756 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.59 -51.43 42.57 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 123.611 0.569 . . . . 0.0 111.353 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -138.28 128.06 14.94 Favored Pre-proline 0 CA--C 1.471 -2.094 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -87.55 126.14 2.18 Favored 'Trans proline' 1 N--CA 1.397 -4.153 0 CA-C-O 122.714 1.048 . . . . 0.0 111.848 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.7 mt -116.42 114.46 46.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -133.78 110.02 9.51 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.438 -170.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -136.03 146.52 47.21 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.359 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 26' ' ' PRO . 45.6 ptt85 -145.58 159.35 43.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 33.7 m -79.35 145.51 9.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 120.134 -0.627 . . . . 0.0 112.049 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HB2' HD22 ' A' ' 27' ' ' LEU . 15.7 t -83.38 144.55 29.57 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.48 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -52.84 -64.23 0.89 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.59 1.156 . . . . 0.0 112.0 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -71.51 -51.92 21.09 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.8 m -75.7 -30.23 59.26 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.03 11.32 74.48 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -99.67 129.48 28.74 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 37.9 Cg_endo -68.02 115.74 3.96 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.859 2.373 . . . . 0.0 112.521 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 27' ' ' LEU . 2.6 pt? -111.37 154.99 23.8 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -78.45 148.94 33.35 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.16 -19.48 63.2 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.461 0.648 . . . . 0.0 110.179 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -82.75 -2.12 53.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.95 6.5 10.86 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.058 0.543 . . . . 0.0 110.685 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.01 -42.28 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.33 -61.0 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.077 0 O-C-N 123.238 0.337 . . . . 0.0 111.159 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.16 -47.68 84.9 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 123.325 0.65 . . . . 0.0 111.388 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.443 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 44.2 t60 -59.06 -53.49 57.77 Favored 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.858 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.49 -28.7 68.77 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.082 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -77.2 -28.33 53.87 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 122.229 -0.294 . . . . 0.0 111.534 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -100.86 -30.66 11.55 Favored 'General case' 0 CA--C 1.49 -1.359 0 O-C-N 121.497 -0.752 . . . . 0.0 111.165 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.34 0.2 OUTLIER -45.78 122.18 3.57 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -165.261 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.8 t -65.72 122.29 16.94 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.49 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.36 152.44 42.06 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.72 18.81 59.29 Favored Glycine 0 C--N 1.298 -1.534 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.556 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.33 115.82 17.42 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--N 1.294 -1.834 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.549 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.55 88.63 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.254 1.969 . . . . 0.0 113.345 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -121.72 91.77 3.59 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.23 133.94 22.23 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.749 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -135.01 111.89 10.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.28 115.12 20.51 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -89.7 96.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.875 0.845 . . . . 0.0 111.195 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -98.59 112.83 24.75 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.187 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.75 119.73 77.74 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.87 124.0 12.47 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.77 1.647 . . . . 0.0 110.664 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.3 tp -84.01 108.96 17.27 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.15 -58.3 8.31 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 123.687 0.617 . . . . 0.0 111.61 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -129.01 100.01 21.27 Favored Pre-proline 0 CA--C 1.46 -2.513 0 CA-C-O 120.988 0.423 . . . . 0.0 110.74 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -64.45 126.47 16.98 Favored 'Trans proline' 0 N--CA 1.423 -2.634 0 N-CA-C 107.096 -1.925 . . . . 0.0 107.096 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.0 pt -120.23 95.39 3.57 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-O 122.347 1.07 . . . . 0.0 111.799 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.546 ' H ' HD22 ' A' ' 29' ' ' LEU . 25.7 mm-40 -99.39 152.33 20.08 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.395 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.84 115.35 30.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.83 0.824 . . . . 0.0 110.313 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -101.25 124.87 47.63 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.343 -174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.83 129.57 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -64.87 131.56 47.05 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.861 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -57.39 -37.21 72.32 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.148 0.979 . . . . 0.0 111.686 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -84.09 -47.69 10.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.33 0.586 . . . . 0.0 111.809 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.0 m -90.41 -21.15 22.08 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.07 33.9 87.23 Favored Glycine 0 N--CA 1.476 1.356 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -118.45 121.03 31.39 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -82.75 135.92 8.08 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 123.049 2.5 . . . . 0.0 113.697 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.481 HD11 ' HA ' ' A' ' 32' ' ' ILE . 1.7 pt? -146.79 169.28 19.42 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.752 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 137.07 43.27 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.86 0.362 . . . . 0.0 110.366 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.546 HD22 ' H ' ' A' ' 16' ' ' GLN . 1.2 pt? -59.07 -14.63 10.42 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.922 0.889 . . . . 0.0 113.027 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -82.35 -9.19 59.56 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.105 0.479 . . . . 0.0 110.816 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.48 6.45 5.24 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.097 0.475 . . . . 0.0 110.704 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HA ' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -63.5 -35.63 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 -174.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -64.92 -46.96 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.313 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.95 -48.03 82.96 Favored 'General case' 0 C--O 1.273 2.329 0 CA-C-O 121.461 0.648 . . . . 0.0 110.061 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.5 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 28.6 t60 -54.97 -56.76 16.11 Favored 'General case' 0 C--O 1.186 -2.243 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.911 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.45 -35.48 72.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.831 0.348 . . . . 0.0 110.655 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -66.45 -37.97 86.33 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.162 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -117.41 4.73 12.5 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 118.72 -1.192 . . . . 0.0 113.202 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.303 0.5 OUTLIER -54.5 115.88 2.36 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 -169.702 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.5 m -106.32 110.09 22.21 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.2 137.13 58.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.726 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.81 15.27 13.47 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.37 130.55 38.02 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.8 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 CA--C 1.5 -0.981 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -71.8 110.17 2.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.31 2.007 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -70.99 -56.39 6.28 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.384 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.9 -42.98 0.21 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -110.42 153.9 24.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.9 mt -78.49 114.76 17.68 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.9 mm -109.83 98.18 6.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -102.37 124.24 47.6 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -87.39 144.32 35.61 Favored Pre-proline 0 C--N 1.29 -1.979 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.39 132.28 43.95 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 122.948 2.432 . . . . 0.0 111.212 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.64 91.9 2.38 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.981 0.895 . . . . 0.0 109.195 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -115.24 -167.91 1.31 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -106.88 116.61 58.39 Favored Pre-proline 0 CA--C 1.481 -1.676 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -89.07 128.89 1.94 Allowed 'Trans proline' 0 N--CA 1.412 -3.284 0 C-N-CA 122.236 1.957 . . . . 0.0 109.07 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.405 HG22 ' CD1' ' A' ' 17' ' ' TYR . 45.4 mt -122.45 137.95 54.25 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.506 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -114.68 107.63 15.73 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 121.85 0.833 . . . . 0.0 109.502 -171.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' CD1' HG22 ' A' ' 15' ' ' ILE . 7.0 m-85 -139.89 137.22 34.68 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.844 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -128.92 144.71 51.26 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 23.1 m -85.91 136.92 21.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.136 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -67.98 120.41 14.19 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 28.0 mp0 -54.37 -45.08 72.71 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 123.843 0.715 . . . . 0.0 111.027 -175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -69.18 -38.58 78.77 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.157 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 60.8 m -98.62 -22.91 15.7 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.2 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.12 25.3 69.18 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -103.45 111.61 65.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.598 -0.801 . . . . 0.0 110.641 -173.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -72.87 121.35 7.27 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.79 1.66 . . . . 0.0 110.278 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 32' ' ' ILE . 3.3 pp -126.06 148.69 49.28 Favored 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.987 -176.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.23 149.96 49.73 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.59 0.556 . . . . 0.0 109.736 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 16' ' ' GLN . 1.9 pt? -52.62 -32.68 42.94 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.803 0.689 . . . . 0.0 111.682 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -77.4 -21.48 53.06 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.915 0.486 . . . . 0.0 111.118 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 3.22 40.59 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -58.3 -50.5 78.3 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.48 -41.04 90.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.8 -56.25 24.61 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.304 0.573 . . . . 0.0 109.512 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -60.66 -48.26 82.56 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.111 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.43 -27.12 68.88 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.883 0.373 . . . . 0.0 110.546 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -84.95 -34.37 22.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.234 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -103.15 4.65 37.17 Favored 'General case' 0 CA--C 1.478 -1.822 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.477 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.54 161.74 22.22 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 118.013 -1.475 . . . . 0.0 109.605 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 69.2 m -86.8 110.64 20.07 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.718 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.4 132.93 37.18 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.56 -33.38 5.9 Favored Glycine 0 C--N 1.31 -0.887 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.57 131.2 41.46 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.293 -1.863 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.131 -179.629 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.509 -0.599 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -86.21 87.51 0.83 Allowed 'Trans proline' 0 N--CA 1.444 -1.412 0 C-N-CA 122.167 1.911 . . . . 0.0 111.447 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -129.72 4.9 5.04 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.977 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.51 161.87 41.95 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -88.27 119.59 28.83 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.0 mt -67.14 135.29 53.32 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.6 pt -76.44 161.84 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.767 170.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.2 130.21 45.52 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 18.8 t70 -47.55 114.47 3.14 Favored Pre-proline 0 C--O 1.243 0.758 0 O-C-N 124.649 1.218 . . . . 0.0 110.931 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' ASP . 4.1 Cg_exo -76.32 131.0 12.41 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.182 1.922 . . . . 0.0 111.288 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.0 tp -136.4 89.07 2.43 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -170.51 170.15 7.02 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -132.91 97.86 16.5 Favored Pre-proline 0 CA--C 1.466 -2.288 0 CA-C-O 121.427 0.632 . . . . 0.0 110.243 170.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -70.01 127.17 14.02 Favored 'Trans proline' 0 N--CA 1.424 -2.612 0 N-CA-C 107.665 -1.706 . . . . 0.0 107.665 167.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -105.55 123.63 60.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 14.2 mm100 -74.05 144.29 45.11 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -108.86 129.69 55.41 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.392 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -122.5 128.1 50.39 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.7 m -74.6 131.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.108 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.4 t -65.63 117.73 8.51 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 173.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.44 -19.75 62.32 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -52.3 4.97 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 120.736 0.303 . . . . 0.0 110.478 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.7 m -87.38 -16.65 34.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.24 38.97 95.74 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 47.1 mmtm -117.26 129.08 25.58 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 16.2 Cg_exo -68.31 114.94 3.62 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.705 2.27 . . . . 0.0 111.632 177.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -109.72 124.81 51.87 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 123.302 0.641 . . . . 0.0 110.61 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -72.33 146.85 46.84 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 16' ' ' GLN . 6.6 mp -50.28 -18.79 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -174.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -89.6 -37.22 14.82 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 119.988 1.267 . . . . 0.0 110.33 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.3 -12.57 43.16 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.75 -38.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.03 -48.19 89.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.074 0.234 . . . . 0.0 110.943 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.26 -56.78 16.8 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 31.5 t60 -54.83 -56.16 22.47 Favored 'General case' 0 C--O 1.204 -1.335 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.47 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.68 -28.02 69.11 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.081 0.467 . . . . 0.0 110.519 -173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -77.72 -36.96 50.42 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.5 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -108.44 0.13 20.87 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 118.497 -1.281 . . . . 0.0 111.454 -172.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.412 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -67.87 165.46 17.55 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.164 -173.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.0 p -55.82 122.68 12.05 Favored 'General case' 0 C--O 1.258 1.543 0 O-C-N 124.127 0.892 . . . . 0.0 111.956 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 157.7 28.07 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.28 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.51 20.6 7.68 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -94.51 97.35 10.09 Favored 'General case' 0 N--CA 1.433 -1.288 0 O-C-N 122.619 -0.342 . . . . 0.0 110.501 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 59.7 m . . . . . 0 C--N 1.303 -1.454 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 175.787 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.72 -44.3 50.95 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.84 2.36 . . . . 0.0 110.753 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -111.55 109.67 19.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.05 147.23 50.51 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -82.82 152.95 25.43 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.671 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.94 129.53 41.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.654 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.4 mm -76.34 101.58 2.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.44 152.96 31.87 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.519 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -108.58 112.4 60.72 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 171.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -44.53 137.43 8.39 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 124.115 3.21 . . . . 0.0 115.316 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.4 tp -92.09 117.02 29.44 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.85 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t70 69.6 -51.26 0.62 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.593 1.557 . . . . 0.0 113.138 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -69.76 128.5 91.9 Favored Pre-proline 0 CA--C 1.471 -2.063 0 CA-C-O 120.997 0.427 . . . . 0.0 110.685 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -90.42 127.34 1.37 Allowed 'Trans proline' 0 N--CA 1.404 -3.769 0 N-CA-C 108.416 -1.417 . . . . 0.0 108.416 168.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.88 118.34 44.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -107.21 110.41 22.46 Favored 'General case' 0 C--N 1.261 -3.241 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -162.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -131.41 154.54 48.54 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.183 -1.372 . . . . 0.0 108.604 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -145.71 137.75 25.4 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 33.1 m -86.31 154.75 3.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.61 -176.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.96 142.08 29.06 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.705 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.08 -46.88 72.95 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.188 0.305 . . . . 0.0 110.635 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.521 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 68.9 mttm -73.76 -52.13 14.19 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 16.5 m -86.29 -25.32 25.55 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -172.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.81 -33.19 3.32 Favored Glycine 0 N--CA 1.469 0.847 0 O-C-N 121.86 -0.525 . . . . 0.0 113.314 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 40.1 mmtm -52.34 135.88 41.42 Favored Pre-proline 0 C--O 1.252 1.196 0 C-N-CA 123.93 0.892 . . . . 0.0 113.024 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 5.2 Cg_exo -73.81 123.49 8.52 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.568 2.178 . . . . 0.0 110.143 172.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 mt -104.01 156.45 17.85 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.44 139.69 58.79 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 1.1 tm? -44.53 -54.33 6.14 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 124.078 0.951 . . . . 0.0 113.439 -171.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -90.77 6.12 45.49 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.36 0.6 . . . . 0.0 111.929 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.46 -2.74 57.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.53 0.681 . . . . 0.0 109.757 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -33.57 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.6 -61.01 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 122.873 0.469 . . . . 0.0 110.36 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.264 1.825 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.155 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 47.6 t60 -57.89 -52.88 63.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.752 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.25 -35.17 74.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.17 -34.5 77.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -113.0 -1.95 14.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.391 -0.924 . . . . 0.0 113.023 -172.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.521 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -70.0 145.71 51.59 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 50.2 t -95.19 142.23 27.87 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.83 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.35 148.52 29.32 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.39 20.06 75.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.847 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 23' ' ' CYS . . . -107.09 141.56 38.13 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.294 -1.831 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.644 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.97 -64.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 121.784 1.656 . . . . 0.0 112.021 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -136.01 -8.94 2.06 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.281 0.563 . . . . 0.0 110.328 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.48 171.55 8.91 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -75.2 107.74 7.5 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.5 tp -109.7 116.23 31.32 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.874 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -121.83 97.82 5.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 171.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.12 114.81 3.05 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 124.209 0.943 . . . . 0.0 110.17 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -75.02 114.69 37.46 Favored Pre-proline 0 C--N 1.308 -1.226 0 O-C-N 124.521 1.138 . . . . 0.0 111.989 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -82.31 142.32 11.91 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 122.523 2.149 . . . . 0.0 109.275 172.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -78.5 103.92 8.76 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.71 144.18 57.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.164 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.67 128.25 92.99 Favored Pre-proline 0 CA--C 1.485 -1.528 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -86.3 125.66 2.61 Favored 'Trans proline' 0 N--CA 1.406 -3.66 0 CA-C-O 122.395 0.914 . . . . 0.0 111.829 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.57 135.24 60.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -108.83 146.71 33.22 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.57 0.224 . . . . 0.0 110.703 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.91 131.74 51.05 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.061 0.851 . . . . 0.0 109.849 -174.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -115.99 131.12 57.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.98 134.78 29.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.676 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.445 ' HB2' HD11 ' A' ' 27' ' ' LEU . 43.1 t -67.95 126.05 28.25 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.38 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 2.1 mp0 -59.03 -29.47 67.31 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.677 0.791 . . . . 0.0 110.762 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HD2' ' SG ' ' A' ' 23' ' ' CYS . 12.9 tmtt? -87.92 -52.54 5.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.151 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 22' ' ' LYS . 18.0 m -93.46 -14.51 26.62 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -171.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.66 99.8 Favored Glycine 0 N--CA 1.463 0.456 0 CA-C-O 121.432 0.462 . . . . 0.0 112.433 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -125.45 140.33 36.06 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.02 115.03 4.15 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.667 2.245 . . . . 0.0 112.128 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 20' ' ' CYS . 16.2 mt -99.81 120.7 40.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.05 150.45 45.55 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.441 ' O ' HG22 ' A' ' 32' ' ' ILE . 93.4 mt -56.43 -27.17 55.84 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.768 0.794 . . . . 0.0 110.874 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -71.43 -27.14 63.08 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.609 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.64 5.96 15.55 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 8.4 tp -60.58 -42.4 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 t -69.89 -47.0 71.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.82 -51.58 68.44 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.035 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -62.94 -54.05 44.6 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.028 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -62.36 -26.83 68.67 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.311 0.96 . . . . 0.0 112.764 -176.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -79.41 -36.37 39.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.072 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -107.5 -1.24 21.56 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.348 -169.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.72 154.07 39.79 Favored 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.195 -176.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 43' ' ' ALA . 40.9 t -62.5 110.63 1.74 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.648 0.593 . . . . 0.0 111.848 -177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.01 128.59 53.94 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.105 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.59 -28.24 11.94 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.201 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.497 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -117.58 134.33 54.99 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.297 -1.695 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.556 -177.869 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.14 -40.05 54.04 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.711 2.274 . . . . 0.0 112.485 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -152.91 128.17 9.84 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.37 -46.85 25.55 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -120.2 154.63 34.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 tp -82.55 118.65 23.42 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.6 tt -104.29 130.2 55.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 120.926 0.393 . . . . 0.0 110.036 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.17 153.18 34.39 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.377 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.07 144.45 67.54 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.14 124.17 14.68 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 121.773 1.648 . . . . 0.0 110.854 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.2 mt -113.02 113.97 26.22 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.062 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.72 -49.94 64.41 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.887 0.851 . . . . 0.0 109.149 174.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -81.17 141.74 50.41 Favored Pre-proline 0 CA--C 1.465 -2.294 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.528 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -82.16 125.93 4.79 Favored 'Trans proline' 0 N--CA 1.403 -3.803 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.2 mt -116.83 103.21 14.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.553 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' H ' HD22 ' A' ' 29' ' ' LEU . 12.6 mm100 -91.33 159.78 15.83 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.01 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -120.36 138.08 53.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -124.99 135.39 52.75 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -98.98 142.86 14.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.147 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -86.88 133.74 33.59 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -50.61 72.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 44' ' ' SER . 9.0 ptpp? -66.17 -47.87 72.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.008 0.432 . . . . 0.0 111.846 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.4 m -79.51 -32.91 42.44 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.676 -175.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 21.36 76.33 Favored Glycine 0 N--CA 1.461 0.345 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -95.79 123.24 56.47 Favored Pre-proline 0 N--CA 1.432 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -83.81 121.56 2.89 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.467 2.111 . . . . 0.0 110.986 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.53 164.55 14.42 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.364 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 150.6 37.41 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 16' ' ' GLN . 1.7 pt? -55.89 -25.61 43.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.071 0.548 . . . . 0.0 111.869 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.8 p -86.09 -33.65 20.87 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.837 0.855 . . . . 0.0 111.517 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.57 6.19 42.22 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.158 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 tp -55.1 -43.44 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.444 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -64.83 -39.13 84.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.26 -51.99 60.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 37.1 t60 -57.83 -53.17 61.21 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.419 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.41 -31.76 71.69 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.891 0.377 . . . . 0.0 110.812 -174.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -72.98 -41.09 64.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.531 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -110.18 5.46 21.92 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.151 -170.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -68.71 149.81 48.63 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.367 -176.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.3 m -76.95 110.86 11.92 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.073 0.463 . . . . 0.0 109.867 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.59 125.46 37.24 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.05 -16.87 57.89 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.03 98.82 6.52 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 5.3 p . . . . . 0 N--CA 1.426 -1.631 0 CA-C-O 118.478 -0.773 . . . . 0.0 110.473 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 2.3 m-20 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 1' ' ' ASN . 7.1 Cg_exo -74.74 58.43 4.7 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.933 2.422 . . . . 0.0 111.829 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.7 m120 72.92 174.32 0.29 Allowed 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 125.531 1.532 . . . . 0.0 109.271 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.88 113.3 20.41 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.166 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.02 117.34 21.54 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.2 pt? -119.07 124.66 47.45 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.998 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.1 pt -97.04 160.78 2.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.35 155.49 18.92 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -78.7 116.7 61.67 Favored Pre-proline 0 C--N 1.302 -1.482 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.177 -173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.76 126.02 8.55 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.093 1.862 . . . . 0.0 111.613 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.13 118.52 27.76 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.749 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -104.93 130.13 53.17 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -115.89 120.69 35.23 Favored Pre-proline 0 CA--C 1.482 -1.664 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -61.48 127.69 22.57 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.104 1.869 . . . . 0.0 107.797 164.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.2 mm -118.92 134.56 62.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -105.31 156.15 18.42 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.687 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 61.3 m-85 -120.66 148.26 44.16 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.999 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -147.12 138.48 24.02 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.06 131.61 34.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.867 0.841 . . . . 0.0 111.225 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.3 t -76.8 138.37 39.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.137 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.6 -49.65 74.29 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 124.271 1.028 . . . . 0.0 111.231 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HD2' ' CE1' ' A' ' 39' ' ' HIS . 62.5 mttp -78.34 -11.28 59.93 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.6 m -128.07 -34.35 2.12 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.849 -1.14 . . . . 0.0 113.86 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.98 89.19 Favored Glycine 0 C--O 1.226 -0.358 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.27 124.85 82.33 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 123.962 0.905 . . . . 0.0 109.523 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.32 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.923 1.749 . . . . 0.0 109.111 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -109.96 157.55 19.16 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.026 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.58 142.28 29.24 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 124.1 0.875 . . . . 0.0 109.408 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HG22 ' A' ' 32' ' ' ILE . 82.3 mt -56.28 -34.07 66.09 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 m -77.74 6.18 7.95 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 121.835 0.826 . . . . 0.0 111.206 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.45 6.79 4.14 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.72 -0.613 . . . . 0.0 110.795 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 11.3 tt -62.07 -43.37 97.63 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -174.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.27 -41.39 92.6 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 121.106 0.479 . . . . 0.0 110.278 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.88 -56.72 18.62 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.835 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -58.07 -52.78 64.12 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.599 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 32' ' ' ILE . 3.1 pp -63.18 -21.67 66.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.608 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.48 -34.42 21.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.168 175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -109.06 4.11 22.75 Favored 'General case' 0 CA--C 1.476 -1.885 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.246 -171.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.541 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -76.66 151.9 35.98 Favored 'General case' 0 N--CA 1.411 -2.412 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.639 -176.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.9 t -89.49 127.98 35.92 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.05 114.66 11.46 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.673 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.53 20.07 42.45 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.746 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.26 106.25 0.22 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.395 0.617 . . . . 0.0 112.032 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.3 m . . . . . 0 C--N 1.306 -1.31 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.34 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.7 -23.02 14.91 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 121.44 1.427 . . . . 0.0 114.853 -176.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -113.83 129.28 56.61 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.577 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.54 91.5 8.26 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -70.11 113.89 7.73 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.887 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.1 mt -103.46 145.18 30.39 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.4 pt -84.15 139.6 17.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 120.936 0.398 . . . . 0.0 111.569 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -90.39 117.88 29.45 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -111.08 127.3 27.1 Favored Pre-proline 0 C--N 1.288 -2.099 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.008 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.33 148.56 55.35 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.272 1.981 . . . . 0.0 111.658 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.3 mt -77.33 144.01 38.35 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.02 174.3 12.05 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -138.19 127.11 14.52 Favored Pre-proline 0 CA--C 1.467 -2.221 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -81.08 128.01 6.28 Favored 'Trans proline' 0 N--CA 1.403 -3.849 0 C-N-CA 120.857 1.038 . . . . 0.0 109.606 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.6 mm -73.89 95.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-O 122.689 1.233 . . . . 0.0 108.132 176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -91.0 164.31 14.02 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.828 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -112.94 156.75 22.46 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.1 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -141.71 129.12 21.24 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.939 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.0 m -73.87 143.91 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.5 t -79.14 143.06 35.83 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.246 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -45.16 -55.57 5.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.755 1.622 . . . . 0.0 111.821 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.463 ' HB3' ' NZ ' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -100.94 -34.63 9.7 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -176.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.8 m -82.52 -20.14 37.28 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.131 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.42 -36.12 1.56 Allowed Glycine 0 N--CA 1.473 1.108 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.579 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -51.89 139.53 31.96 Favored Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 124.581 1.152 . . . . 0.0 112.462 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.3 125.9 4.69 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.941 2.428 . . . . 0.0 112.531 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.53 150.86 27.53 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.234 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.95 45.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.482 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.0 pt? -54.69 -30.11 54.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -82.26 -25.53 34.0 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.778 -0.576 . . . . 0.0 110.832 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.84 -9.71 39.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 29' ' ' LEU . 7.4 tp -61.82 -34.68 63.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.93 -52.41 59.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.45 -48.79 80.3 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -57.37 -52.79 63.93 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -25.86 68.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -72.71 -43.48 62.94 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.683 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -110.42 4.94 21.05 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.264 -0.898 . . . . 0.0 112.705 -170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.97 115.91 7.23 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 119.27 -0.972 . . . . 0.0 112.462 -176.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.4 m -97.31 137.81 35.74 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.134 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.77 133.91 55.49 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.36 -21.91 21.08 Favored Glycine 0 C--N 1.297 -1.602 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -175.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.18 140.75 40.24 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.241 0.652 0 C-N-CA 124.007 0.923 . . . . 0.0 112.016 -174.342 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.505 -0.75 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -47.53 -32.52 15.88 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 124.102 3.202 . . . . 0.0 115.11 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -65.39 -30.47 71.28 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 122.427 -0.171 . . . . 0.0 111.299 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 69.72 145.83 0.06 Allowed 'General case' 0 C--O 1.246 0.883 0 C-N-CA 125.141 1.376 . . . . 0.0 112.404 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -78.92 110.19 13.9 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.6 tp -128.36 132.72 48.57 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.473 0.654 . . . . 0.0 111.676 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.7 tt -123.08 128.38 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.1 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 171.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.5 138.16 58.06 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -78.52 138.51 59.0 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.02 154.8 59.52 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 123.032 2.488 . . . . 0.0 112.051 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -89.73 88.38 7.36 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-O 122.301 1.048 . . . . 0.0 111.498 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -123.75 7.77 8.79 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 170.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -80.53 151.73 72.02 Favored Pre-proline 0 CA--C 1.464 -2.359 0 CA-C-N 112.14 -2.3 . . . . 0.0 109.594 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.75 126.17 2.93 Favored 'Trans proline' 0 N--CA 1.402 -3.901 0 N-CA-C 107.898 -1.616 . . . . 0.0 107.898 170.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.4 mm -131.16 146.78 33.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.425 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 15.9 mm100 -67.62 162.05 24.39 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.051 0.453 . . . . 0.0 111.41 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -122.2 151.96 40.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 111.103 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.43 ' O ' HD23 ' A' ' 27' ' ' LEU . 16.2 ptt180 -135.53 154.32 51.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -92.35 136.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.737 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.2 t -66.19 132.61 48.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.623 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -51.03 -43.52 60.89 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.037 1.335 . . . . 0.0 110.631 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 40' ' ' CYS . 58.8 tttp -82.55 -52.11 7.15 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.941 -1.027 . . . . 0.0 113.018 -174.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.93 -22.23 18.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.58 8.62 86.12 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.037 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -87.06 128.3 56.23 Favored Pre-proline 0 C--N 1.315 -0.899 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.88 114.93 4.16 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 122.356 2.037 . . . . 0.0 111.581 176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 27' ' ' LEU . 2.0 pt? -113.15 148.82 34.58 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.58 147.88 50.14 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 16' ' ' GLN . 85.6 mt -54.81 -32.95 60.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.069 0.461 . . . . 0.0 111.942 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -86.58 -12.04 49.79 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.562 0.745 . . . . 0.0 112.185 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.92 6.43 48.91 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 122.185 -0.322 . . . . 0.0 111.6 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HA ' HD12 ' A' ' 27' ' ' LEU . 5.9 tp -51.92 -43.79 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.203 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.04 -47.86 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 O-C-N 123.084 0.24 . . . . 0.0 111.465 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.58 -54.71 35.67 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.148 0.579 . . . . 0.0 111.104 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -62.5 -45.84 91.18 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.628 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.31 -30.26 70.63 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -76.27 -27.04 56.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -94.68 -23.69 17.48 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.265 0.1 OUTLIER -81.27 148.03 29.64 Favored 'General case' 0 N--CA 1.393 -3.316 0 C-N-CA 117.633 -1.627 . . . . 0.0 110.473 -177.431 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 13.0 p -86.55 130.99 34.29 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.004 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.43 141.87 33.66 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.72 -33.54 4.15 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.92 160.44 21.44 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.29 -2.021 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.692 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.504 -0.802 0 CA-C-O 120.343 0.116 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.25 3.73 7.37 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.77 2.313 . . . . 0.0 110.819 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -151.12 146.02 25.86 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.67 155.74 21.84 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 123.847 0.717 . . . . 0.0 110.787 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -70.8 136.12 48.58 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tt -69.8 114.63 8.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.5 mm -128.17 105.28 13.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.13 136.26 48.09 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -89.65 107.58 19.69 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.51 128.14 9.35 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.666 2.244 . . . . 0.0 113.291 -171.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 11' ' ' LEU . 3.9 pp -113.59 90.02 3.24 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 122.911 1.338 . . . . 0.0 111.606 176.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -106.13 -40.98 5.48 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -92.96 151.91 41.03 Favored Pre-proline 0 CA--C 1.465 -2.298 0 CA-C-N 113.005 -1.907 . . . . 0.0 107.459 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.37 127.27 7.31 Favored 'Trans proline' 0 N--CA 1.404 -3.788 0 N-CA-C 107.525 -1.76 . . . . 0.0 107.525 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.4 mm -93.9 114.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 11.8 mm100 -108.72 153.36 23.56 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.98 -176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.62 122.96 42.72 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -122.42 145.22 48.48 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.0 m -86.86 139.54 17.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.214 0.53 . . . . 0.0 110.484 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.1 t -80.66 145.26 31.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.39 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -47.17 -67.25 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 126.712 2.005 . . . . 0.0 112.998 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -90.39 -11.22 41.17 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.1 m -101.74 -32.06 10.48 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.976 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.76 73.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.73 -176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -87.55 133.91 37.12 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.34 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.31 138.3 15.74 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.982 1.788 . . . . 0.0 110.389 170.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.37 155.15 45.12 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' GLN . . . -81.13 144.31 31.77 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -57.32 -24.91 58.06 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -69.23 -25.15 64.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 121.708 0.765 . . . . 0.0 110.503 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.46 7.05 37.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.75 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 tp -51.47 -46.28 35.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.84 -40.79 88.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.52 -54.27 34.9 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -57.23 -52.24 66.13 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.674 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.35 -32.53 70.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.149 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 -22.71 27.94 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -110.41 3.03 19.34 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.046 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.303 0.4 OUTLIER -68.13 138.5 55.75 Favored 'General case' 0 N--CA 1.411 -2.424 0 C-N-CA 119.051 -1.06 . . . . 0.0 113.814 -175.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.0 m -106.31 152.43 23.56 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.035 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.82 112.96 19.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.26 18.78 15.94 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -174.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.01 101.23 1.75 Allowed 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.452 0.644 . . . . 0.0 109.513 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.419 -1.993 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -178.149 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 40.1 t30 . . . . . 0 C--O 1.236 0.382 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.94 135.31 23.08 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.164 1.91 . . . . 0.0 112.295 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -88.99 -34.6 16.78 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.91 95.66 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.747 1.619 . . . . 0.0 114.834 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.702 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -93.33 107.35 19.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.91 128.38 34.39 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 tt -86.89 116.73 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-O 122.197 0.999 . . . . 0.0 110.521 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -99.69 147.86 24.97 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.01 116.02 53.64 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.19 143.96 73.22 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.297 1.998 . . . . 0.0 110.962 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.1 tp -80.63 89.96 5.73 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.56 -39.92 64.33 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.496 -173.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -97.75 122.29 55.43 Favored Pre-proline 0 CA--C 1.465 -2.305 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 173.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.59 125.78 7.79 Favored 'Trans proline' 0 N--CA 1.401 -3.945 0 CA-C-O 122.391 0.913 . . . . 0.0 109.993 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.6 mt -99.59 105.58 17.71 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.251 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.468 ' H ' HD22 ' A' ' 29' ' ' LEU . 13.7 mm100 -92.78 155.28 17.76 Favored 'General case' 0 C--N 1.269 -2.893 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.165 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 29.9 m-85 -117.52 121.26 40.52 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.154 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 17.1 ttp85 -116.17 134.31 55.07 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.72 137.07 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.179 0.514 . . . . 0.0 111.785 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 t -72.36 143.46 48.59 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.692 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -66.42 -42.92 87.03 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.137 0.575 . . . . 0.0 110.474 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -74.11 -52.86 11.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -86.75 -23.37 25.5 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.03 37.56 94.09 Favored Glycine 0 N--CA 1.467 0.718 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -122.48 125.54 26.45 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.39 118.71 5.84 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.936 2.424 . . . . 0.0 111.113 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 18' ' ' ARG . 4.3 pp -113.48 152.34 30.28 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.593 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.32 131.97 46.79 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.468 HD22 ' H ' ' A' ' 16' ' ' GLN . 1.5 pt? -51.18 -29.6 14.38 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -73.62 -30.22 62.84 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.985 0.514 . . . . 0.0 111.141 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.9 6.54 48.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -172.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.38 -44.64 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.97 -46.32 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.653 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -63.33 -48.95 75.89 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.427 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 15.6 t60 -58.94 -58.31 9.19 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.999 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.95 -22.43 66.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.017 0.437 . . . . 0.0 111.467 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.62 -51.7 12.25 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.422 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -109.3 5.38 23.58 Favored 'General case' 0 CA--C 1.484 -1.571 0 C-N-CA 117.831 -1.547 . . . . 0.0 113.375 -170.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 35' ' ' HIS 0.313 0.5 OUTLIER -45.72 134.83 7.24 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -172.609 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.0 m -52.16 113.26 0.97 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.541 -1.663 . . . . 0.0 114.192 -171.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.67 140.17 29.72 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.12 20.68 58.69 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.463 -175.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.26 143.71 34.0 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.545 -0.327 . . . . 0.0 110.259 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.423 -1.779 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.774 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_